id	sid	tid	token	lemma	pos
dpc-4969	1	1	dermatology	dermatology	NOUN
dpc-4969	1	2	:	:	PUNCT
dpc-4969	1	3	practical	practical	ADJ
dpc-4969	1	4	and	and	CCONJ
dpc-4969	1	5	conceptual	conceptual	ADJ
dpc-4969	1	6	original	original	ADJ
dpc-4969	1	7	article	article	NOUN
dpc-4969	1	8	|	|	ADV
dpc-4969	1	9	dermatol	dermatol	ADJ
dpc-4969	1	10	pract	pract	NOUN
dpc-4969	1	11	concept	concept	NOUN
dpc-4969	1	12	.	.	PUNCT
dpc-4969	2	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	2	2	1	1	NUM
dpc-4969	2	3	evaluation	evaluation	NOUN
dpc-4969	2	4	of	of	ADP
dpc-4969	2	5	the	the	DET
dpc-4969	2	6	effects	effect	NOUN
dpc-4969	2	7	of	of	ADP
dpc-4969	2	8	systemic	systemic	ADJ
dpc-4969	2	9	therapy	therapy	NOUN
dpc-4969	2	10	on	on	ADP
dpc-4969	2	11	inflammatory	inflammatory	ADJ
dpc-4969	2	12	markers	marker	NOUN
dpc-4969	2	13	and	and	CCONJ
dpc-4969	2	14	disease	disease	NOUN
dpc-4969	2	15	severity	severity	NOUN
dpc-4969	2	16	in	in	ADP
dpc-4969	2	17	patients	patient	NOUN
dpc-4969	2	18	with	with	ADP
dpc-4969	2	19	pemphigus	pemphigus	PROPN
dpc-4969	2	20	mehmet	mehmet	PROPN
dpc-4969	2	21	enes	enes	PROPN
dpc-4969	2	22	güner1	güner1	PROPN
dpc-4969	2	23	,	,	PUNCT
dpc-4969	2	24	perihan	perihan	ADJ
dpc-4969	2	25	öztürk1	öztürk1	NOUN
dpc-4969	2	26	,	,	PUNCT
dpc-4969	2	27	mine	mine	NOUN
dpc-4969	2	28	müjde	müjde	NOUN
dpc-4969	2	29	kuş1	kuş1	PROPN
dpc-4969	2	30	1	1	NUM
dpc-4969	2	31	sutcu	sutcu	PROPN
dpc-4969	2	32	imam	imam	PROPN
dpc-4969	2	33	university	university	PROPN
dpc-4969	2	34	hospital	hospital	NOUN
dpc-4969	2	35	of	of	ADP
dpc-4969	2	36	health	health	NOUN
dpc-4969	2	37	,	,	PUNCT
dpc-4969	2	38	practice	practice	NOUN
dpc-4969	2	39	and	and	CCONJ
dpc-4969	2	40	research	research	NOUN
dpc-4969	2	41	,	,	PUNCT
dpc-4969	2	42	kahramanmaras	kahramanmaras	PROPN
dpc-4969	2	43	sutcu	sutcu	PROPN
dpc-4969	2	44	imam	imam	PROPN
dpc-4969	2	45	university	university	PROPN
dpc-4969	2	46	,	,	PUNCT
dpc-4969	2	47	department	department	NOUN
dpc-4969	2	48	of	of	ADP
dpc-4969	2	49	dermatology	dermatology	NOUN
dpc-4969	2	50	,	,	PUNCT
dpc-4969	2	51	kahramanmaras	kahramanmaras	PROPN
dpc-4969	2	52	,	,	PUNCT
dpc-4969	2	53	turkey	turkey	NOUN
dpc-4969	2	54	key	key	ADJ
dpc-4969	2	55	words	word	NOUN
dpc-4969	2	56	:	:	PUNCT
dpc-4969	2	57	inflammatory	inflammatory	ADJ
dpc-4969	2	58	markers	marker	NOUN
dpc-4969	2	59	,	,	PUNCT
dpc-4969	2	60	ivig	ivig	NOUN
dpc-4969	2	61	,	,	PUNCT
dpc-4969	2	62	remission	remission	NOUN
dpc-4969	2	63	,	,	PUNCT
dpc-4969	2	64	pemphigus	pemphigus	NOUN
dpc-4969	2	65	citation	citation	NOUN
dpc-4969	2	66	:	:	PUNCT
dpc-4969	2	67	güner	güner	NOUN
dpc-4969	2	68	me	i	PRON
dpc-4969	2	69	,	,	PUNCT
dpc-4969	2	70	öztürk	öztürk	NOUN
dpc-4969	2	71	p	p	NOUN
dpc-4969	2	72	,	,	PUNCT
dpc-4969	2	73	kuş	kuş	PROPN
dpc-4969	2	74	mm	mm	PROPN
dpc-4969	2	75	.	.	PUNCT
dpc-4969	2	76	evaluation	evaluation	NOUN
dpc-4969	2	77	of	of	ADP
dpc-4969	2	78	the	the	DET
dpc-4969	2	79	effects	effect	NOUN
dpc-4969	2	80	of	of	ADP
dpc-4969	2	81	systemic	systemic	ADJ
dpc-4969	2	82	therapy	therapy	NOUN
dpc-4969	2	83	on	on	ADP
dpc-4969	2	84	inflammatory	inflammatory	ADJ
dpc-4969	2	85	markers	marker	NOUN
dpc-4969	2	86	and	and	CCONJ
dpc-4969	2	87	disease	disease	NOUN
dpc-4969	2	88	severity	severity	NOUN
dpc-4969	2	89	in	in	ADP
dpc-4969	2	90	patients	patient	NOUN
dpc-4969	2	91	with	with	ADP
dpc-4969	2	92	pemphigus	pemphigus	PROPN
dpc-4969	2	93	.	.	PUNCT
dpc-4969	3	1	dermatol	dermatol	NOUN
dpc-4969	3	2	pract	pract	PROPN
dpc-4969	3	3	concept	concept	NOUN
dpc-4969	3	4	.	.	PUNCT
dpc-4969	4	1	2025;15(1):4969	2025;15(1):4969	X
dpc-4969	4	2	.	.	PUNCT
dpc-4969	5	1	doi	doi	NOUN
dpc-4969	5	2	:	:	PUNCT
dpc-4969	5	3	https://doi.org/10.5826/dpc.1501a4969	https://doi.org/10.5826/dpc.1501a4969	ADP
dpc-4969	5	4	accepted	accept	VERB
dpc-4969	5	5	:	:	PUNCT
dpc-4969	5	6	november	november	PROPN
dpc-4969	5	7	11	11	NUM
dpc-4969	5	8	,	,	PUNCT
dpc-4969	5	9	2024	2024	NUM
dpc-4969	5	10	;	;	PUNCT
dpc-4969	5	11	published	publish	VERB
dpc-4969	5	12	:	:	PUNCT
dpc-4969	5	13	january	january	PROPN
dpc-4969	5	14	2025	2025	NUM
dpc-4969	5	15	copyright	copyright	NOUN
dpc-4969	5	16	:	:	PUNCT
dpc-4969	5	17	©	©	PROPN
dpc-4969	5	18	2024	2024	NUM
dpc-4969	5	19	güner	güner	NOUN
dpc-4969	5	20	et	et	PROPN
dpc-4969	5	21	al	al	PROPN
dpc-4969	5	22	.	.	PUNCT
dpc-4969	6	1	this	this	PRON
dpc-4969	6	2	is	be	AUX
dpc-4969	6	3	an	an	DET
dpc-4969	6	4	open	open	ADJ
dpc-4969	6	5	-	-	PUNCT
dpc-4969	6	6	access	access	NOUN
dpc-4969	6	7	article	article	NOUN
dpc-4969	6	8	distributed	distribute	VERB
dpc-4969	6	9	under	under	ADP
dpc-4969	6	10	the	the	DET
dpc-4969	6	11	terms	term	NOUN
dpc-4969	6	12	of	of	ADP
dpc-4969	6	13	the	the	DET
dpc-4969	6	14	creative	creative	ADJ
dpc-4969	6	15	commons	common	NOUN
dpc-4969	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4969	6	17	license	license	NOUN
dpc-4969	6	18	(	(	PUNCT
dpc-4969	6	19	by	by	ADP
dpc-4969	6	20	-	-	PUNCT
dpc-4969	6	21	nc-4.0	nc-4.0	NOUN
dpc-4969	6	22	)	)	PUNCT
dpc-4969	6	23	,	,	PUNCT
dpc-4969	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4969	6	25	,	,	PUNCT
dpc-4969	6	26	which	which	PRON
dpc-4969	6	27	permits	permit	VERB
dpc-4969	6	28	unrestricted	unrestricted	ADJ
dpc-4969	6	29	noncommercial	noncommercial	ADJ
dpc-4969	6	30	use	use	NOUN
dpc-4969	6	31	,	,	PUNCT
dpc-4969	6	32	distribution	distribution	NOUN
dpc-4969	6	33	,	,	PUNCT
dpc-4969	6	34	and	and	CCONJ
dpc-4969	6	35	reproduction	reproduction	NOUN
dpc-4969	6	36	in	in	ADP
dpc-4969	6	37	any	any	DET
dpc-4969	6	38	medium	medium	NOUN
dpc-4969	6	39	,	,	PUNCT
dpc-4969	6	40	provided	provide	VERB
dpc-4969	6	41	the	the	DET
dpc-4969	6	42	original	original	ADJ
dpc-4969	6	43	authors	author	NOUN
dpc-4969	6	44	and	and	CCONJ
dpc-4969	6	45	source	source	NOUN
dpc-4969	6	46	are	be	AUX
dpc-4969	6	47	credited	credit	VERB
dpc-4969	6	48	.	.	PUNCT
dpc-4969	7	1	funding	funding	NOUN
dpc-4969	7	2	:	:	PUNCT
dpc-4969	7	3	none	none	NOUN
dpc-4969	7	4	.	.	PUNCT
dpc-4969	8	1	competing	compete	VERB
dpc-4969	8	2	interests	interest	NOUN
dpc-4969	8	3	:	:	PUNCT
dpc-4969	8	4	none	none	NOUN
dpc-4969	8	5	.	.	PUNCT
dpc-4969	9	1	authorship	authorship	NOUN
dpc-4969	9	2	:	:	PUNCT
dpc-4969	9	3	all	all	DET
dpc-4969	9	4	authors	author	NOUN
dpc-4969	9	5	have	have	AUX
dpc-4969	9	6	contributed	contribute	VERB
dpc-4969	9	7	significantly	significantly	ADV
dpc-4969	9	8	to	to	ADP
dpc-4969	9	9	this	this	DET
dpc-4969	9	10	publication	publication	NOUN
dpc-4969	9	11	.	.	PUNCT
dpc-4969	10	1	corresponding	correspond	VERB
dpc-4969	10	2	author	author	NOUN
dpc-4969	10	3	:	:	PUNCT
dpc-4969	10	4	mehmet	mehmet	PROPN
dpc-4969	10	5	enes	enes	PROPN
dpc-4969	10	6	güner	güner	PROPN
dpc-4969	10	7	,	,	PUNCT
dpc-4969	10	8	md	md	PROPN
dpc-4969	10	9	,	,	PUNCT
dpc-4969	10	10	department	department	PROPN
dpc-4969	10	11	of	of	ADP
dpc-4969	10	12	dermatology	dermatology	NOUN
dpc-4969	10	13	,	,	PUNCT
dpc-4969	10	14	kahramanmaras	kahramanmaras	PROPN
dpc-4969	10	15	sutcu	sutcu	PROPN
dpc-4969	10	16	imam	imam	PROPN
dpc-4969	10	17	university	university	PROPN
dpc-4969	10	18	,	,	PUNCT
dpc-4969	10	19	kahramanmaras	kahramanmaras	PROPN
dpc-4969	10	20	,	,	PUNCT
dpc-4969	10	21	turkey	turkey	NOUN
dpc-4969	10	22	.	.	PUNCT
dpc-4969	11	1	e	e	X
dpc-4969	11	2	-	-	NOUN
dpc-4969	11	3	mail	mail	NOUN
dpc-4969	11	4	:	:	PUNCT
dpc-4969	11	5	mehmetenesguner171@hotmail.com	mehmetenesguner171@hotmail.com	X
dpc-4969	11	6	introduction	introduction	NOUN
dpc-4969	11	7	:	:	PUNCT
dpc-4969	11	8	in	in	ADP
dpc-4969	11	9	recent	recent	ADJ
dpc-4969	11	10	years	year	NOUN
dpc-4969	11	11	,	,	PUNCT
dpc-4969	11	12	various	various	ADJ
dpc-4969	11	13	inflammatory	inflammatory	ADJ
dpc-4969	11	14	markers	marker	NOUN
dpc-4969	11	15	that	that	PRON
dpc-4969	11	16	can	can	AUX
dpc-4969	11	17	change	change	VERB
dpc-4969	11	18	in	in	ADP
dpc-4969	11	19	inflammatory	inflammatory	ADJ
dpc-4969	11	20	states	state	NOUN
dpc-4969	11	21	have	have	AUX
dpc-4969	11	22	been	be	AUX
dpc-4969	11	23	investigated	investigate	VERB
dpc-4969	11	24	.	.	PUNCT
dpc-4969	12	1	on	on	ADP
dpc-4969	12	2	the	the	DET
dpc-4969	12	3	basis	basis	NOUN
dpc-4969	12	4	of	of	ADP
dpc-4969	12	5	these	these	PRON
dpc-4969	12	6	,	,	PUNCT
dpc-4969	12	7	we	we	PRON
dpc-4969	12	8	thought	think	VERB
dpc-4969	12	9	that	that	SCONJ
dpc-4969	12	10	inflammatory	inflammatory	ADJ
dpc-4969	12	11	markers	marker	NOUN
dpc-4969	12	12	could	could	AUX
dpc-4969	12	13	also	also	ADV
dpc-4969	12	14	be	be	AUX
dpc-4969	12	15	used	use	VERB
dpc-4969	12	16	in	in	ADP
dpc-4969	12	17	the	the	DET
dpc-4969	12	18	follow	follow	NOUN
dpc-4969	12	19	-	-	PUNCT
dpc-4969	12	20	up	up	NOUN
dpc-4969	12	21	of	of	ADP
dpc-4969	12	22	pemphigus	pemphigus	NOUN
dpc-4969	12	23	disease	disease	NOUN
dpc-4969	12	24	and	and	CCONJ
dpc-4969	12	25	monitoring	monitor	VERB
dpc-4969	12	26	its	its	PRON
dpc-4969	12	27	activity	activity	NOUN
dpc-4969	12	28	.	.	PUNCT
dpc-4969	13	1	objectives	objective	NOUN
dpc-4969	13	2	:	:	PUNCT
dpc-4969	13	3	in	in	ADP
dpc-4969	13	4	this	this	DET
dpc-4969	13	5	study	study	NOUN
dpc-4969	13	6	,	,	PUNCT
dpc-4969	13	7	our	our	PRON
dpc-4969	13	8	objective	objective	NOUN
dpc-4969	13	9	was	be	AUX
dpc-4969	13	10	to	to	PART
dpc-4969	13	11	investigate	investigate	VERB
dpc-4969	13	12	changes	change	NOUN
dpc-4969	13	13	in	in	ADP
dpc-4969	13	14	the	the	DET
dpc-4969	13	15	inflammatory	inflammatory	ADJ
dpc-4969	13	16	markers	marker	NOUN
dpc-4969	13	17	neutrophil	neutrophil	ADJ
dpc-4969	13	18	to	to	ADP
dpc-4969	13	19	lymphocyte	lymphocyte	ADJ
dpc-4969	13	20	ratio	ratio	NOUN
dpc-4969	13	21	(	(	PUNCT
dpc-4969	13	22	nlr	nlr	PROPN
dpc-4969	13	23	)	)	PUNCT
dpc-4969	13	24	,	,	PUNCT
dpc-4969	13	25	platelet	platelet	NOUN
dpc-4969	13	26	to	to	ADP
dpc-4969	13	27	lymphocyte	lymphocyte	ADJ
dpc-4969	13	28	ratio	ratio	NOUN
dpc-4969	13	29	(	(	PUNCT
dpc-4969	13	30	plr	plr	NOUN
dpc-4969	13	31	)	)	PUNCT
dpc-4969	13	32	,	,	PUNCT
dpc-4969	13	33	mean	mean	VERB
dpc-4969	13	34	platelet	platelet	NOUN
dpc-4969	13	35	volume	volume	NOUN
dpc-4969	13	36	(	(	PUNCT
dpc-4969	13	37	mpv	mpv	PROPN
dpc-4969	13	38	)	)	PUNCT
dpc-4969	13	39	,	,	PUNCT
dpc-4969	13	40	lymphocyte	lymphocyte	NOUN
dpc-4969	13	41	to	to	ADP
dpc-4969	13	42	monocyte	monocyte	NOUN
dpc-4969	13	43	ratio	ratio	NOUN
dpc-4969	13	44	(	(	PUNCT
dpc-4969	13	45	lmr	lmr	PROPN
dpc-4969	13	46	)	)	PUNCT
dpc-4969	13	47	,	,	PUNCT
dpc-4969	13	48	c	c	NOUN
dpc-4969	13	49	-	-	PUNCT
dpc-4969	13	50	reactive	reactive	ADJ
dpc-4969	13	51	protein	protein	NOUN
dpc-4969	13	52	(	(	PUNCT
dpc-4969	13	53	crp	crp	NOUN
dpc-4969	13	54	)	)	PUNCT
dpc-4969	13	55	erythrocyte	erythrocyte	PROPN
dpc-4969	13	56	sedimentation	sedimentation	NOUN
dpc-4969	13	57	rate	rate	NOUN
dpc-4969	13	58	(	(	PUNCT
dpc-4969	13	59	esr	esr	PROPN
dpc-4969	13	60	)	)	PUNCT
dpc-4969	13	61	,	,	PUNCT
dpc-4969	13	62	which	which	PRON
dpc-4969	13	63	are	be	AUX
dpc-4969	13	64	inflammatory	inflammatory	ADJ
dpc-4969	13	65	markers	marker	NOUN
dpc-4969	13	66	,	,	PUNCT
dpc-4969	13	67	before	before	ADP
dpc-4969	13	68	treatment	treatment	NOUN
dpc-4969	13	69	and	and	CCONJ
dpc-4969	13	70	during	during	ADP
dpc-4969	13	71	follow	follow	NOUN
dpc-4969	13	72	-	-	PUNCT
dpc-4969	13	73	up	up	NOUN
dpc-4969	13	74	,	,	PUNCT
dpc-4969	13	75	and	and	CCONJ
dpc-4969	13	76	the	the	DET
dpc-4969	13	77	correlation	correlation	NOUN
dpc-4969	13	78	of	of	ADP
dpc-4969	13	79	disease	disease	NOUN
dpc-4969	13	80	severity	severity	NOUN
dpc-4969	13	81	with	with	ADP
dpc-4969	13	82	these	these	DET
dpc-4969	13	83	markers	marker	NOUN
dpc-4969	13	84	in	in	ADP
dpc-4969	13	85	patients	patient	NOUN
dpc-4969	13	86	with	with	ADP
dpc-4969	13	87	pemphigus	pemphigus	NOUN
dpc-4969	13	88	receiving	receive	VERB
dpc-4969	13	89	intravenous	intravenous	ADJ
dpc-4969	13	90	immunoglobulin	immunoglobulin	NOUN
dpc-4969	13	91	(	(	PUNCT
dpc-4969	13	92	ivig	ivig	NOUN
dpc-4969	13	93	)	)	PUNCT
dpc-4969	13	94	and/or	and/or	CCONJ
dpc-4969	13	95	systemic	systemic	ADJ
dpc-4969	13	96	immunosuppressant	immunosuppressant	ADJ
dpc-4969	13	97	agents	agent	NOUN
dpc-4969	13	98	.	.	PUNCT
dpc-4969	14	1	methods	method	NOUN
dpc-4969	14	2	:	:	PUNCT
dpc-4969	14	3	seventy	seventy	NUM
dpc-4969	14	4	-	-	PUNCT
dpc-4969	14	5	six	six	NUM
dpc-4969	14	6	pemphigus	pemphigus	NOUN
dpc-4969	14	7	patients	patient	NOUN
dpc-4969	14	8	(	(	PUNCT
dpc-4969	14	9	69	69	NUM
dpc-4969	14	10	had	have	VERB
dpc-4969	14	11	pemphigus	pemphigus	NOUN
dpc-4969	14	12	vulgaris	vulgaris	NOUN
dpc-4969	14	13	,	,	PUNCT
dpc-4969	14	14	5	5	NUM
dpc-4969	14	15	had	have	VERB
dpc-4969	14	16	pemphigus	pemphigus	NOUN
dpc-4969	14	17	foliaceus	foliaceus	NOUN
dpc-4969	14	18	,	,	PUNCT
dpc-4969	14	19	2	2	NUM
dpc-4969	14	20	had	have	VERB
dpc-4969	14	21	paraneoplastic	paraneoplastic	ADJ
dpc-4969	14	22	pemphigus	pemphigus	NOUN
dpc-4969	14	23	)	)	PUNCT
dpc-4969	14	24	who	who	PRON
dpc-4969	14	25	received	receive	VERB
dpc-4969	14	26	ivig	ivig	NOUN
dpc-4969	14	27	and/or	and/or	CCONJ
dpc-4969	14	28	systemic	systemic	ADJ
dpc-4969	14	29	immunosuppressant	immunosuppressant	ADJ
dpc-4969	14	30	agents	agent	NOUN
dpc-4969	14	31	such	such	ADJ
dpc-4969	14	32	as	as	ADP
dpc-4969	14	33	corticosteroids	corticosteroid	NOUN
dpc-4969	14	34	and	and	CCONJ
dpc-4969	14	35	azathioprine	azathioprine	NOUN
dpc-4969	14	36	and	and	CCONJ
dpc-4969	14	37	used	use	VERB
dpc-4969	14	38	these	these	DET
dpc-4969	14	39	treatments	treatment	NOUN
dpc-4969	14	40	for	for	SCONJ
dpc-4969	14	41	at	at	ADV
dpc-4969	14	42	least	least	ADV
dpc-4969	14	43	6	6	NUM
dpc-4969	14	44	months	month	NOUN
dpc-4969	14	45	were	be	AUX
dpc-4969	14	46	included	include	VERB
dpc-4969	14	47	.	.	PUNCT
dpc-4969	15	1	changes	change	NOUN
dpc-4969	15	2	in	in	ADP
dpc-4969	15	3	nlr	nlr	PROPN
dpc-4969	15	4	,	,	PUNCT
dpc-4969	15	5	plr	plr	NOUN
dpc-4969	15	6	,	,	PUNCT
dpc-4969	15	7	lmr	lmr	PROPN
dpc-4969	15	8	,	,	PUNCT
dpc-4969	15	9	mpv	mpv	PROPN
dpc-4969	15	10	,	,	PUNCT
dpc-4969	15	11	crp	crp	PROPN
dpc-4969	15	12	and	and	CCONJ
dpc-4969	15	13	sedimentation	sedimentation	NOUN
dpc-4969	15	14	values	value	NOUN
dpc-4969	15	15	were	be	AUX
dpc-4969	15	16	examined	examine	VERB
dpc-4969	15	17	in	in	ADP
dpc-4969	15	18	patients	patient	NOUN
dpc-4969	15	19	who	who	PRON
dpc-4969	15	20	received	receive	VERB
dpc-4969	15	21	systemic	systemic	ADJ
dpc-4969	15	22	treatment	treatment	NOUN
dpc-4969	15	23	for	for	ADP
dpc-4969	15	24	at	at	ADV
dpc-4969	15	25	least	least	ADV
dpc-4969	15	26	6	6	NUM
dpc-4969	15	27	months	month	NOUN
dpc-4969	15	28	,	,	PUNCT
dpc-4969	15	29	before	before	ADP
dpc-4969	15	30	the	the	DET
dpc-4969	15	31	start	start	NOUN
dpc-4969	15	32	of	of	ADP
dpc-4969	15	33	treatment	treatment	NOUN
dpc-4969	15	34	and	and	CCONJ
dpc-4969	15	35	3	3	NUM
dpc-4969	15	36	and	and	CCONJ
dpc-4969	15	37	6	6	NUM
dpc-4969	15	38	months	month	NOUN
dpc-4969	15	39	after	after	ADP
dpc-4969	15	40	the	the	DET
dpc-4969	15	41	start	start	NOUN
dpc-4969	15	42	of	of	ADP
dpc-4969	15	43	treatment	treatment	NOUN
dpc-4969	15	44	.	.	PUNCT
dpc-4969	16	1	results	result	NOUN
dpc-4969	16	2	:	:	PUNCT
dpc-4969	16	3	significant	significant	ADJ
dpc-4969	16	4	changes	change	NOUN
dpc-4969	16	5	in	in	ADP
dpc-4969	16	6	inflammatory	inflammatory	ADJ
dpc-4969	16	7	markers	marker	NOUN
dpc-4969	16	8	and	and	CCONJ
dpc-4969	16	9	correlation	correlation	NOUN
dpc-4969	16	10	values	value	NOUN
dpc-4969	16	11	were	be	AUX
dpc-4969	16	12	found	find	VERB
dpc-4969	16	13	in	in	ADP
dpc-4969	16	14	all	all	DET
dpc-4969	16	15	patients	patient	NOUN
dpc-4969	16	16	.	.	PUNCT
dpc-4969	17	1	abstract	abstract	ADJ
dpc-4969	17	2	2	2	NUM
dpc-4969	17	3	original	original	ADJ
dpc-4969	17	4	article	article	NOUN
dpc-4969	17	5	|	|	ADV
dpc-4969	17	6	dermatol	dermatol	ADJ
dpc-4969	17	7	pract	pract	NOUN
dpc-4969	17	8	concept	concept	NOUN
dpc-4969	17	9	.	.	PUNCT
dpc-4969	18	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	18	2	introduction	introduction	NOUN
dpc-4969	18	3	pemphigus	pemphigus	NOUN
dpc-4969	18	4	is	be	AUX
dpc-4969	18	5	a	a	DET
dpc-4969	18	6	group	group	NOUN
dpc-4969	18	7	of	of	ADP
dpc-4969	18	8	chronic	chronic	ADJ
dpc-4969	18	9	autoimmune	autoimmune	ADJ
dpc-4969	18	10	diseases	disease	NOUN
dpc-4969	18	11	characterized	characterize	VERB
dpc-4969	18	12	by	by	ADP
dpc-4969	18	13	bullae	bullae	PROPN
dpc-4969	18	14	.	.	PUNCT
dpc-4969	19	1	the	the	DET
dpc-4969	19	2	pemphigus	pemphigus	PROPN
dpc-4969	19	3	group	group	NOUN
dpc-4969	19	4	can	can	AUX
dpc-4969	19	5	be	be	AUX
dpc-4969	19	6	divided	divide	VERB
dpc-4969	19	7	into	into	ADP
dpc-4969	19	8	four	four	NUM
dpc-4969	19	9	main	main	ADJ
dpc-4969	19	10	subtypes	subtype	NOUN
dpc-4969	19	11	:	:	PUNCT
dpc-4969	19	12	pemphigus	pemphigus	NOUN
dpc-4969	19	13	vulgaris	vulgaris	NOUN
dpc-4969	19	14	,	,	PUNCT
dpc-4969	19	15	pemphigus	pemphigus	NOUN
dpc-4969	19	16	foliaceous	foliaceous	ADJ
dpc-4969	19	17	,	,	PUNCT
dpc-4969	19	18	paraneoplastic	paraneoplastic	ADJ
dpc-4969	19	19	pemphigus	pemphigus	NOUN
dpc-4969	19	20	and	and	CCONJ
dpc-4969	19	21	iga	iga	PROPN
dpc-4969	19	22	pemphigus	pemphigus	PROPN
dpc-4969	19	23	.	.	PUNCT
dpc-4969	20	1	pemphigus	pemphigus	PROPN
dpc-4969	20	2	herpetiformis	herpetiformis	PROPN
dpc-4969	20	3	and	and	CCONJ
dpc-4969	20	4	drug	drug	NOUN
dpc-4969	20	5	-	-	PUNCT
dpc-4969	20	6	induced	induce	VERB
dpc-4969	20	7	pemphigus	pemphigus	NOUN
dpc-4969	20	8	are	be	AUX
dpc-4969	20	9	rarer	rare	ADJ
dpc-4969	20	10	forms	form	NOUN
dpc-4969	20	11	that	that	PRON
dpc-4969	20	12	show	show	VERB
dpc-4969	20	13	some	some	DET
dpc-4969	20	14	clinical	clinical	ADJ
dpc-4969	20	15	,	,	PUNCT
dpc-4969	20	16	histological	histological	ADJ
dpc-4969	20	17	and	and	CCONJ
dpc-4969	20	18	immunopathological	immunopathological	ADJ
dpc-4969	20	19	features	feature	NOUN
dpc-4969	20	20	that	that	PRON
dpc-4969	20	21	differ	differ	VERB
dpc-4969	20	22	from	from	ADP
dpc-4969	20	23	the	the	DET
dpc-4969	20	24	classical	classical	ADJ
dpc-4969	20	25	types	type	NOUN
dpc-4969	20	26	[	[	X
dpc-4969	20	27	1,2	1,2	NUM
dpc-4969	20	28	]	]	PUNCT
dpc-4969	20	29	.	.	PUNCT
dpc-4969	21	1	the	the	DET
dpc-4969	21	2	inflammatory	inflammatory	ADJ
dpc-4969	21	3	response	response	NOUN
dpc-4969	21	4	,	,	PUNCT
dpc-4969	21	5	also	also	ADV
dpc-4969	21	6	known	know	VERB
dpc-4969	21	7	as	as	ADP
dpc-4969	21	8	inflammation	inflammation	NOUN
dpc-4969	21	9	,	,	PUNCT
dpc-4969	21	10	is	be	AUX
dpc-4969	21	11	a	a	DET
dpc-4969	21	12	process	process	NOUN
dpc-4969	21	13	in	in	ADP
dpc-4969	21	14	which	which	PRON
dpc-4969	21	15	the	the	DET
dpc-4969	21	16	immune	immune	ADJ
dpc-4969	21	17	system	system	NOUN
dpc-4969	21	18	responds	respond	VERB
dpc-4969	21	19	to	to	ADP
dpc-4969	21	20	tissue	tissue	NOUN
dpc-4969	21	21	damage	damage	NOUN
dpc-4969	21	22	,	,	PUNCT
dpc-4969	21	23	infection	infection	NOUN
dpc-4969	21	24	,	,	PUNCT
dpc-4969	21	25	or	or	CCONJ
dpc-4969	21	26	other	other	ADJ
dpc-4969	21	27	types	type	NOUN
dpc-4969	21	28	of	of	ADP
dpc-4969	21	29	stress	stress	NOUN
dpc-4969	21	30	,	,	PUNCT
dpc-4969	21	31	and	and	CCONJ
dpc-4969	21	32	is	be	AUX
dpc-4969	21	33	a	a	DET
dpc-4969	21	34	dynamic	dynamic	ADJ
dpc-4969	21	35	process	process	NOUN
dpc-4969	21	36	involving	involve	VERB
dpc-4969	21	37	a	a	DET
dpc-4969	21	38	variety	variety	NOUN
dpc-4969	21	39	of	of	ADP
dpc-4969	21	40	different	different	ADJ
dpc-4969	21	41	cell	cell	NOUN
dpc-4969	21	42	types	type	NOUN
dpc-4969	21	43	,	,	PUNCT
dpc-4969	21	44	signaling	signal	VERB
dpc-4969	21	45	pathways	pathway	NOUN
dpc-4969	21	46	,	,	PUNCT
dpc-4969	21	47	and	and	CCONJ
dpc-4969	21	48	mediators	mediator	NOUN
dpc-4969	21	49	.	.	PUNCT
dpc-4969	22	1	its	its	PRON
dpc-4969	22	2	primary	primary	ADJ
dpc-4969	22	3	purpose	purpose	NOUN
dpc-4969	22	4	is	be	AUX
dpc-4969	22	5	to	to	PART
dpc-4969	22	6	remove	remove	VERB
dpc-4969	22	7	any	any	DET
dpc-4969	22	8	harmful	harmful	ADJ
dpc-4969	22	9	stimuli	stimulus	NOUN
dpc-4969	22	10	,	,	PUNCT
dpc-4969	22	11	such	such	ADJ
dpc-4969	22	12	as	as	ADP
dpc-4969	22	13	pathogens	pathogen	NOUN
dpc-4969	22	14	or	or	CCONJ
dpc-4969	22	15	damaged	damage	VERB
dpc-4969	22	16	tissue	tissue	NOUN
dpc-4969	22	17	and	and	CCONJ
dpc-4969	22	18	to	to	PART
dpc-4969	22	19	promote	promote	VERB
dpc-4969	22	20	healing	healing	NOUN
dpc-4969	22	21	and	and	CCONJ
dpc-4969	22	22	repair	repair	NOUN
dpc-4969	22	23	of	of	ADP
dpc-4969	22	24	the	the	DET
dpc-4969	22	25	affected	affected	ADJ
dpc-4969	22	26	area	area	NOUN
dpc-4969	22	27	[	[	X
dpc-4969	22	28	3	3	NUM
dpc-4969	22	29	]	]	PUNCT
dpc-4969	22	30	.	.	PUNCT
dpc-4969	23	1	in	in	ADP
dpc-4969	23	2	recent	recent	ADJ
dpc-4969	23	3	years	year	NOUN
dpc-4969	23	4	,	,	PUNCT
dpc-4969	23	5	various	various	ADJ
dpc-4969	23	6	inflammatory	inflammatory	ADJ
dpc-4969	23	7	markers	marker	NOUN
dpc-4969	23	8	that	that	PRON
dpc-4969	23	9	can	can	AUX
dpc-4969	23	10	change	change	VERB
dpc-4969	23	11	in	in	ADP
dpc-4969	23	12	inflammatory	inflammatory	ADJ
dpc-4969	23	13	states	state	NOUN
dpc-4969	23	14	have	have	AUX
dpc-4969	23	15	been	be	AUX
dpc-4969	23	16	investigated	investigate	VERB
dpc-4969	23	17	.	.	PUNCT
dpc-4969	24	1	neutrophils	neutrophil	NOUN
dpc-4969	24	2	constitute	constitute	VERB
dpc-4969	24	3	50%-70	50%-70	NUM
dpc-4969	24	4	%	%	NOUN
dpc-4969	24	5	of	of	ADP
dpc-4969	24	6	circulating	circulate	VERB
dpc-4969	24	7	leukocytes	leukocyte	NOUN
dpc-4969	24	8	and	and	CCONJ
dpc-4969	24	9	are	be	AUX
dpc-4969	24	10	the	the	DET
dpc-4969	24	11	most	most	ADV
dpc-4969	24	12	abundant	abundant	ADJ
dpc-4969	24	13	innate	innate	ADJ
dpc-4969	24	14	immune	immune	ADJ
dpc-4969	24	15	cell	cell	NOUN
dpc-4969	24	16	type	type	NOUN
dpc-4969	24	17	in	in	ADP
dpc-4969	24	18	circulation	circulation	NOUN
dpc-4969	24	19	.	.	PUNCT
dpc-4969	25	1	its	its	PRON
dpc-4969	25	2	amount	amount	NOUN
dpc-4969	25	3	can	can	AUX
dpc-4969	25	4	be	be	AUX
dpc-4969	25	5	measured	measure	VERB
dpc-4969	25	6	with	with	ADP
dpc-4969	25	7	simple	simple	ADJ
dpc-4969	25	8	blood	blood	NOUN
dpc-4969	25	9	count	count	NOUN
dpc-4969	25	10	examinations	examination	NOUN
dpc-4969	25	11	.	.	PUNCT
dpc-4969	26	1	during	during	ADP
dpc-4969	26	2	the	the	DET
dpc-4969	26	3	inflammatory	inflammatory	ADJ
dpc-4969	26	4	reaction	reaction	NOUN
dpc-4969	26	5	,	,	PUNCT
dpc-4969	26	6	neutrophils	neutrophil	NOUN
dpc-4969	26	7	are	be	AUX
dpc-4969	26	8	stimulated	stimulate	VERB
dpc-4969	26	9	and	and	CCONJ
dpc-4969	26	10	activated	activate	VERB
dpc-4969	26	11	by	by	ADP
dpc-4969	26	12	inflammatory	inflammatory	ADJ
dpc-4969	26	13	cytokines	cytokine	NOUN
dpc-4969	26	14	to	to	PART
dpc-4969	26	15	increase	increase	VERB
dpc-4969	26	16	their	their	PRON
dpc-4969	26	17	phagocytic	phagocytic	ADJ
dpc-4969	26	18	and	and	CCONJ
dpc-4969	26	19	bactericidal	bactericidal	ADJ
dpc-4969	26	20	effects	effect	NOUN
dpc-4969	26	21	.	.	PUNCT
dpc-4969	27	1	they	they	PRON
dpc-4969	27	2	also	also	ADV
dpc-4969	27	3	play	play	VERB
dpc-4969	27	4	an	an	DET
dpc-4969	27	5	important	important	ADJ
dpc-4969	27	6	role	role	NOUN
dpc-4969	27	7	in	in	ADP
dpc-4969	27	8	the	the	DET
dpc-4969	27	9	resolution	resolution	NOUN
dpc-4969	27	10	and	and	CCONJ
dpc-4969	27	11	healing	healing	NOUN
dpc-4969	27	12	of	of	ADP
dpc-4969	27	13	inflammation	inflammation	NOUN
dpc-4969	27	14	[	[	X
dpc-4969	27	15	4	4	NUM
dpc-4969	27	16	]	]	PUNCT
dpc-4969	27	17	.	.	PUNCT
dpc-4969	28	1	since	since	SCONJ
dpc-4969	28	2	neutrophils	neutrophil	NOUN
dpc-4969	28	3	have	have	AUX
dpc-4969	28	4	long	long	ADV
dpc-4969	28	5	been	be	AUX
dpc-4969	28	6	focused	focus	VERB
dpc-4969	28	7	only	only	ADV
dpc-4969	28	8	on	on	ADP
dpc-4969	28	9	their	their	PRON
dpc-4969	28	10	lethal	lethal	ADJ
dpc-4969	28	11	function	function	NOUN
dpc-4969	28	12	by	by	ADP
dpc-4969	28	13	researchers	researcher	NOUN
dpc-4969	28	14	,	,	PUNCT
dpc-4969	28	15	their	their	PRON
dpc-4969	28	16	importance	importance	NOUN
dpc-4969	28	17	in	in	ADP
dpc-4969	28	18	diseases	disease	NOUN
dpc-4969	28	19	has	have	AUX
dpc-4969	28	20	not	not	PART
dpc-4969	28	21	been	be	AUX
dpc-4969	28	22	adequately	adequately	ADV
dpc-4969	28	23	understood	understand	VERB
dpc-4969	28	24	.	.	PUNCT
dpc-4969	29	1	studies	study	NOUN
dpc-4969	29	2	conducted	conduct	VERB
dpc-4969	29	3	in	in	ADP
dpc-4969	29	4	recent	recent	ADJ
dpc-4969	29	5	years	year	NOUN
dpc-4969	29	6	shed	shed	VERB
dpc-4969	29	7	light	light	NOUN
dpc-4969	29	8	on	on	ADP
dpc-4969	29	9	the	the	DET
dpc-4969	29	10	role	role	NOUN
dpc-4969	29	11	of	of	ADP
dpc-4969	29	12	neutrophils	neutrophil	NOUN
dpc-4969	29	13	in	in	ADP
dpc-4969	29	14	inflammatory	inflammatory	ADJ
dpc-4969	29	15	diseases	disease	NOUN
dpc-4969	29	16	and	and	CCONJ
dpc-4969	29	17	malignancies	malignancy	NOUN
dpc-4969	29	18	.	.	PUNCT
dpc-4969	30	1	statistically	statistically	ADV
dpc-4969	30	2	significant	significant	ADJ
dpc-4969	30	3	elevation	elevation	NOUN
dpc-4969	30	4	of	of	ADP
dpc-4969	30	5	neutrophils	neutrophil	NOUN
dpc-4969	30	6	has	have	AUX
dpc-4969	30	7	been	be	AUX
dpc-4969	30	8	detected	detect	VERB
dpc-4969	30	9	in	in	ADP
dpc-4969	30	10	patients	patient	NOUN
dpc-4969	30	11	with	with	ADP
dpc-4969	30	12	breast	breast	NOUN
dpc-4969	30	13	cancer	cancer	NOUN
dpc-4969	30	14	and	and	CCONJ
dpc-4969	30	15	lung	lung	NOUN
dpc-4969	30	16	cancer	cancer	NOUN
dpc-4969	30	17	[	[	X
dpc-4969	30	18	4	4	NUM
dpc-4969	30	19	-	-	SYM
dpc-4969	30	20	6	6	NUM
dpc-4969	30	21	]	]	PUNCT
dpc-4969	30	22	.	.	PUNCT
dpc-4969	31	1	recently	recently	ADV
dpc-4969	31	2	,	,	PUNCT
dpc-4969	31	3	it	it	PRON
dpc-4969	31	4	has	have	AUX
dpc-4969	31	5	been	be	AUX
dpc-4969	31	6	understood	understand	VERB
dpc-4969	31	7	that	that	SCONJ
dpc-4969	31	8	platelets	platelet	NOUN
dpc-4969	31	9	play	play	VERB
dpc-4969	31	10	an	an	DET
dpc-4969	31	11	important	important	ADJ
dpc-4969	31	12	role	role	NOUN
dpc-4969	31	13	in	in	ADP
dpc-4969	31	14	immunological	immunological	ADJ
dpc-4969	31	15	and	and	CCONJ
dpc-4969	31	16	inflammatory	inflammatory	ADJ
dpc-4969	31	17	processes	process	NOUN
dpc-4969	31	18	[	[	X
dpc-4969	31	19	7	7	NUM
dpc-4969	31	20	-	-	SYM
dpc-4969	31	21	8	8	NUM
dpc-4969	31	22	]	]	PUNCT
dpc-4969	31	23	.	.	PUNCT
dpc-4969	32	1	since	since	SCONJ
dpc-4969	32	2	platelets	platelet	NOUN
dpc-4969	32	3	increase	increase	VERB
dpc-4969	32	4	in	in	ADP
dpc-4969	32	5	number	number	NOUN
dpc-4969	32	6	in	in	ADP
dpc-4969	32	7	systemic	systemic	ADJ
dpc-4969	32	8	inflammation	inflammation	NOUN
dpc-4969	32	9	,	,	PUNCT
dpc-4969	32	10	their	their	PRON
dpc-4969	32	11	role	role	NOUN
dpc-4969	32	12	has	have	AUX
dpc-4969	32	13	been	be	AUX
dpc-4969	32	14	investigated	investigate	VERB
dpc-4969	32	15	in	in	ADP
dpc-4969	32	16	various	various	ADJ
dpc-4969	32	17	malignancies	malignancy	NOUN
dpc-4969	32	18	and	and	CCONJ
dpc-4969	32	19	inflammatory	inflammatory	ADJ
dpc-4969	32	20	diseases	disease	NOUN
dpc-4969	32	21	such	such	ADJ
dpc-4969	32	22	as	as	ADP
dpc-4969	32	23	crohn	crohn	PROPN
dpc-4969	32	24	disease	disease	NOUN
dpc-4969	32	25	and	and	CCONJ
dpc-4969	32	26	vasculitis	vasculitis	NOUN
dpc-4969	32	27	,	,	PUNCT
dpc-4969	32	28	and	and	CCONJ
dpc-4969	32	29	platelet	platelet	NOUN
dpc-4969	32	30	elevation	elevation	NOUN
dpc-4969	32	31	has	have	AUX
dpc-4969	32	32	been	be	AUX
dpc-4969	32	33	found	find	VERB
dpc-4969	32	34	to	to	PART
dpc-4969	32	35	be	be	AUX
dpc-4969	32	36	associated	associate	VERB
dpc-4969	32	37	with	with	ADP
dpc-4969	32	38	disease	disease	NOUN
dpc-4969	32	39	severity	severity	NOUN
dpc-4969	32	40	and	and	CCONJ
dpc-4969	32	41	poor	poor	ADJ
dpc-4969	32	42	prognosis	prognosis	NOUN
dpc-4969	33	1	[	[	X
dpc-4969	33	2	9	9	NUM
dpc-4969	33	3	-	-	SYM
dpc-4969	33	4	13	13	NUM
dpc-4969	33	5	]	]	PUNCT
dpc-4969	33	6	.	.	PUNCT
dpc-4969	34	1	platelets	platelet	NOUN
dpc-4969	34	2	have	have	AUX
dpc-4969	34	3	also	also	ADV
dpc-4969	34	4	been	be	AUX
dpc-4969	34	5	studied	study	VERB
dpc-4969	34	6	in	in	ADP
dpc-4969	34	7	various	various	ADJ
dpc-4969	34	8	dermatological	dermatological	ADJ
dpc-4969	34	9	diseases	disease	NOUN
dpc-4969	34	10	.	.	PUNCT
dpc-4969	35	1	the	the	DET
dpc-4969	35	2	condition	condition	NOUN
dpc-4969	35	3	shown	show	VERB
dpc-4969	35	4	to	to	PART
dpc-4969	35	5	be	be	AUX
dpc-4969	35	6	most	most	ADV
dpc-4969	35	7	clearly	clearly	ADV
dpc-4969	35	8	related	relate	VERB
dpc-4969	35	9	to	to	ADP
dpc-4969	35	10	its	its	PRON
dpc-4969	35	11	pathogenesis	pathogenesis	NOUN
dpc-4969	35	12	is	be	AUX
dpc-4969	35	13	atopic	atopic	NOUN
dpc-4969	35	14	dermatitis	dermatitis	NOUN
dpc-4969	35	15	[	[	X
dpc-4969	35	16	7	7	NUM
dpc-4969	35	17	]	]	PUNCT
dpc-4969	35	18	.	.	PUNCT
dpc-4969	36	1	many	many	ADJ
dpc-4969	36	2	studies	study	NOUN
dpc-4969	36	3	have	have	AUX
dpc-4969	36	4	been	be	AUX
dpc-4969	36	5	conducted	conduct	VERB
dpc-4969	36	6	on	on	ADP
dpc-4969	36	7	inflammatory	inflammatory	ADJ
dpc-4969	36	8	diseases	disease	NOUN
dpc-4969	36	9	and	and	CCONJ
dpc-4969	36	10	lymphocyte	lymphocyte	NOUN
dpc-4969	36	11	-	-	PUNCT
dpc-4969	36	12	related	relate	VERB
dpc-4969	36	13	malignancies	malignancy	NOUN
dpc-4969	36	14	,	,	PUNCT
dpc-4969	36	15	which	which	PRON
dpc-4969	36	16	are	be	AUX
dpc-4969	36	17	important	important	ADJ
dpc-4969	36	18	components	component	NOUN
dpc-4969	36	19	of	of	ADP
dpc-4969	36	20	the	the	DET
dpc-4969	36	21	immune	immune	ADJ
dpc-4969	36	22	system	system	NOUN
dpc-4969	36	23	.	.	PUNCT
dpc-4969	37	1	it	it	PRON
dpc-4969	37	2	has	have	AUX
dpc-4969	37	3	been	be	AUX
dpc-4969	37	4	suggested	suggest	VERB
dpc-4969	37	5	that	that	SCONJ
dpc-4969	37	6	the	the	DET
dpc-4969	37	7	number	number	NOUN
dpc-4969	37	8	of	of	ADP
dpc-4969	37	9	lymphocytes	lymphocyte	NOUN
dpc-4969	37	10	in	in	ADP
dpc-4969	37	11	peripheral	peripheral	ADJ
dpc-4969	37	12	blood	blood	NOUN
dpc-4969	37	13	decreases	decrease	VERB
dpc-4969	37	14	with	with	ADP
dpc-4969	37	15	bexarotene	bexarotene	NOUN
dpc-4969	37	16	treatment	treatment	NOUN
dpc-4969	37	17	in	in	ADP
dpc-4969	37	18	mycosis	mycosis	NOUN
dpc-4969	37	19	fungoides	fungoide	NOUN
dpc-4969	37	20	and	and	CCONJ
dpc-4969	37	21	may	may	AUX
dpc-4969	37	22	be	be	AUX
dpc-4969	37	23	a	a	DET
dpc-4969	37	24	prognostic	prognostic	ADJ
dpc-4969	37	25	factor	factor	NOUN
dpc-4969	37	26	in	in	ADP
dpc-4969	37	27	the	the	DET
dpc-4969	37	28	follow	follow	NOUN
dpc-4969	37	29	-	-	PUNCT
dpc-4969	37	30	up	up	NOUN
dpc-4969	37	31	of	of	ADP
dpc-4969	37	32	mycosis	mycosis	NOUN
dpc-4969	37	33	fungoides	fungoide	NOUN
dpc-4969	37	34	[	[	X
dpc-4969	37	35	14	14	NUM
dpc-4969	37	36	]	]	PUNCT
dpc-4969	37	37	.	.	PUNCT
dpc-4969	38	1	the	the	DET
dpc-4969	38	2	role	role	NOUN
dpc-4969	38	3	of	of	ADP
dpc-4969	38	4	platelets	platelet	NOUN
dpc-4969	38	5	in	in	ADP
dpc-4969	38	6	various	various	ADJ
dpc-4969	38	7	inflammatory	inflammatory	ADJ
dpc-4969	38	8	disorders	disorder	NOUN
dpc-4969	38	9	is	be	AUX
dpc-4969	38	10	understood	understand	VERB
dpc-4969	38	11	,	,	PUNCT
dpc-4969	38	12	and	and	CCONJ
dpc-4969	38	13	the	the	DET
dpc-4969	38	14	activation	activation	NOUN
dpc-4969	38	15	and	and	CCONJ
dpc-4969	38	16	function	function	NOUN
dpc-4969	38	17	of	of	ADP
dpc-4969	38	18	platelets	platelet	NOUN
dpc-4969	38	19	can	can	AUX
dpc-4969	38	20	be	be	AUX
dpc-4969	38	21	seen	see	VERB
dpc-4969	38	22	with	with	ADP
dpc-4969	38	23	the	the	DET
dpc-4969	38	24	mean	mean	ADJ
dpc-4969	38	25	platelet	platelet	NOUN
dpc-4969	38	26	volume	volume	NOUN
dpc-4969	38	27	(	(	PUNCT
dpc-4969	38	28	mpv	mpv	PROPN
dpc-4969	38	29	)	)	PUNCT
dpc-4969	38	30	,	,	PUNCT
dpc-4969	38	31	one	one	NUM
dpc-4969	38	32	of	of	ADP
dpc-4969	38	33	the	the	DET
dpc-4969	38	34	parameters	parameter	NOUN
dpc-4969	38	35	included	include	VERB
dpc-4969	38	36	in	in	ADP
dpc-4969	38	37	the	the	DET
dpc-4969	38	38	whole	whole	ADJ
dpc-4969	38	39	blood	blood	NOUN
dpc-4969	38	40	analysis	analysis	NOUN
dpc-4969	38	41	.	.	PUNCT
dpc-4969	39	1	neutrophil	neutrophil	ADJ
dpc-4969	39	2	lymphocyte	lymphocyte	ADJ
dpc-4969	39	3	ratio	ratio	NOUN
dpc-4969	39	4	(	(	PUNCT
dpc-4969	39	5	nlr	nlr	PROPN
dpc-4969	39	6	)	)	PUNCT
dpc-4969	39	7	,	,	PUNCT
dpc-4969	39	8	lymphocyte	lymphocyte	ADJ
dpc-4969	39	9	-	-	PUNCT
dpc-4969	39	10	monocyte	monocyte	NOUN
dpc-4969	39	11	ratio	ratio	NOUN
dpc-4969	39	12	(	(	PUNCT
dpc-4969	39	13	lmr	lmr	PROPN
dpc-4969	39	14	)	)	PUNCT
dpc-4969	39	15	,	,	PUNCT
dpc-4969	39	16	platelet	platelet	ADJ
dpc-4969	39	17	-	-	PUNCT
dpc-4969	39	18	lymphocyte	lymphocyte	ADJ
dpc-4969	39	19	ratio	ratio	NOUN
dpc-4969	39	20	(	(	PUNCT
dpc-4969	39	21	plr	plr	NOUN
dpc-4969	39	22	)	)	PUNCT
dpc-4969	39	23	,	,	PUNCT
dpc-4969	39	24	c	c	NOUN
dpc-4969	39	25	reactive	reactive	ADJ
dpc-4969	39	26	protein	protein	NOUN
dpc-4969	39	27	(	(	PUNCT
dpc-4969	39	28	crp	crp	NOUN
dpc-4969	39	29	)	)	PUNCT
dpc-4969	39	30	and	and	CCONJ
dpc-4969	39	31	erythrocyte	erythrocyte	PROPN
dpc-4969	39	32	sedimentation	sedimentation	NOUN
dpc-4969	39	33	values	value	NOUN
dpc-4969	39	34	(	(	PUNCT
dpc-4969	39	35	esr	esr	NOUN
dpc-4969	39	36	)	)	PUNCT
dpc-4969	39	37	,	,	PUNCT
dpc-4969	39	38	which	which	PRON
dpc-4969	39	39	can	can	AUX
dpc-4969	39	40	be	be	AUX
dpc-4969	39	41	measured	measure	VERB
dpc-4969	39	42	by	by	ADP
dpc-4969	39	43	simple	simple	ADJ
dpc-4969	39	44	blood	blood	NOUN
dpc-4969	39	45	tests	test	NOUN
dpc-4969	39	46	,	,	PUNCT
dpc-4969	39	47	increase	increase	VERB
dpc-4969	39	48	in	in	ADP
dpc-4969	39	49	cases	case	NOUN
dpc-4969	39	50	of	of	ADP
dpc-4969	39	51	systemic	systemic	ADJ
dpc-4969	39	52	inflammation	inflammation	NOUN
dpc-4969	39	53	and	and	CCONJ
dpc-4969	39	54	can	can	AUX
dpc-4969	39	55	be	be	AUX
dpc-4969	39	56	easily	easily	ADV
dpc-4969	39	57	detected	detect	VERB
dpc-4969	39	58	.	.	PUNCT
dpc-4969	40	1	their	their	PRON
dpc-4969	40	2	place	place	NOUN
dpc-4969	40	3	in	in	ADP
dpc-4969	40	4	the	the	DET
dpc-4969	40	5	diagnosis	diagnosis	NOUN
dpc-4969	40	6	and	and	CCONJ
dpc-4969	40	7	prognosis	prognosis	NOUN
dpc-4969	40	8	of	of	ADP
dpc-4969	40	9	malignancies	malignancy	NOUN
dpc-4969	40	10	and	and	CCONJ
dpc-4969	40	11	inflammatory	inflammatory	ADJ
dpc-4969	40	12	diseases	disease	NOUN
dpc-4969	40	13	has	have	AUX
dpc-4969	40	14	been	be	AUX
dpc-4969	40	15	investigated	investigate	VERB
dpc-4969	40	16	.	.	PUNCT
dpc-4969	41	1	these	these	DET
dpc-4969	41	2	markers	marker	NOUN
dpc-4969	41	3	have	have	AUX
dpc-4969	41	4	been	be	AUX
dpc-4969	41	5	investigated	investigate	VERB
dpc-4969	41	6	in	in	ADP
dpc-4969	41	7	response	response	NOUN
dpc-4969	41	8	to	to	ADP
dpc-4969	41	9	psoriasis	psoriasis	NOUN
dpc-4969	41	10	treatment	treatment	NOUN
dpc-4969	41	11	and	and	CCONJ
dpc-4969	41	12	in	in	ADP
dpc-4969	41	13	correlation	correlation	NOUN
dpc-4969	41	14	with	with	ADP
dpc-4969	41	15	disease	disease	NOUN
dpc-4969	41	16	severity	severity	NOUN
dpc-4969	41	17	,	,	PUNCT
dpc-4969	41	18	and	and	CCONJ
dpc-4969	41	19	significant	significant	ADJ
dpc-4969	41	20	results	result	NOUN
dpc-4969	41	21	have	have	AUX
dpc-4969	41	22	been	be	AUX
dpc-4969	41	23	found	find	VERB
dpc-4969	41	24	.	.	PUNCT
dpc-4969	42	1	on	on	ADP
dpc-4969	42	2	the	the	DET
dpc-4969	42	3	basis	basis	NOUN
dpc-4969	42	4	of	of	ADP
dpc-4969	42	5	these	these	PRON
dpc-4969	42	6	,	,	PUNCT
dpc-4969	42	7	we	we	PRON
dpc-4969	42	8	thought	think	VERB
dpc-4969	42	9	that	that	SCONJ
dpc-4969	42	10	inflammatory	inflammatory	ADJ
dpc-4969	42	11	markers	marker	NOUN
dpc-4969	42	12	could	could	AUX
dpc-4969	42	13	also	also	ADV
dpc-4969	42	14	be	be	AUX
dpc-4969	42	15	used	use	VERB
dpc-4969	42	16	in	in	ADP
dpc-4969	42	17	the	the	DET
dpc-4969	42	18	follow	follow	NOUN
dpc-4969	42	19	-	-	PUNCT
dpc-4969	42	20	up	up	NOUN
dpc-4969	42	21	of	of	ADP
dpc-4969	42	22	pemphigus	pemphigus	NOUN
dpc-4969	42	23	disease	disease	NOUN
dpc-4969	42	24	and	and	CCONJ
dpc-4969	42	25	monitoring	monitor	VERB
dpc-4969	42	26	its	its	PRON
dpc-4969	42	27	activity	activity	NOUN
dpc-4969	42	28	.	.	PUNCT
dpc-4969	43	1	objectives	objective	NOUN
dpc-4969	43	2	in	in	ADP
dpc-4969	43	3	this	this	DET
dpc-4969	43	4	study	study	NOUN
dpc-4969	43	5	,	,	PUNCT
dpc-4969	43	6	our	our	PRON
dpc-4969	43	7	objective	objective	NOUN
dpc-4969	43	8	was	be	AUX
dpc-4969	43	9	to	to	PART
dpc-4969	43	10	investigate	investigate	VERB
dpc-4969	43	11	the	the	DET
dpc-4969	43	12	changes	change	NOUN
dpc-4969	43	13	in	in	ADP
dpc-4969	43	14	the	the	DET
dpc-4969	43	15	values	value	NOUN
dpc-4969	43	16	of	of	ADP
dpc-4969	43	17	the	the	DET
dpc-4969	43	18	inflammatory	inflammatory	ADJ
dpc-4969	43	19	markers	marker	NOUN
dpc-4969	43	20	nlr	nlr	PROPN
dpc-4969	43	21	,	,	PUNCT
dpc-4969	43	22	plr	plr	NOUN
dpc-4969	43	23	,	,	PUNCT
dpc-4969	43	24	mpv	mpv	PROPN
dpc-4969	43	25	,	,	PUNCT
dpc-4969	43	26	lmr	lmr	PROPN
dpc-4969	43	27	,	,	PUNCT
dpc-4969	43	28	crp	crp	PROPN
dpc-4969	43	29	and	and	CCONJ
dpc-4969	43	30	esr	esr	PROPN
dpc-4969	43	31	values	value	NOUN
dpc-4969	43	32	,	,	PUNCT
dpc-4969	43	33	which	which	PRON
dpc-4969	43	34	are	be	AUX
dpc-4969	43	35	inflammatory	inflammatory	ADJ
dpc-4969	43	36	markers	marker	NOUN
dpc-4969	43	37	,	,	PUNCT
dpc-4969	43	38	before	before	ADP
dpc-4969	43	39	treatment	treatment	NOUN
dpc-4969	43	40	and	and	CCONJ
dpc-4969	43	41	during	during	ADP
dpc-4969	43	42	follow	follow	NOUN
dpc-4969	43	43	-	-	PUNCT
dpc-4969	43	44	up	up	NOUN
dpc-4969	43	45	,	,	PUNCT
dpc-4969	43	46	and	and	CCONJ
dpc-4969	43	47	the	the	DET
dpc-4969	43	48	correlation	correlation	NOUN
dpc-4969	43	49	of	of	ADP
dpc-4969	43	50	disease	disease	NOUN
dpc-4969	43	51	severity	severity	NOUN
dpc-4969	43	52	with	with	ADP
dpc-4969	43	53	these	these	DET
dpc-4969	43	54	markers	marker	NOUN
dpc-4969	43	55	in	in	ADP
dpc-4969	43	56	pemphigus	pemphigus	NOUN
dpc-4969	43	57	patients	patient	NOUN
dpc-4969	43	58	who	who	PRON
dpc-4969	43	59	received	receive	VERB
dpc-4969	43	60	ivig	ivig	NOUN
dpc-4969	43	61	and/or	and/or	CCONJ
dpc-4969	43	62	systemic	systemic	ADJ
dpc-4969	43	63	immunosuppressant	immunosuppressant	ADJ
dpc-4969	43	64	agents	agent	NOUN
dpc-4969	43	65	such	such	ADJ
dpc-4969	43	66	as	as	ADP
dpc-4969	43	67	corticosteroids	corticosteroid	NOUN
dpc-4969	43	68	,	,	PUNCT
dpc-4969	43	69	azathioprine	azathioprine	NOUN
dpc-4969	43	70	and/or	and/or	CCONJ
dpc-4969	43	71	mycophenolate	mycophenolate	PROPN
dpc-4969	43	72	mofetil	mofetil	NOUN
dpc-4969	43	73	(	(	PUNCT
dpc-4969	43	74	figure	figure	NOUN
dpc-4969	43	75	1	1	NUM
dpc-4969	43	76	)	)	PUNCT
dpc-4969	43	77	.	.	PUNCT
dpc-4969	44	1	methods	method	VERB
dpc-4969	44	2	the	the	DET
dpc-4969	44	3	approval	approval	NOUN
dpc-4969	44	4	for	for	ADP
dpc-4969	44	5	the	the	DET
dpc-4969	44	6	study	study	NOUN
dpc-4969	44	7	was	be	AUX
dpc-4969	44	8	received	receive	VERB
dpc-4969	44	9	from	from	ADP
dpc-4969	44	10	clinical	clinical	ADJ
dpc-4969	44	11	research	research	NOUN
dpc-4969	44	12	ethics	ethic	NOUN
dpc-4969	44	13	committee	committee	PROPN
dpc-4969	44	14	of	of	ADP
dpc-4969	44	15	kahramanmaras	kahramanmaras	PROPN
dpc-4969	44	16	sutcu	sutcu	PROPN
dpc-4969	44	17	imam	imam	PROPN
dpc-4969	44	18	university	university	PROPN
dpc-4969	44	19	.	.	PUNCT
dpc-4969	45	1	(	(	PUNCT
dpc-4969	45	2	date	date	NOUN
dpc-4969	45	3	:	:	PUNCT
dpc-4969	45	4	11.01.2022	11.01.2022	PROPN
dpc-4969	45	5	session	session	NOUN
dpc-4969	45	6	:	:	PUNCT
dpc-4969	45	7	2022/02	2022/02	NUM
dpc-4969	45	8	decision	decision	NOUN
dpc-4969	45	9	no	no	INTJ
dpc-4969	45	10	:	:	PUNCT
dpc-4969	45	11	03	03	NUM
dpc-4969	45	12	)	)	PUNCT
dpc-4969	45	13	.	.	PUNCT
dpc-4969	46	1	it	it	PRON
dpc-4969	46	2	was	be	AUX
dpc-4969	46	3	planned	plan	VERB
dpc-4969	46	4	to	to	PART
dpc-4969	46	5	compare	compare	VERB
dpc-4969	46	6	the	the	DET
dpc-4969	46	7	efficacy	efficacy	NOUN
dpc-4969	46	8	of	of	ADP
dpc-4969	46	9	these	these	DET
dpc-4969	46	10	drugs	drug	NOUN
dpc-4969	46	11	with	with	ADP
dpc-4969	46	12	changes	change	NOUN
dpc-4969	46	13	in	in	ADP
dpc-4969	46	14	inflammatory	inflammatory	ADJ
dpc-4969	46	15	markers	marker	NOUN
dpc-4969	46	16	and	and	CCONJ
dpc-4969	46	17	pemphigus	pemphigus	PROPN
dpc-4969	46	18	disease	disease	PROPN
dpc-4969	46	19	area	area	NOUN
dpc-4969	46	20	index	index	NOUN
dpc-4969	46	21	(	(	PUNCT
dpc-4969	46	22	pdai	pdai	NOUN
dpc-4969	46	23	)	)	PUNCT
dpc-4969	46	24	in	in	ADP
dpc-4969	46	25	different	different	ADJ
dpc-4969	46	26	groups	group	NOUN
dpc-4969	46	27	.	.	PUNCT
dpc-4969	47	1	additionally	additionally	ADV
dpc-4969	47	2	,	,	PUNCT
dpc-4969	47	3	conclusions	conclusion	NOUN
dpc-4969	47	4	:	:	PUNCT
dpc-4969	47	5	we	we	PRON
dpc-4969	47	6	think	think	VERB
dpc-4969	47	7	that	that	SCONJ
dpc-4969	47	8	neutrophil	neutrophil	ADJ
dpc-4969	47	9	,	,	PUNCT
dpc-4969	47	10	platelet	platelet	NOUN
dpc-4969	47	11	,	,	PUNCT
dpc-4969	47	12	nlr	nlr	PROPN
dpc-4969	47	13	and	and	CCONJ
dpc-4969	47	14	plr	plr	NOUN
dpc-4969	47	15	values	value	NOUN
dpc-4969	47	16	can	can	AUX
dpc-4969	47	17	be	be	AUX
dpc-4969	47	18	used	use	VERB
dpc-4969	47	19	to	to	PART
dpc-4969	47	20	monitor	monitor	VERB
dpc-4969	47	21	the	the	DET
dpc-4969	47	22	response	response	NOUN
dpc-4969	47	23	to	to	ADP
dpc-4969	47	24	treatment	treatment	NOUN
dpc-4969	47	25	in	in	ADP
dpc-4969	47	26	pemphigus	pemphigus	PROPN
dpc-4969	47	27	,	,	PUNCT
dpc-4969	47	28	since	since	SCONJ
dpc-4969	47	29	they	they	PRON
dpc-4969	47	30	show	show	VERB
dpc-4969	47	31	a	a	DET
dpc-4969	47	32	significant	significant	ADJ
dpc-4969	47	33	decrease	decrease	NOUN
dpc-4969	47	34	with	with	ADP
dpc-4969	47	35	treatment	treatment	NOUN
dpc-4969	47	36	and	and	CCONJ
dpc-4969	47	37	are	be	AUX
dpc-4969	47	38	significantly	significantly	ADV
dpc-4969	47	39	positively	positively	ADV
dpc-4969	47	40	correlated	correlate	VERB
dpc-4969	47	41	with	with	ADP
dpc-4969	47	42	pemphigus	pemphigus	PROPN
dpc-4969	47	43	disease	disease	PROPN
dpc-4969	47	44	area	area	PROPN
dpc-4969	47	45	index	index	PROPN
dpc-4969	47	46	,	,	PUNCT
dpc-4969	47	47	which	which	PRON
dpc-4969	47	48	indicates	indicate	VERB
dpc-4969	47	49	the	the	DET
dpc-4969	47	50	severity	severity	NOUN
dpc-4969	47	51	of	of	ADP
dpc-4969	47	52	the	the	DET
dpc-4969	47	53	disease	disease	NOUN
dpc-4969	47	54	.	.	PUNCT
dpc-4969	48	1	lmr	lmr	PROPN
dpc-4969	48	2	values	value	NOUN
dpc-4969	48	3	were	be	AUX
dpc-4969	48	4	indicators	indicator	NOUN
dpc-4969	48	5	of	of	ADP
dpc-4969	48	6	a	a	DET
dpc-4969	48	7	poor	poor	ADJ
dpc-4969	48	8	prognosis	prognosis	NOUN
dpc-4969	48	9	.	.	PUNCT
dpc-4969	49	1	we	we	PRON
dpc-4969	49	2	found	find	VERB
dpc-4969	49	3	that	that	SCONJ
dpc-4969	49	4	the	the	DET
dpc-4969	49	5	duration	duration	NOUN
dpc-4969	49	6	of	of	ADP
dpc-4969	49	7	remission	remission	NOUN
dpc-4969	49	8	was	be	AUX
dpc-4969	49	9	longer	long	ADJ
dpc-4969	49	10	in	in	ADP
dpc-4969	49	11	the	the	DET
dpc-4969	49	12	group	group	NOUN
dpc-4969	49	13	receiving	receive	VERB
dpc-4969	49	14	ivig	ivig	NOUN
dpc-4969	49	15	.	.	PUNCT
dpc-4969	50	1	although	although	SCONJ
dpc-4969	50	2	there	there	PRON
dpc-4969	50	3	was	be	VERB
dpc-4969	50	4	no	no	DET
dpc-4969	50	5	difference	difference	NOUN
dpc-4969	50	6	between	between	ADP
dpc-4969	50	7	the	the	DET
dpc-4969	50	8	treatments	treatment	NOUN
dpc-4969	50	9	in	in	ADP
dpc-4969	50	10	terms	term	NOUN
dpc-4969	50	11	of	of	ADP
dpc-4969	50	12	disease	disease	NOUN
dpc-4969	50	13	recovery	recovery	NOUN
dpc-4969	50	14	,	,	PUNCT
dpc-4969	50	15	only	only	ADV
dpc-4969	50	16	ivig	ivig	NOUN
dpc-4969	50	17	prolonged	prolong	VERB
dpc-4969	50	18	the	the	DET
dpc-4969	50	19	duration	duration	NOUN
dpc-4969	50	20	of	of	ADP
dpc-4969	50	21	remission	remission	NOUN
dpc-4969	50	22	.	.	PUNCT
dpc-4969	51	1	original	original	ADJ
dpc-4969	51	2	article	article	NOUN
dpc-4969	51	3	|	|	ADV
dpc-4969	51	4	dermatol	dermatol	ADJ
dpc-4969	51	5	pract	pract	NOUN
dpc-4969	51	6	concept	concept	NOUN
dpc-4969	51	7	.	.	PUNCT
dpc-4969	52	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	52	2	3	3	NUM
dpc-4969	52	3	figure	figure	NOUN
dpc-4969	52	4	1	1	NUM
dpc-4969	52	5	.	.	PUNCT
dpc-4969	52	6	flowchart	flowchart	NOUN
dpc-4969	52	7	of	of	ADP
dpc-4969	52	8	materials	material	NOUN
dpc-4969	52	9	and	and	CCONJ
dpc-4969	52	10	methods	method	NOUN
dpc-4969	52	11	.	.	PUNCT
dpc-4969	53	1	abbreviations	abbreviation	NOUN
dpc-4969	53	2	.	.	PUNCT
dpc-4969	54	1	crp	crp	PROPN
dpc-4969	54	2	:	:	PUNCT
dpc-4969	55	1	c	c	X
dpc-4969	55	2	-	-	PUNCT
dpc-4969	55	3	reactive	reactive	ADJ
dpc-4969	55	4	protein	protein	NOUN
dpc-4969	55	5	;	;	PUNCT
dpc-4969	55	6	lmr	lmr	NOUN
dpc-4969	55	7	:	:	PUNCT
dpc-4969	55	8	lymphocyte	lymphocyte	NOUN
dpc-4969	55	9	-	-	PUNCT
dpc-4969	55	10	to	to	ADP
dpc-4969	55	11	-	-	PUNCT
dpc-4969	55	12	monocyte	monocyte	NOUN
dpc-4969	55	13	ratio	ratio	NOUN
dpc-4969	55	14	;	;	PUNCT
dpc-4969	55	15	mpv	mpv	PROPN
dpc-4969	55	16	:	:	PUNCT
dpc-4969	55	17	mean	mean	ADJ
dpc-4969	55	18	platelet	platelet	NOUN
dpc-4969	55	19	volume	volume	NOUN
dpc-4969	55	20	;	;	PUNCT
dpc-4969	56	1	nlr	nlr	PROPN
dpc-4969	56	2	:	:	PUNCT
dpc-4969	56	3	neutrophil	neutrophil	ADJ
dpc-4969	56	4	-	-	PUNCT
dpc-4969	56	5	to	to	ADP
dpc-4969	56	6	-	-	PUNCT
dpc-4969	56	7	lymphocyte	lymphocyte	NOUN
dpc-4969	56	8	ratio	ratio	NOUN
dpc-4969	56	9	;	;	PUNCT
dpc-4969	56	10	pdai	pdai	X
dpc-4969	56	11	:	:	PUNCT
dpc-4969	56	12	pemphigus	pemphigus	PROPN
dpc-4969	56	13	disease	disease	PROPN
dpc-4969	56	14	area	area	PROPN
dpc-4969	56	15	index	index	NOUN
dpc-4969	56	16	;	;	PUNCT
dpc-4969	56	17	plr	plr	NOUN
dpc-4969	56	18	:	:	PUNCT
dpc-4969	56	19	platelet	platelet	NOUN
dpc-4969	56	20	-	-	PUNCT
dpc-4969	56	21	to	to	ADP
dpc-4969	56	22	-	-	PUNCT
dpc-4969	56	23	lymphocyte	lymphocyte	NOUN
dpc-4969	56	24	ratio	ratio	NOUN
dpc-4969	56	25	;	;	PUNCT
dpc-4969	56	26	plt	plt	NOUN
dpc-4969	56	27	:	:	PUNCT
dpc-4969	56	28	platelet	platelet	NOUN
dpc-4969	56	29	.	.	PUNCT
dpc-4969	57	1	the	the	DET
dpc-4969	57	2	duration	duration	NOUN
dpc-4969	57	3	of	of	ADP
dpc-4969	57	4	patients	patient	NOUN
dpc-4969	57	5	staying	stay	VERB
dpc-4969	57	6	in	in	ADP
dpc-4969	57	7	remission	remission	NOUN
dpc-4969	57	8	from	from	ADP
dpc-4969	57	9	the	the	DET
dpc-4969	57	10	time	time	NOUN
dpc-4969	57	11	they	they	PRON
dpc-4969	57	12	entered	enter	VERB
dpc-4969	57	13	their	their	PRON
dpc-4969	57	14	first	first	ADJ
dpc-4969	57	15	remission	remission	NOUN
dpc-4969	57	16	was	be	AUX
dpc-4969	57	17	recorded	record	VERB
dpc-4969	57	18	according	accord	VERB
dpc-4969	57	19	to	to	ADP
dpc-4969	57	20	the	the	DET
dpc-4969	57	21	remission	remission	NOUN
dpc-4969	57	22	criteria	criterion	NOUN
dpc-4969	57	23	determined	determine	VERB
dpc-4969	57	24	by	by	ADP
dpc-4969	57	25	the	the	DET
dpc-4969	57	26	international	international	ADJ
dpc-4969	57	27	pemphigus	pemphigus	PROPN
dpc-4969	57	28	committee	committee	PROPN
dpc-4969	57	29	[	[	X
dpc-4969	57	30	15	15	NUM
dpc-4969	57	31	]	]	PUNCT
dpc-4969	57	32	.	.	PUNCT
dpc-4969	58	1	we	we	PRON
dpc-4969	58	2	diagnosed	diagnose	VERB
dpc-4969	58	3	all	all	PRON
dpc-4969	58	4	of	of	ADP
dpc-4969	58	5	our	our	PRON
dpc-4969	58	6	patients	patient	NOUN
dpc-4969	58	7	based	base	VERB
dpc-4969	58	8	on	on	ADP
dpc-4969	58	9	the	the	DET
dpc-4969	58	10	results	result	NOUN
dpc-4969	58	11	of	of	ADP
dpc-4969	58	12	the	the	DET
dpc-4969	58	13	direct	direct	ADJ
dpc-4969	58	14	immunofluorescence	immunofluorescence	NOUN
dpc-4969	58	15	method	method	NOUN
dpc-4969	58	16	applied	apply	VERB
dpc-4969	58	17	by	by	ADP
dpc-4969	58	18	the	the	DET
dpc-4969	58	19	pathology	pathology	NOUN
dpc-4969	58	20	department	department	NOUN
dpc-4969	58	21	on	on	ADP
dpc-4969	58	22	the	the	DET
dpc-4969	58	23	biopsies	biopsy	NOUN
dpc-4969	58	24	we	we	PRON
dpc-4969	58	25	took	take	VERB
dpc-4969	58	26	from	from	ADP
dpc-4969	58	27	our	our	PRON
dpc-4969	58	28	patients	patient	NOUN
dpc-4969	58	29	,	,	PUNCT
dpc-4969	58	30	in	in	ADP
dpc-4969	58	31	addition	addition	NOUN
dpc-4969	58	32	to	to	ADP
dpc-4969	58	33	the	the	DET
dpc-4969	58	34	clinical	clinical	ADJ
dpc-4969	58	35	findings	finding	NOUN
dpc-4969	58	36	.	.	PUNCT
dpc-4969	59	1	we	we	PRON
dpc-4969	59	2	use	use	VERB
dpc-4969	59	3	the	the	DET
dpc-4969	59	4	guideline	guideline	NOUN
dpc-4969	59	5	by	by	ADP
dpc-4969	59	6	the	the	DET
dpc-4969	59	7	european	european	PROPN
dpc-4969	59	8	dermatology	dermatology	PROPN
dpc-4969	59	9	forum	forum	PROPN
dpc-4969	59	10	(	(	PUNCT
dpc-4969	59	11	edf	edf	PROPN
dpc-4969	59	12	)	)	PUNCT
dpc-4969	59	13	in	in	ADP
dpc-4969	59	14	cooperation	cooperation	NOUN
dpc-4969	59	15	with	with	ADP
dpc-4969	59	16	the	the	DET
dpc-4969	59	17	european	european	PROPN
dpc-4969	59	18	academy	academy	PROPN
dpc-4969	59	19	of	of	ADP
dpc-4969	59	20	dermatology	dermatology	NOUN
dpc-4969	59	21	and	and	CCONJ
dpc-4969	59	22	venereology	venereology	NOUN
dpc-4969	59	23	(	(	PUNCT
dpc-4969	59	24	eadv	eadv	ADJ
dpc-4969	59	25	)	)	PUNCT
dpc-4969	59	26	for	for	ADP
dpc-4969	59	27	the	the	DET
dpc-4969	59	28	management	management	NOUN
dpc-4969	59	29	and	and	CCONJ
dpc-4969	59	30	treatment	treatment	NOUN
dpc-4969	59	31	of	of	ADP
dpc-4969	59	32	pemphigus	pemphigus	NOUN
dpc-4969	59	33	patients	patient	NOUN
dpc-4969	59	34	in	in	ADP
dpc-4969	59	35	our	our	PRON
dpc-4969	59	36	clinic	clinic	NOUN
dpc-4969	59	37	[	[	X
dpc-4969	59	38	16	16	NUM
dpc-4969	59	39	]	]	PUNCT
dpc-4969	59	40	.	.	PUNCT
dpc-4969	60	1	the	the	DET
dpc-4969	60	2	analyzes	analyze	NOUN
dpc-4969	60	3	were	be	AUX
dpc-4969	60	4	evaluated	evaluate	VERB
dpc-4969	60	5	in	in	ADP
dpc-4969	60	6	ibm	ibm	PROPN
dpc-4969	60	7	bm	bm	PROPN
dpc-4969	60	8	spss	spss	PROPN
dpc-4969	60	9	(	(	PUNCT
dpc-4969	60	10	statistical	statistical	ADJ
dpc-4969	60	11	package	package	NOUN
dpc-4969	60	12	for	for	ADP
dpc-4969	60	13	social	social	ADJ
dpc-4969	60	14	sciences	science	NOUN
dpc-4969	60	15	;	;	PUNCT
dpc-4969	60	16	spss	spss	PROPN
dpc-4969	60	17	inc	inc	PROPN
dpc-4969	60	18	.	.	PROPN
dpc-4969	60	19	)	)	PUNCT
dpc-4969	61	1	statistics	statistic	NOUN
dpc-4969	61	2	22	22	NUM
dpc-4969	61	3	,	,	PUNCT
dpc-4969	61	4	statistic	statistic	ADJ
dpc-4969	61	5	software	software	NOUN
dpc-4969	61	6	.	.	PUNCT
dpc-4969	62	1	in	in	ADP
dpc-4969	62	2	the	the	DET
dpc-4969	62	3	study	study	NOUN
dpc-4969	62	4	,	,	PUNCT
dpc-4969	62	5	descriptive	descriptive	ADJ
dpc-4969	62	6	data	datum	NOUN
dpc-4969	62	7	are	be	AUX
dpc-4969	62	8	shown	show	VERB
dpc-4969	62	9	with	with	ADP
dpc-4969	62	10	n	n	PRON
dpc-4969	62	11	and	and	CCONJ
dpc-4969	62	12	%	%	NOUN
dpc-4969	62	13	values	value	NOUN
dpc-4969	62	14	when	when	SCONJ
dpc-4969	62	15	using	use	VERB
dpc-4969	62	16	categorical	categorical	ADJ
dpc-4969	62	17	data	datum	NOUN
dpc-4969	62	18	,	,	PUNCT
dpc-4969	62	19	while	while	SCONJ
dpc-4969	62	20	they	they	PRON
dpc-4969	62	21	are	be	AUX
dpc-4969	62	22	shown	show	VERB
dpc-4969	62	23	with	with	ADP
dpc-4969	62	24	mean	mean	PROPN
dpc-4969	62	25	±	±	NUM
dpc-4969	62	26	standard	standard	ADJ
dpc-4969	62	27	deviation	deviation	NOUN
dpc-4969	62	28	(	(	PUNCT
dpc-4969	62	29	mean±sd	mean±sd	NOUN
dpc-4969	62	30	)	)	PUNCT
dpc-4969	62	31	values	value	NOUN
dpc-4969	62	32	when	when	SCONJ
dpc-4969	62	33	using	use	VERB
dpc-4969	62	34	continuous	continuous	ADJ
dpc-4969	62	35	data	datum	NOUN
dpc-4969	62	36	.	.	PUNCT
dpc-4969	63	1	the	the	DET
dpc-4969	63	2	suitability	suitability	NOUN
dpc-4969	63	3	of	of	ADP
dpc-4969	63	4	continuous	continuous	ADJ
dpc-4969	63	5	variables	variable	NOUN
dpc-4969	63	6	for	for	ADP
dpc-4969	63	7	normal	normal	ADJ
dpc-4969	63	8	distribution	distribution	NOUN
dpc-4969	63	9	was	be	AUX
dpc-4969	63	10	evaluated	evaluate	VERB
dpc-4969	63	11	with	with	ADP
dpc-4969	63	12	the	the	DET
dpc-4969	63	13	kolmogorov	kolmogorov	ADJ
dpc-4969	63	14	-	-	PUNCT
dpc-4969	63	15	smirnov	smirnov	ADJ
dpc-4969	63	16	test	test	NOUN
dpc-4969	63	17	.	.	PUNCT
dpc-4969	64	1	the	the	DET
dpc-4969	64	2	mann	mann	PROPN
dpc-4969	64	3	whitney	whitney	PROPN
dpc-4969	64	4	u	u	PROPN
dpc-4969	64	5	test	test	NOUN
dpc-4969	64	6	was	be	AUX
dpc-4969	64	7	applied	apply	VERB
dpc-4969	64	8	to	to	PART
dpc-4969	64	9	compare	compare	VERB
dpc-4969	64	10	paired	pair	VERB
dpc-4969	64	11	groups	group	NOUN
dpc-4969	64	12	.	.	PUNCT
dpc-4969	65	1	friedman	friedman	NOUN
dpc-4969	65	2	analysis	analysis	NOUN
dpc-4969	65	3	was	be	AUX
dpc-4969	65	4	applied	apply	VERB
dpc-4969	65	5	to	to	PART
dpc-4969	65	6	compare	compare	VERB
dpc-4969	65	7	the	the	DET
dpc-4969	65	8	measurement	measurement	NOUN
dpc-4969	65	9	parameters	parameter	NOUN
dpc-4969	65	10	over	over	ADP
dpc-4969	65	11	time	time	NOUN
dpc-4969	65	12	.	.	PUNCT
dpc-4969	66	1	in	in	ADP
dpc-4969	66	2	the	the	DET
dpc-4969	66	3	analyses	analysis	NOUN
dpc-4969	66	4	the	the	DET
dpc-4969	66	5	level	level	NOUN
dpc-4969	66	6	of	of	ADP
dpc-4969	66	7	statistical	statistical	ADJ
dpc-4969	66	8	significance	significance	NOUN
dpc-4969	66	9	was	be	AUX
dpc-4969	66	10	accepted	accept	VERB
dpc-4969	66	11	as	as	ADP
dpc-4969	66	12	p	p	NOUN
dpc-4969	66	13	less	less	ADJ
dpc-4969	66	14	than	than	ADP
dpc-4969	66	15	0.05	0.05	NUM
dpc-4969	66	16	.	.	PUNCT
dpc-4969	66	17	4	4	NUM
dpc-4969	66	18	original	original	ADJ
dpc-4969	66	19	article	article	NOUN
dpc-4969	66	20	|	|	ADV
dpc-4969	66	21	dermatol	dermatol	ADJ
dpc-4969	66	22	pract	pract	NOUN
dpc-4969	66	23	concept	concept	NOUN
dpc-4969	66	24	.	.	PUNCT
dpc-4969	67	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	67	2	table	table	NOUN
dpc-4969	67	3	1	1	NUM
dpc-4969	67	4	.	.	PUNCT
dpc-4969	67	5	evaluation	evaluation	NOUN
dpc-4969	67	6	of	of	ADP
dpc-4969	67	7	parameters	parameter	NOUN
dpc-4969	67	8	according	accord	VERB
dpc-4969	67	9	to	to	ADP
dpc-4969	67	10	time	time	NOUN
dpc-4969	67	11	.	.	PUNCT
dpc-4969	68	1	beginning	begin	VERB
dpc-4969	68	2	mean±sd	mean±sd	ADP
dpc-4969	68	3	3rd	3rd	ADJ
dpc-4969	68	4	month	month	NOUN
dpc-4969	68	5	mean±sd	mean±sd	ADP
dpc-4969	68	6	6th	6th	ADJ
dpc-4969	68	7	month	month	NOUN
dpc-4969	68	8	mean±sd	mean±sd	ADP
dpc-4969	68	9	p	p	X
dpc-4969	68	10	neutrophil	neutrophil	ADJ
dpc-4969	68	11	6.81±3.08a	6.81±3.08a	NUM
dpc-4969	68	12	5.92±2.58a.b	5.92±2.58a.b	NUM
dpc-4969	68	13	5.84±2.66b	5.84±2.66b	NUM
dpc-4969	68	14	0.039	0.039	NUM
dpc-4969	68	15	lymphocyte	lymphocyte	ADJ
dpc-4969	68	16	2.03±1.00a.b	2.03±1.00a.b	NUM
dpc-4969	68	17	2.22±1.01a	2.22±1.01a	NOUN
dpc-4969	68	18	1.97±.89b	1.97±.89b	NUM
dpc-4969	68	19	0.029	0.029	NUM
dpc-4969	68	20	plt	plt	NOUN
dpc-4969	68	21	306.42±111.05a	306.42±111.05a	NUM
dpc-4969	68	22	296.79±108.11a.b	296.79±108.11a.b	NUM
dpc-4969	68	23	275.96±106.26b	275.96±106.26b	NUM
dpc-4969	68	24	0.049	0.049	NUM
dpc-4969	68	25	mpv	mpv	PROPN
dpc-4969	68	26	9.71±1.65	9.71±1.65	PROPN
dpc-4969	69	1	9.90±1.21	9.90±1.21	NUM
dpc-4969	69	2	10.06±1.49	10.06±1.49	NUM
dpc-4969	69	3	0.204	0.204	NUM
dpc-4969	69	4	crp	crp	NOUN
dpc-4969	69	5	11.78±23.91	11.78±23.91	NUM
dpc-4969	70	1	9.14±14.51	9.14±14.51	NUM
dpc-4969	70	2	6.02±4.72	6.02±4.72	NOUN
dpc-4969	70	3	0.083	0.083	NUM
dpc-4969	70	4	nlr	nlr	PROPN
dpc-4969	70	5	4.51±4.53a	4.51±4.53a	NUM
dpc-4969	70	6	3.30±2.62b	3.30±2.62b	NUM
dpc-4969	70	7	3.54±2.31a.b	3.54±2.31a.b	NUM
dpc-4969	70	8	0.019	0.019	NUM
dpc-4969	70	9	lmr	lmr	PROPN
dpc-4969	70	10	3.66±1.70	3.66±1.70	NUM
dpc-4969	70	11	3.99±1.79	3.99±1.79	NUM
dpc-4969	70	12	3.77±1.51	3.77±1.51	NOUN
dpc-4969	70	13	0.196	0.196	NUM
dpc-4969	70	14	plr	plr	NOUN
dpc-4969	70	15	184.03±121.34a	184.03±121.34a	NUM
dpc-4969	70	16	161.94±103.86b	161.94±103.86b	NUM
dpc-4969	70	17	162.06±83.28a.b	162.06±83.28a.b	NUM
dpc-4969	70	18	0.014	0.014	NUM
dpc-4969	70	19	pdai	pdai	NOUN
dpc-4969	70	20	13.01±11.91a	13.01±11.91a	NUM
dpc-4969	70	21	7.74±8.33b	7.74±8.33b	NUM
dpc-4969	70	22	7.07±9.37b	7.07±9.37b	NUM
dpc-4969	70	23	<	<	NOUN
dpc-4969	70	24	0.001	0.001	NUM
dpc-4969	70	25	sedimantation	sedimantation	NOUN
dpc-4969	70	26	20.26±16.38	20.26±16.38	PUNCT
dpc-4969	70	27	22.29±17.98	22.29±17.98	NUM
dpc-4969	70	28	19.83±16.61	19.83±16.61	NUM
dpc-4969	70	29	0.370	0.370	NUM
dpc-4969	70	30	friedman	friedman	NOUN
dpc-4969	70	31	analysis	analysis	NOUN
dpc-4969	70	32	was	be	AUX
dpc-4969	70	33	applied	apply	VERB
dpc-4969	70	34	.	.	PUNCT
dpc-4969	71	1	a.b.c	a.b.c	PROPN
dpc-4969	71	2	.	.	PUNCT
dpc-4969	72	1	the	the	DET
dpc-4969	72	2	groups	group	NOUN
dpc-4969	72	3	from	from	ADP
dpc-4969	72	4	which	which	PRON
dpc-4969	72	5	the	the	DET
dpc-4969	72	6	statistical	statistical	ADJ
dpc-4969	72	7	significance	significance	NOUN
dpc-4969	72	8	found	find	VERB
dpc-4969	72	9	in	in	ADP
dpc-4969	72	10	the	the	DET
dpc-4969	72	11	analysis	analysis	NOUN
dpc-4969	72	12	originates	originate	NOUN
dpc-4969	72	13	.	.	PUNCT
dpc-4969	73	1	abbreviations	abbreviation	NOUN
dpc-4969	73	2	.	.	PUNCT
dpc-4969	74	1	crp	crp	PROPN
dpc-4969	74	2	:	:	PUNCT
dpc-4969	75	1	c	c	X
dpc-4969	75	2	-	-	PUNCT
dpc-4969	75	3	reactive	reactive	ADJ
dpc-4969	75	4	protein	protein	NOUN
dpc-4969	75	5	;	;	PUNCT
dpc-4969	75	6	lmr	lmr	NOUN
dpc-4969	75	7	:	:	PUNCT
dpc-4969	75	8	lymphocyte	lymphocyte	NOUN
dpc-4969	75	9	-	-	PUNCT
dpc-4969	75	10	to	to	ADP
dpc-4969	75	11	-	-	PUNCT
dpc-4969	75	12	monocyte	monocyte	NOUN
dpc-4969	75	13	ratio	ratio	NOUN
dpc-4969	75	14	;	;	PUNCT
dpc-4969	75	15	mpv	mpv	PROPN
dpc-4969	75	16	:	:	PUNCT
dpc-4969	75	17	mean	mean	ADJ
dpc-4969	75	18	platelet	platelet	NOUN
dpc-4969	75	19	volume	volume	NOUN
dpc-4969	75	20	;	;	PUNCT
dpc-4969	76	1	nlr	nlr	PROPN
dpc-4969	76	2	:	:	PUNCT
dpc-4969	76	3	neutrophil	neutrophil	ADJ
dpc-4969	76	4	-	-	PUNCT
dpc-4969	76	5	to	to	ADP
dpc-4969	76	6	-	-	PUNCT
dpc-4969	76	7	lymphocyte	lymphocyte	NOUN
dpc-4969	76	8	ratio	ratio	NOUN
dpc-4969	76	9	;	;	PUNCT
dpc-4969	76	10	pdai	pdai	X
dpc-4969	76	11	:	:	PUNCT
dpc-4969	76	12	pemphigus	pemphigus	PROPN
dpc-4969	76	13	disease	disease	PROPN
dpc-4969	76	14	area	area	PROPN
dpc-4969	76	15	index	index	NOUN
dpc-4969	76	16	;	;	PUNCT
dpc-4969	76	17	plr	plr	NOUN
dpc-4969	76	18	:	:	PUNCT
dpc-4969	76	19	platelet	platelet	NOUN
dpc-4969	76	20	-	-	PUNCT
dpc-4969	76	21	to	to	ADP
dpc-4969	76	22	-	-	PUNCT
dpc-4969	76	23	lymphocyte	lymphocyte	NOUN
dpc-4969	76	24	ratio	ratio	NOUN
dpc-4969	76	25	;	;	PUNCT
dpc-4969	76	26	plt	plt	NOUN
dpc-4969	76	27	:	:	PUNCT
dpc-4969	76	28	platelet	platelet	NOUN
dpc-4969	76	29	;	;	PUNCT
dpc-4969	76	30	sd	sd	NUM
dpc-4969	76	31	:	:	PUNCT
dpc-4969	76	32	standart	standart	NOUN
dpc-4969	76	33	deviation	deviation	NOUN
dpc-4969	76	34	.	.	PUNCT
dpc-4969	77	1	results	result	VERB
dpc-4969	77	2	seventy	seventy	NUM
dpc-4969	77	3	-	-	PUNCT
dpc-4969	77	4	six	six	NUM
dpc-4969	77	5	patients	patient	NOUN
dpc-4969	77	6	with	with	ADP
dpc-4969	77	7	pemphigus	pemphigus	PROPN
dpc-4969	77	8	with	with	ADP
dpc-4969	77	9	an	an	DET
dpc-4969	77	10	average	average	ADJ
dpc-4969	77	11	age	age	NOUN
dpc-4969	77	12	of	of	ADP
dpc-4969	77	13	49.59±16.03	49.59±16.03	PROPN
dpc-4969	77	14	(	(	PUNCT
dpc-4969	77	15	min=18	min=18	NOUN
dpc-4969	77	16	-	-	PUNCT
dpc-4969	77	17	max=99	max=99	NOUN
dpc-4969	77	18	)	)	PUNCT
dpc-4969	77	19	were	be	AUX
dpc-4969	77	20	included	include	VERB
dpc-4969	77	21	in	in	ADP
dpc-4969	77	22	the	the	DET
dpc-4969	77	23	study	study	NOUN
dpc-4969	77	24	.	.	PUNCT
dpc-4969	78	1	34	34	NUM
dpc-4969	78	2	(	(	PUNCT
dpc-4969	78	3	44.7	44.7	NUM
dpc-4969	78	4	%	%	NOUN
dpc-4969	78	5	)	)	PUNCT
dpc-4969	78	6	of	of	ADP
dpc-4969	78	7	the	the	DET
dpc-4969	78	8	patients	patient	NOUN
dpc-4969	78	9	are	be	AUX
dpc-4969	78	10	male	male	ADJ
dpc-4969	78	11	and	and	CCONJ
dpc-4969	78	12	42	42	NUM
dpc-4969	78	13	(	(	PUNCT
dpc-4969	78	14	55.3	55.3	NUM
dpc-4969	78	15	%	%	NOUN
dpc-4969	78	16	)	)	PUNCT
dpc-4969	78	17	are	be	AUX
dpc-4969	78	18	female	female	ADJ
dpc-4969	78	19	.	.	PUNCT
dpc-4969	79	1	it	it	PRON
dpc-4969	79	2	was	be	AUX
dpc-4969	79	3	observed	observe	VERB
dpc-4969	79	4	that	that	SCONJ
dpc-4969	79	5	45	45	NUM
dpc-4969	79	6	(	(	PUNCT
dpc-4969	79	7	59.2	59.2	NUM
dpc-4969	79	8	%	%	NOUN
dpc-4969	79	9	)	)	PUNCT
dpc-4969	79	10	of	of	ADP
dpc-4969	79	11	the	the	DET
dpc-4969	79	12	patients	patient	NOUN
dpc-4969	79	13	received	receive	VERB
dpc-4969	79	14	intravenous	intravenous	ADJ
dpc-4969	79	15	immunoglobulin	immunoglobulin	NOUN
dpc-4969	79	16	(	(	PUNCT
dpc-4969	79	17	ivig	ivig	NOUN
dpc-4969	79	18	)	)	PUNCT
dpc-4969	79	19	,	,	PUNCT
dpc-4969	79	20	systemic	systemic	ADJ
dpc-4969	79	21	steroid	steroid	NOUN
dpc-4969	79	22	and	and	CCONJ
dpc-4969	79	23	azathioprine	azathioprine	ADJ
dpc-4969	79	24	treatment	treatment	NOUN
dpc-4969	79	25	,	,	PUNCT
dpc-4969	79	26	and	and	CCONJ
dpc-4969	79	27	31	31	NUM
dpc-4969	79	28	(	(	PUNCT
dpc-4969	79	29	40.8	40.8	NUM
dpc-4969	79	30	%	%	NOUN
dpc-4969	79	31	)	)	PUNCT
dpc-4969	79	32	received	receive	VERB
dpc-4969	79	33	azathioprine	azathioprine	NOUN
dpc-4969	79	34	and	and	CCONJ
dpc-4969	79	35	systemic	systemic	ADJ
dpc-4969	79	36	steroid	steroid	NOUN
dpc-4969	79	37	treatment	treatment	NOUN
dpc-4969	79	38	without	without	ADP
dpc-4969	79	39	ivig	ivig	NOUN
dpc-4969	79	40	.	.	PUNCT
dpc-4969	80	1	in	in	ADP
dpc-4969	80	2	all	all	DET
dpc-4969	80	3	patients	patient	NOUN
dpc-4969	80	4	,	,	PUNCT
dpc-4969	80	5	the	the	DET
dpc-4969	80	6	value	value	NOUN
dpc-4969	80	7	of	of	ADP
dpc-4969	80	8	neutrophil	neutrophil	ADJ
dpc-4969	80	9	count	count	NOUN
dpc-4969	80	10	at	at	ADP
dpc-4969	80	11	6	6	NUM
dpc-4969	80	12	months	month	NOUN
dpc-4969	80	13	was	be	AUX
dpc-4969	80	14	found	find	VERB
dpc-4969	80	15	to	to	PART
dpc-4969	80	16	be	be	AUX
dpc-4969	80	17	significantly	significantly	ADV
dpc-4969	80	18	decreased	decrease	VERB
dpc-4969	80	19	(	(	PUNCT
dpc-4969	80	20	p	p	X
dpc-4969	80	21	=	=	NOUN
dpc-4969	80	22	0.039	0.039	NUM
dpc-4969	80	23	)	)	PUNCT
dpc-4969	80	24	compared	compare	VERB
dpc-4969	80	25	to	to	ADP
dpc-4969	80	26	the	the	DET
dpc-4969	80	27	baseline	baseline	NOUN
dpc-4969	80	28	value	value	NOUN
dpc-4969	80	29	.	.	PUNCT
dpc-4969	81	1	additionally	additionally	ADV
dpc-4969	81	2	,	,	PUNCT
dpc-4969	81	3	neutrophil	neutrophil	ADJ
dpc-4969	81	4	counts	count	NOUN
dpc-4969	81	5	showed	show	VERB
dpc-4969	81	6	a	a	DET
dpc-4969	81	7	significant	significant	ADJ
dpc-4969	81	8	positive	positive	ADJ
dpc-4969	81	9	correlation	correlation	NOUN
dpc-4969	81	10	(	(	PUNCT
dpc-4969	81	11	baseline	baseline	NOUN
dpc-4969	81	12	p	p	X
dpc-4969	81	13	=	=	NOUN
dpc-4969	81	14	0.037	0.037	NUM
dpc-4969	81	15	;	;	PUNCT
dpc-4969	81	16	6th	6th	ADJ
dpc-4969	81	17	month	month	NOUN
dpc-4969	81	18	p	p	X
dpc-4969	81	19	=	=	NOUN
dpc-4969	81	20	0.030	0.030	NUM
dpc-4969	81	21	)	)	PUNCT
dpc-4969	81	22	with	with	ADP
dpc-4969	81	23	simultaneously	simultaneously	ADV
dpc-4969	81	24	measured	measure	VERB
dpc-4969	81	25	pdai	pdai	ADJ
dpc-4969	81	26	scores	score	NOUN
dpc-4969	81	27	at	at	ADP
dpc-4969	81	28	the	the	DET
dpc-4969	81	29	beginning	beginning	NOUN
dpc-4969	81	30	of	of	ADP
dpc-4969	81	31	treatment	treatment	NOUN
dpc-4969	81	32	and	and	CCONJ
dpc-4969	81	33	at	at	ADP
dpc-4969	81	34	6	6	NUM
dpc-4969	81	35	months	month	NOUN
dpc-4969	81	36	of	of	ADP
dpc-4969	81	37	treatment	treatment	NOUN
dpc-4969	81	38	.	.	PUNCT
dpc-4969	82	1	there	there	PRON
dpc-4969	82	2	was	be	VERB
dpc-4969	82	3	a	a	DET
dpc-4969	82	4	significant	significant	ADJ
dpc-4969	82	5	decrease	decrease	NOUN
dpc-4969	82	6	(	(	PUNCT
dpc-4969	82	7	p	p	X
dpc-4969	82	8	=	=	NOUN
dpc-4969	82	9	0.049	0.049	NUM
dpc-4969	82	10	)	)	PUNCT
dpc-4969	82	11	in	in	ADP
dpc-4969	82	12	platelet	platelet	NOUN
dpc-4969	82	13	values	value	NOUN
dpc-4969	82	14	at	at	ADP
dpc-4969	82	15	6	6	NUM
dpc-4969	82	16	months	month	NOUN
dpc-4969	82	17	from	from	ADP
dpc-4969	82	18	baseline	baseline	NOUN
dpc-4969	82	19	in	in	ADP
dpc-4969	82	20	all	all	DET
dpc-4969	82	21	patients	patient	NOUN
dpc-4969	82	22	,	,	PUNCT
dpc-4969	82	23	but	but	CCONJ
dpc-4969	82	24	there	there	PRON
dpc-4969	82	25	was	be	VERB
dpc-4969	82	26	no	no	DET
dpc-4969	82	27	significant	significant	ADJ
dpc-4969	82	28	correlation	correlation	NOUN
dpc-4969	82	29	between	between	ADP
dpc-4969	82	30	platelet	platelet	NOUN
dpc-4969	82	31	values	value	NOUN
dpc-4969	82	32	and	and	CCONJ
dpc-4969	82	33	pdai	pdai	NOUN
dpc-4969	82	34	at	at	ADP
dpc-4969	82	35	any	any	DET
dpc-4969	82	36	time	time	NOUN
dpc-4969	82	37	.	.	PUNCT
dpc-4969	83	1	in	in	ADP
dpc-4969	83	2	all	all	DET
dpc-4969	83	3	patients	patient	NOUN
dpc-4969	83	4	,	,	PUNCT
dpc-4969	83	5	both	both	CCONJ
dpc-4969	83	6	nlr	nlr	PROPN
dpc-4969	83	7	and	and	CCONJ
dpc-4969	83	8	plr	plr	NOUN
dpc-4969	83	9	values	value	NOUN
dpc-4969	83	10	were	be	AUX
dpc-4969	83	11	found	find	VERB
dpc-4969	83	12	to	to	PART
dpc-4969	83	13	decrease	decrease	VERB
dpc-4969	83	14	significantly	significantly	ADV
dpc-4969	83	15	in	in	ADP
dpc-4969	83	16	the	the	DET
dpc-4969	83	17	third	third	ADJ
dpc-4969	83	18	month	month	NOUN
dpc-4969	83	19	of	of	ADP
dpc-4969	83	20	treatment	treatment	NOUN
dpc-4969	83	21	(	(	PUNCT
dpc-4969	83	22	p	p	X
dpc-4969	83	23	=	=	NOUN
dpc-4969	83	24	0.019	0.019	NUM
dpc-4969	83	25	for	for	ADP
dpc-4969	83	26	nlr	nlr	PROPN
dpc-4969	83	27	;	;	PUNCT
dpc-4969	83	28	p	p	X
dpc-4969	83	29	=	=	NOUN
dpc-4969	83	30	0.014	0.014	NUM
dpc-4969	83	31	for	for	ADP
dpc-4969	83	32	plr	plr	NOUN
dpc-4969	83	33	)	)	PUNCT
dpc-4969	83	34	compared	compare	VERB
dpc-4969	83	35	to	to	ADP
dpc-4969	83	36	the	the	DET
dpc-4969	83	37	baseline	baseline	NOUN
dpc-4969	83	38	value	value	NOUN
dpc-4969	83	39	,	,	PUNCT
dpc-4969	83	40	and	and	CCONJ
dpc-4969	83	41	also	also	ADV
dpc-4969	83	42	showed	show	VERB
dpc-4969	83	43	a	a	DET
dpc-4969	83	44	significant	significant	ADJ
dpc-4969	83	45	positive	positive	ADJ
dpc-4969	83	46	correlation	correlation	NOUN
dpc-4969	83	47	with	with	ADP
dpc-4969	83	48	pdai	pdai	NOUN
dpc-4969	83	49	at	at	ADP
dpc-4969	83	50	3	3	NUM
dpc-4969	83	51	and	and	CCONJ
dpc-4969	83	52	6	6	NUM
dpc-4969	83	53	months	month	NOUN
dpc-4969	83	54	.	.	PUNCT
dpc-4969	84	1	lmr	lmr	PROPN
dpc-4969	84	2	values	value	NOUN
dpc-4969	84	3	in	in	ADP
dpc-4969	84	4	all	all	DET
dpc-4969	84	5	patients	patient	NOUN
dpc-4969	84	6	showed	show	VERB
dpc-4969	84	7	a	a	DET
dpc-4969	84	8	negative	negative	ADJ
dpc-4969	84	9	and	and	CCONJ
dpc-4969	84	10	significant	significant	ADJ
dpc-4969	84	11	correlation	correlation	NOUN
dpc-4969	84	12	with	with	ADP
dpc-4969	84	13	pdai	pdai	PROPN
dpc-4969	84	14	scores	score	NOUN
dpc-4969	84	15	at	at	ADP
dpc-4969	84	16	3	3	NUM
dpc-4969	84	17	months	month	NOUN
dpc-4969	84	18	and	and	CCONJ
dpc-4969	84	19	6	6	NUM
dpc-4969	84	20	months	month	NOUN
dpc-4969	84	21	(	(	PUNCT
dpc-4969	84	22	3	3	NUM
dpc-4969	84	23	months	month	NOUN
dpc-4969	84	24	r	r	NOUN
dpc-4969	84	25	=	=	PUNCT
dpc-4969	84	26	-0.318	-0.318	PUNCT
dpc-4969	84	27	p	p	NOUN
dpc-4969	84	28	=	=	NOUN
dpc-4969	84	29	0.005	0.005	NUM
dpc-4969	84	30	;	;	PUNCT
dpc-4969	84	31	6	6	NUM
dpc-4969	84	32	months	month	NOUN
dpc-4969	84	33	r	r	NOUN
dpc-4969	84	34	=	=	SYM
dpc-4969	84	35	-0.353	-0.353	PUNCT
dpc-4969	84	36	p	p	NOUN
dpc-4969	84	37	=	=	NOUN
dpc-4969	84	38	0.002	0.002	NUM
dpc-4969	84	39	)	)	PUNCT
dpc-4969	84	40	.	.	PUNCT
dpc-4969	85	1	mpv	mpv	PROPN
dpc-4969	85	2	and	and	CCONJ
dpc-4969	85	3	crp	crp	PROPN
dpc-4969	85	4	values	value	NOUN
dpc-4969	85	5	in	in	ADP
dpc-4969	85	6	all	all	DET
dpc-4969	85	7	patients	patient	NOUN
dpc-4969	85	8	showed	show	VERB
dpc-4969	85	9	a	a	DET
dpc-4969	85	10	significant	significant	ADJ
dpc-4969	85	11	positive	positive	ADJ
dpc-4969	85	12	correlation	correlation	NOUN
dpc-4969	85	13	with	with	ADP
dpc-4969	85	14	pdai	pdai	NOUN
dpc-4969	85	15	(	(	PUNCT
dpc-4969	85	16	p	p	X
dpc-4969	85	17	=	=	NOUN
dpc-4969	85	18	0.027	0.027	NUM
dpc-4969	85	19	;	;	PUNCT
dpc-4969	85	20	p	p	X
dpc-4969	85	21	=	=	NOUN
dpc-4969	85	22	0.005	0.005	NUM
dpc-4969	85	23	,	,	PUNCT
dpc-4969	85	24	respectively	respectively	ADV
dpc-4969	85	25	)	)	PUNCT
dpc-4969	85	26	.	.	PUNCT
dpc-4969	86	1	there	there	PRON
dpc-4969	86	2	was	be	VERB
dpc-4969	86	3	no	no	DET
dpc-4969	86	4	significant	significant	ADJ
dpc-4969	86	5	change	change	NOUN
dpc-4969	86	6	in	in	ADP
dpc-4969	86	7	sedimentation	sedimentation	NOUN
dpc-4969	86	8	at	at	ADP
dpc-4969	86	9	any	any	DET
dpc-4969	86	10	time	time	NOUN
dpc-4969	86	11	of	of	ADP
dpc-4969	86	12	treatment	treatment	NOUN
dpc-4969	86	13	and	and	CCONJ
dpc-4969	86	14	no	no	DET
dpc-4969	86	15	correlation	correlation	NOUN
dpc-4969	86	16	with	with	ADP
dpc-4969	86	17	pdai	pdai	PROPN
dpc-4969	86	18	was	be	AUX
dpc-4969	86	19	found	find	VERB
dpc-4969	86	20	.	.	PUNCT
dpc-4969	87	1	the	the	DET
dpc-4969	87	2	change	change	NOUN
dpc-4969	87	3	in	in	ADP
dpc-4969	87	4	pdai	pdai	PROPN
dpc-4969	87	5	did	do	AUX
dpc-4969	87	6	not	not	PART
dpc-4969	87	7	differ	differ	VERB
dpc-4969	87	8	significantly	significantly	ADV
dpc-4969	87	9	in	in	ADP
dpc-4969	87	10	the	the	DET
dpc-4969	87	11	group	group	NOUN
dpc-4969	87	12	of	of	ADP
dpc-4969	87	13	patients	patient	NOUN
dpc-4969	87	14	who	who	PRON
dpc-4969	87	15	received	receive	VERB
dpc-4969	87	16	ivig	ivig	NOUN
dpc-4969	87	17	compared	compare	VERB
dpc-4969	87	18	to	to	ADP
dpc-4969	87	19	the	the	DET
dpc-4969	87	20	group	group	NOUN
dpc-4969	87	21	of	of	ADP
dpc-4969	87	22	patients	patient	NOUN
dpc-4969	87	23	who	who	PRON
dpc-4969	87	24	did	do	AUX
dpc-4969	87	25	not	not	PART
dpc-4969	87	26	receive	receive	VERB
dpc-4969	87	27	ivig	ivig	NOUN
dpc-4969	87	28	.	.	PUNCT
dpc-4969	88	1	furthermore	furthermore	ADV
dpc-4969	88	2	,	,	PUNCT
dpc-4969	88	3	when	when	SCONJ
dpc-4969	88	4	the	the	DET
dpc-4969	88	5	6	6	NUM
dpc-4969	88	6	-	-	PUNCT
dpc-4969	88	7	month	month	NOUN
dpc-4969	88	8	change	change	NOUN
dpc-4969	88	9	in	in	ADP
dpc-4969	88	10	inflammatory	inflammatory	ADJ
dpc-4969	88	11	markers	marker	NOUN
dpc-4969	88	12	was	be	AUX
dpc-4969	88	13	examined	examine	VERB
dpc-4969	88	14	in	in	ADP
dpc-4969	88	15	the	the	DET
dpc-4969	88	16	treatment	treatment	NOUN
dpc-4969	88	17	groups	group	NOUN
dpc-4969	88	18	,	,	PUNCT
dpc-4969	88	19	no	no	DET
dpc-4969	88	20	significant	significant	ADJ
dpc-4969	88	21	differences	difference	NOUN
dpc-4969	88	22	were	be	AUX
dpc-4969	88	23	found	find	VERB
dpc-4969	88	24	between	between	ADP
dpc-4969	88	25	the	the	DET
dpc-4969	88	26	two	two	NUM
dpc-4969	88	27	groups	group	NOUN
dpc-4969	88	28	in	in	ADP
dpc-4969	88	29	the	the	DET
dpc-4969	88	30	change	change	NOUN
dpc-4969	88	31	of	of	ADP
dpc-4969	88	32	any	any	DET
dpc-4969	88	33	parameter	parameter	NOUN
dpc-4969	88	34	other	other	ADJ
dpc-4969	88	35	than	than	ADP
dpc-4969	88	36	lmr	lmr	PROPN
dpc-4969	88	37	(	(	PUNCT
dpc-4969	88	38	p	p	X
dpc-4969	88	39	>	>	X
dpc-4969	88	40	0.05	0.05	NUM
dpc-4969	88	41	)	)	PUNCT
dpc-4969	88	42	.	.	PUNCT
dpc-4969	89	1	lmr	lmr	PROPN
dpc-4969	89	2	change	change	NOUN
dpc-4969	89	3	was	be	AUX
dpc-4969	89	4	found	find	VERB
dpc-4969	89	5	to	to	PART
dpc-4969	89	6	be	be	AUX
dpc-4969	89	7	significantly	significantly	ADV
dpc-4969	89	8	higher	high	ADJ
dpc-4969	89	9	in	in	ADP
dpc-4969	89	10	the	the	DET
dpc-4969	89	11	group	group	NOUN
dpc-4969	89	12	that	that	PRON
dpc-4969	89	13	received	receive	VERB
dpc-4969	89	14	ivig	ivig	NOUN
dpc-4969	89	15	than	than	ADP
dpc-4969	89	16	in	in	ADP
dpc-4969	89	17	the	the	DET
dpc-4969	89	18	group	group	NOUN
dpc-4969	89	19	that	that	PRON
dpc-4969	89	20	did	do	VERB
dpc-4969	89	21	not	not	PART
dpc-4969	89	22	.	.	PUNCT
dpc-4969	90	1	while	while	SCONJ
dpc-4969	90	2	the	the	DET
dpc-4969	90	3	mean	mean	ADJ
dpc-4969	90	4	6	6	NUM
dpc-4969	90	5	-	-	PUNCT
dpc-4969	90	6	month	month	NOUN
dpc-4969	90	7	lmr	lmr	PROPN
dpc-4969	90	8	change	change	NOUN
dpc-4969	90	9	in	in	ADP
dpc-4969	90	10	the	the	DET
dpc-4969	90	11	ivig	ivig	NOUN
dpc-4969	90	12	group	group	NOUN
dpc-4969	90	13	was	be	AUX
dpc-4969	90	14	0.54	0.54	NUM
dpc-4969	90	15	in	in	ADP
dpc-4969	90	16	the	the	DET
dpc-4969	90	17	positive	positive	ADJ
dpc-4969	90	18	direction	direction	NOUN
dpc-4969	90	19	,	,	PUNCT
dpc-4969	90	20	the	the	DET
dpc-4969	90	21	mean	mean	PROPN
dpc-4969	90	22	lmr	lmr	PROPN
dpc-4969	90	23	change	change	NOUN
dpc-4969	90	24	in	in	ADP
dpc-4969	90	25	the	the	DET
dpc-4969	90	26	group	group	NOUN
dpc-4969	90	27	that	that	PRON
dpc-4969	90	28	did	do	AUX
dpc-4969	90	29	not	not	PART
dpc-4969	90	30	receive	receive	VERB
dpc-4969	90	31	ivig	ivig	NOUN
dpc-4969	90	32	was	be	AUX
dpc-4969	90	33	0.51	0.51	NUM
dpc-4969	90	34	in	in	ADP
dpc-4969	90	35	the	the	DET
dpc-4969	90	36	negative	negative	ADJ
dpc-4969	90	37	direction	direction	NOUN
dpc-4969	90	38	,	,	PUNCT
dpc-4969	90	39	and	and	CCONJ
dpc-4969	90	40	these	these	DET
dpc-4969	90	41	findings	finding	NOUN
dpc-4969	90	42	were	be	AUX
dpc-4969	90	43	statistically	statistically	ADV
dpc-4969	90	44	significant	significant	ADJ
dpc-4969	90	45	(	(	PUNCT
dpc-4969	90	46	p	p	X
dpc-4969	90	47	=	=	NOUN
dpc-4969	90	48	0.002	0.002	NUM
dpc-4969	90	49	)	)	PUNCT
dpc-4969	90	50	.	.	PUNCT
dpc-4969	91	1	taking	take	VERB
dpc-4969	91	2	into	into	ADP
dpc-4969	91	3	account	account	NOUN
dpc-4969	91	4	the	the	DET
dpc-4969	91	5	duration	duration	NOUN
dpc-4969	91	6	of	of	ADP
dpc-4969	91	7	the	the	DET
dpc-4969	91	8	first	first	ADJ
dpc-4969	91	9	remission	remission	NOUN
dpc-4969	91	10	after	after	ADP
dpc-4969	91	11	treatment	treatment	NOUN
dpc-4969	91	12	,	,	PUNCT
dpc-4969	91	13	the	the	DET
dpc-4969	91	14	duration	duration	NOUN
dpc-4969	91	15	of	of	ADP
dpc-4969	91	16	the	the	DET
dpc-4969	91	17	first	first	ADJ
dpc-4969	91	18	remission	remission	NOUN
dpc-4969	91	19	in	in	ADP
dpc-4969	91	20	the	the	DET
dpc-4969	91	21	group	group	NOUN
dpc-4969	91	22	receiving	receive	VERB
dpc-4969	91	23	ivig	ivig	NOUN
dpc-4969	91	24	was	be	AUX
dpc-4969	91	25	found	find	VERB
dpc-4969	91	26	to	to	PART
dpc-4969	91	27	be	be	AUX
dpc-4969	91	28	significantly	significantly	ADV
dpc-4969	91	29	higher	high	ADJ
dpc-4969	91	30	in	in	ADP
dpc-4969	91	31	the	the	DET
dpc-4969	91	32	ivig	ivig	NOUN
dpc-4969	91	33	group	group	NOUN
dpc-4969	91	34	(	(	PUNCT
dpc-4969	91	35	30.95±20.17	30.95±20.17	NUM
dpc-4969	91	36	months	month	NOUN
dpc-4969	91	37	)	)	PUNCT
dpc-4969	91	38	than	than	ADP
dpc-4969	91	39	in	in	ADP
dpc-4969	91	40	the	the	DET
dpc-4969	91	41	group	group	NOUN
dpc-4969	91	42	that	that	PRON
dpc-4969	91	43	did	do	AUX
dpc-4969	91	44	not	not	PART
dpc-4969	91	45	receive	receive	VERB
dpc-4969	91	46	ivig	ivig	NOUN
dpc-4969	91	47	(	(	PUNCT
dpc-4969	91	48	11.87±10.53	11.87±10.53	NUM
dpc-4969	91	49	months	month	NOUN
dpc-4969	91	50	)	)	PUNCT
dpc-4969	92	1	(	(	PUNCT
dpc-4969	92	2	p	p	X
dpc-4969	92	3	<	<	X
dpc-4969	92	4	0.001	0.001	NUM
dpc-4969	92	5	)	)	PUNCT
dpc-4969	92	6	.	.	PUNCT
dpc-4969	93	1	lmr	lmr	PROPN
dpc-4969	93	2	values	value	NOUN
dpc-4969	93	3	measured	measure	VERB
dpc-4969	93	4	at	at	ADP
dpc-4969	93	5	all	all	DET
dpc-4969	93	6	times	time	NOUN
dpc-4969	93	7	in	in	ADP
dpc-4969	93	8	ivig	ivig	NOUN
dpc-4969	93	9	patients	patient	NOUN
dpc-4969	93	10	were	be	AUX
dpc-4969	93	11	found	find	VERB
dpc-4969	93	12	to	to	PART
dpc-4969	93	13	be	be	AUX
dpc-4969	93	14	significantly	significantly	ADV
dpc-4969	93	15	positively	positively	ADV
dpc-4969	93	16	correlated	correlate	VERB
dpc-4969	93	17	with	with	ADP
dpc-4969	93	18	the	the	DET
dpc-4969	93	19	duration	duration	NOUN
dpc-4969	93	20	of	of	ADP
dpc-4969	93	21	the	the	DET
dpc-4969	93	22	first	first	ADJ
dpc-4969	93	23	remission	remission	NOUN
dpc-4969	93	24	of	of	ADP
dpc-4969	93	25	the	the	DET
dpc-4969	93	26	disease	disease	NOUN
dpc-4969	93	27	(	(	PUNCT
dpc-4969	93	28	baseline	baseline	NOUN
dpc-4969	93	29	p	p	X
dpc-4969	93	30	=	=	NOUN
dpc-4969	93	31	0.007	0.007	NUM
dpc-4969	93	32	;	;	PUNCT
dpc-4969	93	33	3rd	3rd	ADJ
dpc-4969	93	34	month	month	NOUN
dpc-4969	93	35	p=0.005	p=0.005	NOUN
dpc-4969	93	36	;	;	PUNCT
dpc-4969	93	37	6th	6th	ADJ
dpc-4969	93	38	month	month	NOUN
dpc-4969	93	39	pp	pp	ADP
dpc-4969	93	40	0.02	0.02	NUM
dpc-4969	93	41	)	)	PUNCT
dpc-4969	93	42	.	.	PUNCT
dpc-4969	94	1	a	a	DET
dpc-4969	94	2	significant	significant	ADJ
dpc-4969	94	3	decrease	decrease	NOUN
dpc-4969	94	4	in	in	ADP
dpc-4969	94	5	neutrophil	neutrophil	ADJ
dpc-4969	94	6	(	(	PUNCT
dpc-4969	94	7	p=0.039	p=0.039	NOUN
dpc-4969	94	8	)	)	PUNCT
dpc-4969	94	9	and	and	CCONJ
dpc-4969	94	10	plt	plt	NOUN
dpc-4969	94	11	(	(	PUNCT
dpc-4969	94	12	p=0.049	p=0.049	PROPN
dpc-4969	94	13	)	)	PUNCT
dpc-4969	94	14	values	value	NOUN
dpc-4969	94	15	was	be	AUX
dpc-4969	94	16	observed	observe	VERB
dpc-4969	94	17	between	between	ADP
dpc-4969	94	18	the	the	DET
dpc-4969	94	19	baseline	baseline	NOUN
dpc-4969	94	20	and	and	CCONJ
dpc-4969	94	21	the	the	DET
dpc-4969	94	22	6th	6th	ADJ
dpc-4969	94	23	month	month	NOUN
dpc-4969	94	24	.	.	PUNCT
dpc-4969	95	1	in	in	ADP
dpc-4969	95	2	all	all	DET
dpc-4969	95	3	patients	patient	NOUN
dpc-4969	95	4	,	,	PUNCT
dpc-4969	95	5	there	there	PRON
dpc-4969	95	6	was	be	VERB
dpc-4969	95	7	a	a	DET
dpc-4969	95	8	significant	significant	ADJ
dpc-4969	95	9	decrease	decrease	NOUN
dpc-4969	95	10	in	in	ADP
dpc-4969	95	11	the	the	DET
dpc-4969	95	12	lymphocyte	lymphocyte	ADJ
dpc-4969	95	13	values	value	NOUN
dpc-4969	95	14	in	in	ADP
dpc-4969	95	15	the	the	DET
dpc-4969	95	16	sixth	sixth	ADJ
dpc-4969	95	17	month	month	NOUN
dpc-4969	95	18	compared	compare	VERB
dpc-4969	95	19	to	to	ADP
dpc-4969	95	20	the	the	DET
dpc-4969	95	21	values	value	NOUN
dpc-4969	95	22	of	of	ADP
dpc-4969	95	23	the	the	DET
dpc-4969	95	24	third	third	ADJ
dpc-4969	95	25	month	month	NOUN
dpc-4969	95	26	(	(	PUNCT
dpc-4969	95	27	p	p	X
dpc-4969	95	28	=	=	NOUN
dpc-4969	95	29	0.029	0.029	NUM
dpc-4969	95	30	)	)	PUNCT
dpc-4969	95	31	.	.	PUNCT
dpc-4969	96	1	there	there	PRON
dpc-4969	96	2	was	be	VERB
dpc-4969	96	3	a	a	DET
dpc-4969	96	4	significant	significant	ADJ
dpc-4969	96	5	decrease	decrease	NOUN
dpc-4969	96	6	in	in	ADP
dpc-4969	96	7	nlr	nlr	PROPN
dpc-4969	96	8	(	(	PUNCT
dpc-4969	96	9	p	p	NOUN
dpc-4969	96	10	=	=	NOUN
dpc-4969	96	11	0.019	0.019	NUM
dpc-4969	96	12	)	)	PUNCT
dpc-4969	96	13	and	and	CCONJ
dpc-4969	96	14	plr	plr	NOUN
dpc-4969	96	15	(	(	PUNCT
dpc-4969	96	16	p	p	X
dpc-4969	96	17	=	=	NOUN
dpc-4969	96	18	0.014	0.014	NUM
dpc-4969	96	19	)	)	PUNCT
dpc-4969	96	20	in	in	ADP
dpc-4969	96	21	all	all	DET
dpc-4969	96	22	patients	patient	NOUN
dpc-4969	96	23	at	at	ADP
dpc-4969	96	24	the	the	DET
dpc-4969	96	25	third	third	ADJ
dpc-4969	96	26	month	month	NOUN
dpc-4969	96	27	.	.	PUNCT
dpc-4969	97	1	there	there	PRON
dpc-4969	97	2	was	be	VERB
dpc-4969	97	3	a	a	DET
dpc-4969	97	4	significant	significant	ADJ
dpc-4969	97	5	decrease	decrease	NOUN
dpc-4969	97	6	in	in	ADP
dpc-4969	97	7	the	the	DET
dpc-4969	97	8	pdai	pdai	ADJ
dpc-4969	97	9	value	value	NOUN
dpc-4969	97	10	between	between	ADP
dpc-4969	97	11	all	all	DET
dpc-4969	97	12	times	time	NOUN
dpc-4969	97	13	(	(	PUNCT
dpc-4969	97	14	table	table	NOUN
dpc-4969	97	15	1	1	NUM
dpc-4969	97	16	)	)	PUNCT
dpc-4969	97	17	.	.	PUNCT
dpc-4969	98	1	when	when	SCONJ
dpc-4969	98	2	the	the	DET
dpc-4969	98	3	initial	initial	ADJ
dpc-4969	98	4	parameters	parameter	NOUN
dpc-4969	98	5	were	be	AUX
dpc-4969	98	6	examined	examine	VERB
dpc-4969	98	7	,	,	PUNCT
dpc-4969	98	8	a	a	DET
dpc-4969	98	9	significant	significant	ADJ
dpc-4969	98	10	positive	positive	ADJ
dpc-4969	98	11	correlation	correlation	NOUN
dpc-4969	98	12	was	be	AUX
dpc-4969	98	13	observed	observe	VERB
dpc-4969	98	14	between	between	ADP
dpc-4969	98	15	pdai	pdai	NOUN
dpc-4969	98	16	and	and	CCONJ
dpc-4969	98	17	neutrophils	neutrophil	NOUN
dpc-4969	98	18	.	.	PUNCT
dpc-4969	99	1	when	when	SCONJ
dpc-4969	99	2	the	the	DET
dpc-4969	99	3	3rd	3rd	ADJ
dpc-4969	99	4	month	month	NOUN
dpc-4969	99	5	parameters	parameter	NOUN
dpc-4969	99	6	are	be	AUX
dpc-4969	99	7	examined	examine	VERB
dpc-4969	99	8	,	,	PUNCT
dpc-4969	99	9	there	there	PRON
dpc-4969	99	10	is	be	VERB
dpc-4969	99	11	a	a	DET
dpc-4969	99	12	positive	positive	ADJ
dpc-4969	99	13	relationship	relationship	NOUN
dpc-4969	99	14	between	between	ADP
dpc-4969	99	15	3rd	3rd	ADJ
dpc-4969	99	16	month	month	NOUN
dpc-4969	99	17	pdai	pdai	NOUN
dpc-4969	99	18	and	and	CCONJ
dpc-4969	99	19	nlr	nlr	PROPN
dpc-4969	99	20	and	and	CCONJ
dpc-4969	99	21	plr	plr	NOUN
dpc-4969	99	22	;	;	PUNCT
dpc-4969	99	23	a	a	DET
dpc-4969	99	24	significant	significant	ADJ
dpc-4969	99	25	negative	negative	ADJ
dpc-4969	99	26	correlation	correlation	NOUN
dpc-4969	99	27	was	be	AUX
dpc-4969	99	28	observed	observe	VERB
dpc-4969	99	29	between	between	ADP
dpc-4969	99	30	pdai	pdai	NOUN
dpc-4969	99	31	and	and	CCONJ
dpc-4969	99	32	lymphocyte	lymphocyte	NOUN
dpc-4969	99	33	and	and	CCONJ
dpc-4969	99	34	lmr	lmr	PROPN
dpc-4969	99	35	.	.	PUNCT
dpc-4969	100	1	when	when	SCONJ
dpc-4969	100	2	original	original	ADJ
dpc-4969	100	3	article	article	NOUN
dpc-4969	100	4	|	|	ADV
dpc-4969	100	5	dermatol	dermatol	ADJ
dpc-4969	100	6	pract	pract	NOUN
dpc-4969	100	7	concept	concept	NOUN
dpc-4969	100	8	.	.	PUNCT
dpc-4969	101	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	101	2	5	5	NUM
dpc-4969	101	3	the	the	DET
dpc-4969	101	4	parameters	parameter	NOUN
dpc-4969	101	5	of	of	ADP
dpc-4969	101	6	the	the	DET
dpc-4969	101	7	6th	6th	ADJ
dpc-4969	101	8	month	month	NOUN
dpc-4969	101	9	were	be	AUX
dpc-4969	101	10	examined	examine	VERB
dpc-4969	101	11	,	,	PUNCT
dpc-4969	101	12	there	there	PRON
dpc-4969	101	13	was	be	VERB
dpc-4969	101	14	a	a	DET
dpc-4969	101	15	positive	positive	ADJ
dpc-4969	101	16	correlation	correlation	NOUN
dpc-4969	101	17	between	between	ADP
dpc-4969	101	18	the	the	DET
dpc-4969	101	19	pdai	pdai	NOUN
dpc-4969	101	20	of	of	ADP
dpc-4969	101	21	the	the	DET
dpc-4969	101	22	6th	6th	ADJ
dpc-4969	101	23	month	month	NOUN
dpc-4969	101	24	and	and	CCONJ
dpc-4969	101	25	neutrophils	neutrophil	NOUN
dpc-4969	101	26	,	,	PUNCT
dpc-4969	101	27	mpv	mpv	PROPN
dpc-4969	101	28	,	,	PUNCT
dpc-4969	101	29	crp	crp	PROPN
dpc-4969	101	30	,	,	PUNCT
dpc-4969	101	31	nlr	nlr	PROPN
dpc-4969	101	32	and	and	CCONJ
dpc-4969	101	33	plr	plr	NOUN
dpc-4969	101	34	;	;	PUNCT
dpc-4969	101	35	a	a	DET
dpc-4969	101	36	significant	significant	ADJ
dpc-4969	101	37	negative	negative	ADJ
dpc-4969	101	38	correlation	correlation	NOUN
dpc-4969	101	39	was	be	AUX
dpc-4969	101	40	observed	observe	VERB
dpc-4969	101	41	between	between	ADP
dpc-4969	101	42	pdai	pdai	PROPN
dpc-4969	101	43	and	and	CCONJ
dpc-4969	101	44	lymphocytes	lymphocyte	NOUN
dpc-4969	101	45	and	and	CCONJ
dpc-4969	101	46	lmr	lmr	PROPN
dpc-4969	101	47	(	(	PUNCT
dpc-4969	101	48	table	table	NOUN
dpc-4969	101	49	2	2	NUM
dpc-4969	101	50	)	)	PUNCT
dpc-4969	101	51	.	.	PUNCT
dpc-4969	102	1	the	the	DET
dpc-4969	102	2	mean	mean	ADJ
dpc-4969	102	3	follow	follow	VERB
dpc-4969	102	4	-	-	PUNCT
dpc-4969	102	5	up	up	NOUN
dpc-4969	102	6	period	period	NOUN
dpc-4969	102	7	of	of	ADP
dpc-4969	102	8	the	the	DET
dpc-4969	102	9	patients	patient	NOUN
dpc-4969	102	10	was	be	AUX
dpc-4969	102	11	found	find	VERB
dpc-4969	102	12	to	to	PART
dpc-4969	102	13	be	be	AUX
dpc-4969	102	14	57	57	NUM
dpc-4969	102	15	months	month	NOUN
dpc-4969	102	16	(	(	PUNCT
dpc-4969	102	17	min	min	NOUN
dpc-4969	102	18	=	=	SYM
dpc-4969	102	19	18	18	NUM
dpc-4969	102	20	,	,	PUNCT
dpc-4969	102	21	max	max	PROPN
dpc-4969	102	22	123	123	NUM
dpc-4969	102	23	)	)	PUNCT
dpc-4969	102	24	.	.	PUNCT
dpc-4969	103	1	the	the	DET
dpc-4969	103	2	duration	duration	NOUN
dpc-4969	103	3	of	of	ADP
dpc-4969	103	4	remission	remission	NOUN
dpc-4969	103	5	in	in	ADP
dpc-4969	103	6	the	the	DET
dpc-4969	103	7	ivig	ivig	NOUN
dpc-4969	103	8	-	-	PUNCT
dpc-4969	103	9	treated	treat	VERB
dpc-4969	103	10	group	group	NOUN
dpc-4969	103	11	was	be	AUX
dpc-4969	103	12	significantly	significantly	ADV
dpc-4969	103	13	longer	long	ADJ
dpc-4969	103	14	than	than	ADP
dpc-4969	103	15	the	the	DET
dpc-4969	103	16	duration	duration	NOUN
dpc-4969	103	17	of	of	ADP
dpc-4969	103	18	the	the	DET
dpc-4969	103	19	group	group	NOUN
dpc-4969	103	20	not	not	PART
dpc-4969	103	21	receiving	receive	VERB
dpc-4969	103	22	ivig	ivig	NOUN
dpc-4969	103	23	(	(	PUNCT
dpc-4969	103	24	p	p	X
dpc-4969	103	25	<	<	X
dpc-4969	103	26	0.001	0.001	NUM
dpc-4969	103	27	)	)	PUNCT
dpc-4969	103	28	.	.	PUNCT
dpc-4969	104	1	the	the	DET
dpc-4969	104	2	change	change	NOUN
dpc-4969	104	3	in	in	ADP
dpc-4969	104	4	lmr	lmr	PROPN
dpc-4969	104	5	in	in	ADP
dpc-4969	104	6	the	the	DET
dpc-4969	104	7	group	group	NOUN
dpc-4969	104	8	that	that	PRON
dpc-4969	104	9	received	receive	VERB
dpc-4969	104	10	ivig	ivig	NOUN
dpc-4969	104	11	was	be	AUX
dpc-4969	104	12	significantly	significantly	ADV
dpc-4969	104	13	higher	high	ADJ
dpc-4969	104	14	than	than	ADP
dpc-4969	104	15	the	the	DET
dpc-4969	104	16	change	change	NOUN
dpc-4969	104	17	in	in	ADP
dpc-4969	104	18	the	the	DET
dpc-4969	104	19	group	group	NOUN
dpc-4969	104	20	that	that	PRON
dpc-4969	104	21	did	do	AUX
dpc-4969	104	22	not	not	PART
dpc-4969	104	23	receive	receive	VERB
dpc-4969	104	24	ivig	ivig	NOUN
dpc-4969	104	25	(	(	PUNCT
dpc-4969	104	26	p	p	NOUN
dpc-4969	104	27	=	=	NOUN
dpc-4969	104	28	0.002	0.002	NUM
dpc-4969	104	29	)	)	PUNCT
dpc-4969	104	30	.	.	PUNCT
dpc-4969	105	1	there	there	PRON
dpc-4969	105	2	was	be	VERB
dpc-4969	105	3	no	no	DET
dpc-4969	105	4	significant	significant	ADJ
dpc-4969	105	5	difference	difference	NOUN
dpc-4969	105	6	between	between	ADP
dpc-4969	105	7	those	those	PRON
dpc-4969	105	8	who	who	PRON
dpc-4969	105	9	received	receive	VERB
dpc-4969	105	10	ivig	ivig	NOUN
dpc-4969	105	11	and	and	CCONJ
dpc-4969	105	12	those	those	PRON
dpc-4969	105	13	who	who	PRON
dpc-4969	105	14	did	do	VERB
dpc-4969	105	15	not	not	PART
dpc-4969	105	16	(	(	PUNCT
dpc-4969	105	17	p	p	X
dpc-4969	105	18	>	>	X
dpc-4969	105	19	0.05	0.05	NUM
dpc-4969	105	20	)	)	PUNCT
dpc-4969	105	21	in	in	ADP
dpc-4969	105	22	terms	term	NOUN
dpc-4969	105	23	of	of	ADP
dpc-4969	105	24	changes	change	NOUN
dpc-4969	105	25	in	in	ADP
dpc-4969	105	26	other	other	ADJ
dpc-4969	105	27	parameters	parameter	NOUN
dpc-4969	105	28	(	(	PUNCT
dpc-4969	105	29	table	table	NOUN
dpc-4969	105	30	3	3	NUM
dpc-4969	105	31	)	)	PUNCT
dpc-4969	105	32	.	.	PUNCT
dpc-4969	106	1	a	a	DET
dpc-4969	106	2	significant	significant	ADJ
dpc-4969	106	3	positive	positive	ADJ
dpc-4969	106	4	correlation	correlation	NOUN
dpc-4969	106	5	was	be	AUX
dpc-4969	106	6	observed	observe	VERB
dpc-4969	106	7	between	between	ADP
dpc-4969	106	8	the	the	DET
dpc-4969	106	9	duration	duration	NOUN
dpc-4969	106	10	of	of	ADP
dpc-4969	106	11	remission	remission	NOUN
dpc-4969	106	12	and	and	CCONJ
dpc-4969	106	13	the	the	DET
dpc-4969	106	14	lmr	lmr	PROPN
dpc-4969	106	15	value	value	NOUN
dpc-4969	106	16	at	at	ADP
dpc-4969	106	17	baseline	baseline	NOUN
dpc-4969	106	18	.	.	PUNCT
dpc-4969	107	1	3rd	3rd	ADJ
dpc-4969	107	2	and	and	CCONJ
dpc-4969	107	3	6th	6th	ADJ
dpc-4969	107	4	months	month	NOUN
dpc-4969	107	5	in	in	ADP
dpc-4969	107	6	patients	patient	NOUN
dpc-4969	107	7	receiving	receive	VERB
dpc-4969	107	8	ivig	ivig	NOUN
dpc-4969	107	9	(	(	PUNCT
dpc-4969	107	10	table	table	NOUN
dpc-4969	107	11	4	4	NUM
dpc-4969	107	12	)	)	PUNCT
dpc-4969	107	13	.	.	PUNCT
dpc-4969	108	1	table	table	NOUN
dpc-4969	108	2	2	2	NUM
dpc-4969	108	3	.	.	PUNCT
dpc-4969	108	4	correlation	correlation	NOUN
dpc-4969	108	5	of	of	ADP
dpc-4969	108	6	pdai	pdai	ADJ
dpc-4969	108	7	values	value	NOUN
dpc-4969	108	8	with	with	ADP
dpc-4969	108	9	other	other	ADJ
dpc-4969	108	10	parameters	parameter	NOUN
dpc-4969	108	11	over	over	ADP
dpc-4969	108	12	time	time	NOUN
dpc-4969	108	13	.	.	PUNCT
dpc-4969	109	1	pdai	pdai	PROPN
dpc-4969	109	2	at	at	ADP
dpc-4969	109	3	the	the	DET
dpc-4969	109	4	beginning	beginning	NOUN
dpc-4969	109	5	pdai	pdai	NOUN
dpc-4969	109	6	at	at	ADP
dpc-4969	109	7	3	3	NUM
dpc-4969	109	8	months	month	NOUN
dpc-4969	109	9	pdai	pdai	X
dpc-4969	109	10	at	at	ADP
dpc-4969	109	11	6	6	NUM
dpc-4969	109	12	months	month	NOUN
dpc-4969	109	13	r	r	NOUN
dpc-4969	109	14	p	p	NOUN
dpc-4969	109	15	r	r	NOUN
dpc-4969	109	16	p	p	NOUN
dpc-4969	109	17	r	r	NOUN
dpc-4969	109	18	p	p	NOUN
dpc-4969	109	19	neutrophil	neutrophil	ADJ
dpc-4969	109	20	.237	.237	NUM
dpc-4969	109	21	.039	.039	NUM
dpc-4969	109	22	.142	.142	NUM
dpc-4969	109	23	.222	.222	NUM
dpc-4969	109	24	.249	.249	NUM
dpc-4969	109	25	.030	.030	NUM
dpc-4969	109	26	lymphocyte	lymphocyte	PROPN
dpc-4969	109	27	-.110	-.110	PROPN
dpc-4969	109	28	.346	.346	NUM
dpc-4969	109	29	-.238	-.238	PROPN
dpc-4969	109	30	.039	.039	NUM
dpc-4969	109	31	-.226	-.226	NOUN
dpc-4969	109	32	.049	.049	NUM
dpc-4969	109	33	monocyte	monocyte	NOUN
dpc-4969	109	34	-.016	-.016	PROPN
dpc-4969	109	35	.891	.891	NUM
dpc-4969	109	36	.023	.023	NUM
dpc-4969	109	37	.841	.841	NUM
dpc-4969	109	38	.152	.152	NUM
dpc-4969	109	39	.189	.189	NUM
dpc-4969	110	1	plt	plt	PROPN
dpc-4969	110	2	-.026	-.026	PROPN
dpc-4969	110	3	.822	.822	NUM
dpc-4969	110	4	.072	.072	NUM
dpc-4969	110	5	.538	.538	NUM
dpc-4969	110	6	-.004	-.004	PROPN
dpc-4969	110	7	.975	.975	NUM
dpc-4969	110	8	mpv	mpv	PROPN
dpc-4969	110	9	.002	.002	NUM
dpc-4969	110	10	.989	.989	NUM
dpc-4969	110	11	.148	.148	NUM
dpc-4969	110	12	.203	.203	NUM
dpc-4969	110	13	.254	.254	NUM
dpc-4969	110	14	.027	.027	NUM
dpc-4969	110	15	crp	crp	PROPN
dpc-4969	110	16	-.082	-.082	PROPN
dpc-4969	110	17	.482	.482	NUM
dpc-4969	110	18	.195	.195	NUM
dpc-4969	110	19	.091	.091	NUM
dpc-4969	110	20	.322	.322	NUM
dpc-4969	110	21	.005	.005	NUM
dpc-4969	110	22	sedimantation	sedimantation	NOUN
dpc-4969	110	23	.001	.001	NUM
dpc-4969	110	24	.990	.990	NUM
dpc-4969	110	25	.109	.109	NUM
dpc-4969	110	26	.350	.350	NUM
dpc-4969	110	27	.089	.089	NUM
dpc-4969	110	28	.445	.445	NUM
dpc-4969	111	1	nlr	nlr	PROPN
dpc-4969	111	2	.213	.213	NUM
dpc-4969	111	3	.065	.065	NUM
dpc-4969	111	4	.282	.282	NUM
dpc-4969	111	5	.014	.014	NUM
dpc-4969	111	6	.386	.386	NUM
dpc-4969	111	7	.001	.001	NUM
dpc-4969	111	8	lmr	lmr	PROPN
dpc-4969	111	9	-.064	-.064	PROPN
dpc-4969	111	10	.582	.582	NUM
dpc-4969	112	1	-.318	-.318	PROPN
dpc-4969	112	2	.005	.005	NUM
dpc-4969	112	3	-.353	-.353	PROPN
dpc-4969	112	4	.002	.002	NUM
dpc-4969	112	5	plr	plr	NOUN
dpc-4969	112	6	.073	.073	NUM
dpc-4969	112	7	.531	.531	NUM
dpc-4969	112	8	.240	.240	NUM
dpc-4969	112	9	.037	.037	NUM
dpc-4969	112	10	.236	.236	NUM
dpc-4969	112	11	.041	.041	NUM
dpc-4969	112	12	abbreviations	abbreviation	NOUN
dpc-4969	112	13	.	.	PUNCT
dpc-4969	113	1	crp	crp	PROPN
dpc-4969	113	2	:	:	PUNCT
dpc-4969	114	1	c	c	X
dpc-4969	114	2	-	-	PUNCT
dpc-4969	114	3	reactive	reactive	ADJ
dpc-4969	114	4	protein	protein	NOUN
dpc-4969	114	5	;	;	PUNCT
dpc-4969	114	6	lmr	lmr	NOUN
dpc-4969	114	7	:	:	PUNCT
dpc-4969	114	8	lymphocyte	lymphocyte	NOUN
dpc-4969	114	9	-	-	PUNCT
dpc-4969	114	10	to	to	ADP
dpc-4969	114	11	-	-	PUNCT
dpc-4969	114	12	monocyte	monocyte	NOUN
dpc-4969	114	13	ratio	ratio	NOUN
dpc-4969	114	14	;	;	PUNCT
dpc-4969	114	15	mpv	mpv	PROPN
dpc-4969	114	16	:	:	PUNCT
dpc-4969	114	17	mean	mean	ADJ
dpc-4969	114	18	platelet	platelet	NOUN
dpc-4969	114	19	volume	volume	NOUN
dpc-4969	114	20	;	;	PUNCT
dpc-4969	115	1	nlr	nlr	PROPN
dpc-4969	115	2	:	:	PUNCT
dpc-4969	115	3	neutrophil	neutrophil	ADJ
dpc-4969	115	4	-	-	PUNCT
dpc-4969	115	5	to	to	ADP
dpc-4969	115	6	-	-	PUNCT
dpc-4969	115	7	lymphocyte	lymphocyte	NOUN
dpc-4969	115	8	ratio	ratio	NOUN
dpc-4969	115	9	;	;	PUNCT
dpc-4969	115	10	pdai	pdai	X
dpc-4969	115	11	:	:	PUNCT
dpc-4969	115	12	pemphigus	pemphigus	PROPN
dpc-4969	115	13	disease	disease	PROPN
dpc-4969	115	14	area	area	PROPN
dpc-4969	115	15	index	index	NOUN
dpc-4969	115	16	;	;	PUNCT
dpc-4969	115	17	plr	plr	NOUN
dpc-4969	115	18	:	:	PUNCT
dpc-4969	115	19	platelet	platelet	NOUN
dpc-4969	115	20	-	-	PUNCT
dpc-4969	115	21	to	to	ADP
dpc-4969	115	22	-	-	PUNCT
dpc-4969	115	23	lymphocyte	lymphocyte	NOUN
dpc-4969	115	24	ratio	ratio	NOUN
dpc-4969	115	25	;	;	PUNCT
dpc-4969	115	26	plt	plt	NOUN
dpc-4969	115	27	:	:	PUNCT
dpc-4969	115	28	platelet	platelet	NOUN
dpc-4969	115	29	.	.	PUNCT
dpc-4969	115	30	table	table	NOUN
dpc-4969	116	1	3	3	NUM
dpc-4969	116	2	.	.	PUNCT
dpc-4969	116	3	comparison	comparison	NOUN
dpc-4969	116	4	of	of	ADP
dpc-4969	116	5	changes	change	NOUN
dpc-4969	116	6	in	in	ADP
dpc-4969	116	7	parameters	parameter	NOUN
dpc-4969	116	8	according	accord	VERB
dpc-4969	116	9	to	to	ADP
dpc-4969	116	10	treatment	treatment	NOUN
dpc-4969	116	11	status	status	NOUN
dpc-4969	116	12	.	.	PUNCT
dpc-4969	117	1	receiving	receive	VERB
dpc-4969	117	2	ivig	ivig	NOUN
dpc-4969	117	3	not	not	PART
dpc-4969	117	4	receiving	receive	VERB
dpc-4969	117	5	ivig	ivig	NOUN
dpc-4969	117	6	pmean±sd	pmean±sd	X
dpc-4969	117	7	mean±sd	mean±sd	ADP
dpc-4969	117	8	duration	duration	NOUN
dpc-4969	117	9	of	of	ADP
dpc-4969	117	10	remission	remission	NOUN
dpc-4969	117	11	30.95±20.17	30.95±20.17	NUM
dpc-4969	117	12	11.87±10.53	11.87±10.53	NUM
dpc-4969	117	13	<	<	X
dpc-4969	117	14	0.001	0.001	NUM
dpc-4969	117	15	change	change	NOUN
dpc-4969	117	16	of	of	ADP
dpc-4969	117	17	mpv	mpv	PROPN
dpc-4969	117	18	value	value	PROPN
dpc-4969	117	19	.50±1.97	.50±1.97	X
dpc-4969	117	20	.15±1.30	.15±1.30	PUNCT
dpc-4969	117	21	0.330	0.330	NUM
dpc-4969	117	22	change	change	NOUN
dpc-4969	117	23	of	of	ADP
dpc-4969	117	24	crp	crp	NOUN
dpc-4969	117	25	value	value	NOUN
dpc-4969	117	26	5.02±18.59	5.02±18.59	NUM
dpc-4969	117	27	6.84±28.61	6.84±28.61	NUM
dpc-4969	117	28	0.232	0.232	NUM
dpc-4969	117	29	change	change	NOUN
dpc-4969	117	30	of	of	ADP
dpc-4969	117	31	sedimantation	sedimantation	NOUN
dpc-4969	117	32	-.60±16.69	-.60±16.69	NOUN
dpc-4969	117	33	1.94±19.32	1.94±19.32	NUM
dpc-4969	117	34	0.582	0.582	NUM
dpc-4969	117	35	change	change	NOUN
dpc-4969	117	36	of	of	ADP
dpc-4969	117	37	nlr	nlr	PROPN
dpc-4969	117	38	1.50±5.55	1.50±5.55	PROPN
dpc-4969	117	39	.22±3.74	.22±3.74	NUM
dpc-4969	117	40	0.234	0.234	NUM
dpc-4969	117	41	change	change	NOUN
dpc-4969	117	42	of	of	ADP
dpc-4969	117	43	lmr	lmr	PROPN
dpc-4969	117	44	.54±1.38	.54±1.38	PROPN
dpc-4969	117	45	-.51±1.49	-.51±1.49	ADP
dpc-4969	117	46	0.002	0.002	NUM
dpc-4969	117	47	change	change	NOUN
dpc-4969	117	48	of	of	ADP
dpc-4969	117	49	plr	plr	NOUN
dpc-4969	117	50	31.76±109.30	31.76±109.30	PROPN
dpc-4969	117	51	7.75±102.87	7.75±102.87	NUM
dpc-4969	117	52	0.456	0.456	NUM
dpc-4969	117	53	change	change	NOUN
dpc-4969	117	54	of	of	ADP
dpc-4969	117	55	pdai	pdai	ADJ
dpc-4969	117	56	6.62±7.13	6.62±7.13	NUM
dpc-4969	117	57	4.97±6.03	4.97±6.03	NUM
dpc-4969	117	58	0.186	0.186	NUM
dpc-4969	117	59	*	*	PUNCT
dpc-4969	117	60	mann	mann	PROPN
dpc-4969	117	61	whitney	whitney	PROPN
dpc-4969	117	62	u	u	PROPN
dpc-4969	117	63	analysis	analysis	NOUN
dpc-4969	117	64	was	be	AUX
dpc-4969	117	65	applied	apply	VERB
dpc-4969	117	66	.	.	PUNCT
dpc-4969	118	1	abbreviations	abbreviation	NOUN
dpc-4969	118	2	.	.	PUNCT
dpc-4969	119	1	crp	crp	PROPN
dpc-4969	119	2	:	:	PUNCT
dpc-4969	120	1	c	c	X
dpc-4969	120	2	-	-	PUNCT
dpc-4969	120	3	reactive	reactive	ADJ
dpc-4969	120	4	protein	protein	NOUN
dpc-4969	120	5	;	;	PUNCT
dpc-4969	120	6	ivig	ivig	NOUN
dpc-4969	120	7	:	:	PUNCT
dpc-4969	120	8	intravenous	intravenous	ADJ
dpc-4969	120	9	immunoglobulin	immunoglobulin	NOUN
dpc-4969	120	10	;	;	PUNCT
dpc-4969	120	11	lmr	lmr	NOUN
dpc-4969	120	12	:	:	PUNCT
dpc-4969	120	13	lymphocyte	lymphocyte	NOUN
dpc-4969	120	14	-	-	PUNCT
dpc-4969	120	15	to	to	ADP
dpc-4969	120	16	-	-	PUNCT
dpc-4969	120	17	monocyte	monocyte	NOUN
dpc-4969	120	18	ratio	ratio	NOUN
dpc-4969	120	19	;	;	PUNCT
dpc-4969	120	20	mpv	mpv	PROPN
dpc-4969	120	21	:	:	PUNCT
dpc-4969	120	22	mean	mean	ADJ
dpc-4969	120	23	platelet	platelet	NOUN
dpc-4969	120	24	volume	volume	NOUN
dpc-4969	120	25	;	;	PUNCT
dpc-4969	121	1	nlr	nlr	PROPN
dpc-4969	121	2	:	:	PUNCT
dpc-4969	121	3	neutrophil	neutrophil	ADJ
dpc-4969	121	4	-	-	PUNCT
dpc-4969	121	5	to	to	ADP
dpc-4969	121	6	-	-	PUNCT
dpc-4969	121	7	lymphocyte	lymphocyte	NOUN
dpc-4969	121	8	ratio	ratio	NOUN
dpc-4969	121	9	;	;	PUNCT
dpc-4969	121	10	pdai	pdai	X
dpc-4969	121	11	:	:	PUNCT
dpc-4969	121	12	pemphigus	pemphigus	PROPN
dpc-4969	121	13	disease	disease	PROPN
dpc-4969	121	14	area	area	PROPN
dpc-4969	121	15	index	index	NOUN
dpc-4969	121	16	;	;	PUNCT
dpc-4969	121	17	plr	plr	NOUN
dpc-4969	121	18	:	:	PUNCT
dpc-4969	121	19	platelet	platelet	NOUN
dpc-4969	121	20	-	-	PUNCT
dpc-4969	121	21	to	to	ADP
dpc-4969	121	22	-	-	PUNCT
dpc-4969	121	23	lymphocyte	lymphocyte	NOUN
dpc-4969	121	24	ratio	ratio	NOUN
dpc-4969	121	25	;	;	PUNCT
dpc-4969	121	26	plt	plt	NOUN
dpc-4969	121	27	:	:	PUNCT
dpc-4969	121	28	platelet	platelet	NOUN
dpc-4969	121	29	;	;	PUNCT
dpc-4969	121	30	sd	sd	NUM
dpc-4969	121	31	:	:	PUNCT
dpc-4969	121	32	standart	standart	NOUN
dpc-4969	121	33	deviation	deviation	NOUN
dpc-4969	121	34	.	.	PUNCT
dpc-4969	122	1	table	table	NOUN
dpc-4969	122	2	4	4	NUM
dpc-4969	122	3	.	.	PUNCT
dpc-4969	122	4	correlation	correlation	NOUN
dpc-4969	122	5	of	of	ADP
dpc-4969	122	6	the	the	DET
dpc-4969	122	7	duration	duration	NOUN
dpc-4969	122	8	of	of	ADP
dpc-4969	122	9	remission	remission	NOUN
dpc-4969	122	10	and	and	CCONJ
dpc-4969	122	11	the	the	DET
dpc-4969	122	12	lmr	lmr	PROPN
dpc-4969	122	13	value	value	NOUN
dpc-4969	122	14	in	in	ADP
dpc-4969	122	15	patients	patient	NOUN
dpc-4969	122	16	receiving	receive	VERB
dpc-4969	122	17	ivig	ivig	NOUN
dpc-4969	122	18	.	.	PUNCT
dpc-4969	123	1	duration	duration	NOUN
dpc-4969	123	2	of	of	ADP
dpc-4969	123	3	remission	remission	NOUN
dpc-4969	123	4	r	r	PROPN
dpc-4969	123	5	p	p	PROPN
dpc-4969	123	6	lmr	lmr	PROPN
dpc-4969	123	7	at	at	ADP
dpc-4969	123	8	the	the	DET
dpc-4969	123	9	beginning	begin	VERB
dpc-4969	123	10	0.398	0.398	NUM
dpc-4969	123	11	0.007	0.007	NUM
dpc-4969	123	12	lmr	lmr	PROPN
dpc-4969	123	13	at	at	ADP
dpc-4969	123	14	3	3	NUM
dpc-4969	123	15	months	month	NOUN
dpc-4969	123	16	0.414	0.414	NUM
dpc-4969	123	17	0.005	0.005	NUM
dpc-4969	123	18	lmr	lmr	NOUN
dpc-4969	123	19	at	at	ADP
dpc-4969	123	20	6	6	NUM
dpc-4969	123	21	months	month	NOUN
dpc-4969	123	22	0.350	0.350	NUM
dpc-4969	123	23	0.020	0.020	NUM
dpc-4969	123	24	change	change	NOUN
dpc-4969	123	25	of	of	ADP
dpc-4969	123	26	lmr	lmr	PROPN
dpc-4969	123	27	-0.077	-0.077	PUNCT
dpc-4969	123	28	0.617	0.617	NUM
dpc-4969	123	29	abbreviations	abbreviation	NOUN
dpc-4969	123	30	.	.	PUNCT
dpc-4969	124	1	lmr	lmr	NOUN
dpc-4969	124	2	:	:	PUNCT
dpc-4969	124	3	lymphocyte	lymphocyte	PROPN
dpc-4969	124	4	-	-	PUNCT
dpc-4969	124	5	to	to	ADP
dpc-4969	124	6	-	-	PUNCT
dpc-4969	124	7	monocyte	monocyte	NOUN
dpc-4969	124	8	ratio	ratio	NOUN
dpc-4969	124	9	conclusions	conclusion	NOUN
dpc-4969	124	10	currently	currently	ADV
dpc-4969	124	11	,	,	PUNCT
dpc-4969	124	12	there	there	PRON
dpc-4969	124	13	is	be	VERB
dpc-4969	124	14	no	no	DET
dpc-4969	124	15	biomarker	biomarker	NOUN
dpc-4969	124	16	that	that	PRON
dpc-4969	124	17	shows	show	VERB
dpc-4969	124	18	the	the	DET
dpc-4969	124	19	efficacy	efficacy	NOUN
dpc-4969	124	20	of	of	ADP
dpc-4969	124	21	pemphigus	pemphigus	NOUN
dpc-4969	124	22	treatment	treatment	NOUN
dpc-4969	124	23	and	and	CCONJ
dpc-4969	124	24	the	the	DET
dpc-4969	124	25	duration	duration	NOUN
dpc-4969	124	26	of	of	ADP
dpc-4969	124	27	disease	disease	NOUN
dpc-4969	124	28	remission	remission	NOUN
dpc-4969	124	29	.	.	PUNCT
dpc-4969	125	1	we	we	PRON
dpc-4969	125	2	think	think	VERB
dpc-4969	125	3	that	that	SCONJ
dpc-4969	125	4	neutrophil	neutrophil	ADJ
dpc-4969	125	5	,	,	PUNCT
dpc-4969	125	6	platelet	platelet	NOUN
dpc-4969	125	7	,	,	PUNCT
dpc-4969	125	8	nlr	nlr	PROPN
dpc-4969	125	9	and	and	CCONJ
dpc-4969	125	10	plr	plr	NOUN
dpc-4969	125	11	values	value	NOUN
dpc-4969	125	12	can	can	AUX
dpc-4969	125	13	be	be	AUX
dpc-4969	125	14	used	use	VERB
dpc-4969	125	15	to	to	PART
dpc-4969	125	16	monitor	monitor	VERB
dpc-4969	125	17	the	the	DET
dpc-4969	125	18	response	response	NOUN
dpc-4969	125	19	to	to	ADP
dpc-4969	125	20	treatment	treatment	NOUN
dpc-4969	125	21	in	in	ADP
dpc-4969	125	22	pemphigus	pemphigus	NOUN
dpc-4969	125	23	,	,	PUNCT
dpc-4969	125	24	6	6	NUM
dpc-4969	125	25	original	original	ADJ
dpc-4969	125	26	article	article	NOUN
dpc-4969	125	27	|	|	ADV
dpc-4969	125	28	dermatol	dermatol	ADJ
dpc-4969	125	29	pract	pract	NOUN
dpc-4969	125	30	concept	concept	NOUN
dpc-4969	125	31	.	.	PUNCT
dpc-4969	126	1	2025;15(1):4969	2025;15(1):4969	PROPN
dpc-4969	126	2	think	think	VERB
dpc-4969	126	3	that	that	SCONJ
dpc-4969	126	4	the	the	DET
dpc-4969	126	5	number	number	NOUN
dpc-4969	126	6	of	of	ADP
dpc-4969	126	7	lymphocytes	lymphocyte	NOUN
dpc-4969	126	8	measured	measure	VERB
dpc-4969	126	9	in	in	ADP
dpc-4969	126	10	peripheral	peripheral	ADJ
dpc-4969	126	11	blood	blood	NOUN
dpc-4969	126	12	can	can	AUX
dpc-4969	126	13	be	be	AUX
dpc-4969	126	14	used	use	VERB
dpc-4969	126	15	in	in	ADP
dpc-4969	126	16	pemphigus	pemphigus	NOUN
dpc-4969	126	17	diseases	disease	NOUN
dpc-4969	126	18	after	after	ADP
dpc-4969	126	19	the	the	DET
dpc-4969	126	20	beginning	beginning	NOUN
dpc-4969	126	21	of	of	ADP
dpc-4969	126	22	treatment	treatment	NOUN
dpc-4969	126	23	,	,	PUNCT
dpc-4969	126	24	both	both	CCONJ
dpc-4969	126	25	in	in	ADP
dpc-4969	126	26	estimating	estimate	VERB
dpc-4969	126	27	the	the	DET
dpc-4969	126	28	severity	severity	NOUN
dpc-4969	126	29	of	of	ADP
dpc-4969	126	30	the	the	DET
dpc-4969	126	31	disease	disease	NOUN
dpc-4969	126	32	and	and	CCONJ
dpc-4969	126	33	in	in	ADP
dpc-4969	126	34	the	the	DET
dpc-4969	126	35	follow	follow	NOUN
dpc-4969	126	36	-	-	PUNCT
dpc-4969	126	37	up	up	NOUN
dpc-4969	126	38	of	of	ADP
dpc-4969	126	39	the	the	DET
dpc-4969	126	40	treatment	treatment	NOUN
dpc-4969	126	41	.	.	PUNCT
dpc-4969	127	1	nlr	nlr	PROPN
dpc-4969	127	2	levels	level	NOUN
dpc-4969	127	3	,	,	PUNCT
dpc-4969	127	4	obtained	obtain	VERB
dpc-4969	127	5	by	by	ADP
dpc-4969	127	6	dividing	divide	VERB
dpc-4969	127	7	the	the	DET
dpc-4969	127	8	number	number	NOUN
dpc-4969	127	9	of	of	ADP
dpc-4969	127	10	neutrophils	neutrophil	NOUN
dpc-4969	127	11	measured	measure	VERB
dpc-4969	127	12	in	in	ADP
dpc-4969	127	13	peripheral	peripheral	ADJ
dpc-4969	127	14	blood	blood	NOUN
dpc-4969	127	15	by	by	ADP
dpc-4969	127	16	the	the	DET
dpc-4969	127	17	number	number	NOUN
dpc-4969	127	18	of	of	ADP
dpc-4969	127	19	lymphocytes	lymphocyte	NOUN
dpc-4969	127	20	,	,	PUNCT
dpc-4969	127	21	have	have	AUX
dpc-4969	127	22	been	be	AUX
dpc-4969	127	23	investigated	investigate	VERB
dpc-4969	127	24	for	for	ADP
dpc-4969	127	25	use	use	NOUN
dpc-4969	127	26	in	in	ADP
dpc-4969	127	27	the	the	DET
dpc-4969	127	28	follow	follow	NOUN
dpc-4969	127	29	-	-	PUNCT
dpc-4969	127	30	up	up	NOUN
dpc-4969	127	31	of	of	ADP
dpc-4969	127	32	many	many	ADJ
dpc-4969	127	33	different	different	ADJ
dpc-4969	127	34	diseases	disease	NOUN
dpc-4969	127	35	such	such	ADJ
dpc-4969	127	36	as	as	ADP
dpc-4969	127	37	malignant	malignant	ADJ
dpc-4969	127	38	,	,	PUNCT
dpc-4969	127	39	inflammatory	inflammatory	ADJ
dpc-4969	127	40	and	and	CCONJ
dpc-4969	127	41	psychiatric	psychiatric	ADJ
dpc-4969	127	42	diseases	disease	NOUN
dpc-4969	127	43	[	[	X
dpc-4969	127	44	22	22	NUM
dpc-4969	127	45	-	-	SYM
dpc-4969	127	46	28	28	NUM
dpc-4969	127	47	]	]	PUNCT
dpc-4969	127	48	.	.	PUNCT
dpc-4969	128	1	nlr	nlr	PROPN
dpc-4969	128	2	was	be	AUX
dpc-4969	128	3	also	also	ADV
dpc-4969	128	4	investigated	investigate	VERB
dpc-4969	128	5	in	in	ADP
dpc-4969	128	6	dermatological	dermatological	ADJ
dpc-4969	128	7	diseases	disease	NOUN
dpc-4969	128	8	such	such	ADJ
dpc-4969	128	9	as	as	ADP
dpc-4969	128	10	bullous	bullous	ADJ
dpc-4969	128	11	pemphigoid	pemphigoid	NOUN
dpc-4969	128	12	[	[	X
dpc-4969	128	13	29	29	NUM
dpc-4969	128	14	]	]	PUNCT
dpc-4969	128	15	,	,	PUNCT
dpc-4969	128	16	psoriasis	psoriasis	NOUN
dpc-4969	128	17	[	[	X
dpc-4969	128	18	30	30	NUM
dpc-4969	128	19	]	]	PUNCT
dpc-4969	128	20	and	and	CCONJ
dpc-4969	128	21	lichen	lichen	NOUN
dpc-4969	128	22	planus	planu	NOUN
dpc-4969	128	23	,	,	PUNCT
dpc-4969	128	24	and	and	CCONJ
dpc-4969	128	25	significantly	significantly	ADV
dpc-4969	128	26	higher	high	ADJ
dpc-4969	128	27	values	value	NOUN
dpc-4969	128	28	were	be	AUX
dpc-4969	128	29	found	find	VERB
dpc-4969	128	30	in	in	ADP
dpc-4969	128	31	the	the	DET
dpc-4969	128	32	patient	patient	NOUN
dpc-4969	128	33	group	group	NOUN
dpc-4969	128	34	compared	compare	VERB
dpc-4969	128	35	to	to	ADP
dpc-4969	128	36	healthy	healthy	ADJ
dpc-4969	128	37	controls	control	NOUN
dpc-4969	128	38	[	[	X
dpc-4969	128	39	31	31	NUM
dpc-4969	128	40	]	]	PUNCT
dpc-4969	128	41	.	.	PUNCT
dpc-4969	129	1	in	in	ADP
dpc-4969	129	2	the	the	DET
dpc-4969	129	3	study	study	NOUN
dpc-4969	129	4	by	by	ADP
dpc-4969	129	5	ucmak	ucmak	PROPN
dpc-4969	129	6	et	et	PROPN
dpc-4969	129	7	al	al	PROPN
dpc-4969	129	8	,	,	PUNCT
dpc-4969	129	9	it	it	PRON
dpc-4969	129	10	was	be	AUX
dpc-4969	129	11	determined	determine	VERB
dpc-4969	129	12	that	that	SCONJ
dpc-4969	129	13	the	the	DET
dpc-4969	129	14	value	value	NOUN
dpc-4969	129	15	of	of	ADP
dpc-4969	129	16	nlr	nlr	PROPN
dpc-4969	129	17	was	be	AUX
dpc-4969	129	18	higher	high	ADJ
dpc-4969	129	19	in	in	ADP
dpc-4969	129	20	patients	patient	NOUN
dpc-4969	129	21	with	with	ADP
dpc-4969	129	22	pv	pv	NOUN
dpc-4969	129	23	than	than	ADP
dpc-4969	129	24	in	in	ADP
dpc-4969	129	25	healthy	healthy	ADJ
dpc-4969	129	26	controls	control	NOUN
dpc-4969	129	27	,	,	PUNCT
dpc-4969	129	28	but	but	CCONJ
dpc-4969	129	29	was	be	AUX
dpc-4969	129	30	not	not	PART
dpc-4969	129	31	correlated	correlate	VERB
dpc-4969	129	32	with	with	ADP
dpc-4969	129	33	the	the	DET
dpc-4969	129	34	severity	severity	NOUN
dpc-4969	129	35	of	of	ADP
dpc-4969	129	36	the	the	DET
dpc-4969	129	37	disease	disease	NOUN
dpc-4969	129	38	[	[	X
dpc-4969	129	39	32	32	NUM
dpc-4969	129	40	]	]	PUNCT
dpc-4969	129	41	.	.	PUNCT
dpc-4969	130	1	in	in	ADP
dpc-4969	130	2	the	the	DET
dpc-4969	130	3	study	study	NOUN
dpc-4969	130	4	by	by	ADP
dpc-4969	130	5	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	130	6	et	et	PROPN
dpc-4969	130	7	al	al	PROPN
dpc-4969	130	8	,	,	PUNCT
dpc-4969	130	9	a	a	DET
dpc-4969	130	10	significant	significant	ADJ
dpc-4969	130	11	positive	positive	ADJ
dpc-4969	130	12	correlation	correlation	NOUN
dpc-4969	130	13	was	be	AUX
dpc-4969	130	14	observed	observe	VERB
dpc-4969	130	15	between	between	ADP
dpc-4969	130	16	disease	disease	NOUN
dpc-4969	130	17	activity	activity	NOUN
dpc-4969	130	18	and	and	CCONJ
dpc-4969	130	19	the	the	DET
dpc-4969	130	20	value	value	NOUN
dpc-4969	130	21	of	of	ADP
dpc-4969	130	22	nlr	nlr	PROPN
dpc-4969	130	23	in	in	ADP
dpc-4969	130	24	pemphigus	pemphigus	PROPN
dpc-4969	130	25	.	.	PUNCT
dpc-4969	131	1	nlr	nlr	PROPN
dpc-4969	131	2	was	be	AUX
dpc-4969	131	3	found	find	VERB
dpc-4969	131	4	to	to	PART
dpc-4969	131	5	be	be	AUX
dpc-4969	131	6	high	high	ADJ
dpc-4969	131	7	at	at	ADP
dpc-4969	131	8	diagnosis	diagnosis	NOUN
dpc-4969	131	9	,	,	PUNCT
dpc-4969	131	10	showed	show	VERB
dpc-4969	131	11	a	a	DET
dpc-4969	131	12	significant	significant	ADJ
dpc-4969	131	13	decrease	decrease	NOUN
dpc-4969	131	14	in	in	ADP
dpc-4969	131	15	remission	remission	NOUN
dpc-4969	131	16	,	,	PUNCT
dpc-4969	131	17	and	and	CCONJ
dpc-4969	131	18	increased	increase	VERB
dpc-4969	131	19	again	again	ADV
dpc-4969	131	20	in	in	ADP
dpc-4969	131	21	relapse	relapse	NOUN
dpc-4969	131	22	[	[	X
dpc-4969	131	23	33	33	NUM
dpc-4969	131	24	]	]	PUNCT
dpc-4969	131	25	.	.	PUNCT
dpc-4969	132	1	in	in	ADP
dpc-4969	132	2	our	our	PRON
dpc-4969	132	3	study	study	NOUN
dpc-4969	132	4	,	,	PUNCT
dpc-4969	132	5	consistent	consistent	ADJ
dpc-4969	132	6	with	with	ADP
dpc-4969	132	7	the	the	DET
dpc-4969	132	8	study	study	NOUN
dpc-4969	132	9	by	by	ADP
dpc-4969	132	10	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	132	11	et	et	PROPN
dpc-4969	132	12	al	al	PROPN
dpc-4969	132	13	,	,	PUNCT
dpc-4969	132	14	it	it	PRON
dpc-4969	132	15	was	be	AUX
dpc-4969	132	16	found	find	VERB
dpc-4969	132	17	that	that	SCONJ
dpc-4969	132	18	the	the	DET
dpc-4969	132	19	nlr	nlr	PROPN
dpc-4969	132	20	value	value	NOUN
dpc-4969	132	21	showed	show	VERB
dpc-4969	132	22	a	a	DET
dpc-4969	132	23	significant	significant	ADJ
dpc-4969	132	24	difference	difference	NOUN
dpc-4969	132	25	(	(	PUNCT
dpc-4969	132	26	p	p	NOUN
dpc-4969	132	27	=	=	NOUN
dpc-4969	132	28	0.019	0.019	NUM
dpc-4969	132	29	)	)	PUNCT
dpc-4969	132	30	and	and	CCONJ
dpc-4969	132	31	decreased	decrease	VERB
dpc-4969	132	32	significantly	significantly	ADV
dpc-4969	132	33	in	in	ADP
dpc-4969	132	34	the	the	DET
dpc-4969	132	35	third	third	ADJ
dpc-4969	132	36	month	month	NOUN
dpc-4969	132	37	of	of	ADP
dpc-4969	132	38	treatment	treatment	NOUN
dpc-4969	132	39	compared	compare	VERB
dpc-4969	132	40	to	to	ADP
dpc-4969	132	41	the	the	DET
dpc-4969	132	42	beginning	beginning	NOUN
dpc-4969	132	43	of	of	ADP
dpc-4969	132	44	treatment	treatment	NOUN
dpc-4969	132	45	,	,	PUNCT
dpc-4969	132	46	and	and	CCONJ
dpc-4969	132	47	there	there	PRON
dpc-4969	132	48	was	be	VERB
dpc-4969	132	49	also	also	ADV
dpc-4969	132	50	a	a	DET
dpc-4969	132	51	significant	significant	ADJ
dpc-4969	132	52	positive	positive	ADJ
dpc-4969	132	53	correlation	correlation	NOUN
dpc-4969	132	54	with	with	ADP
dpc-4969	132	55	pdai	pdai	PROPN
dpc-4969	132	56	,	,	PUNCT
dpc-4969	132	57	which	which	PRON
dpc-4969	132	58	indicates	indicate	VERB
dpc-4969	132	59	disease	disease	NOUN
dpc-4969	132	60	activity	activity	NOUN
dpc-4969	132	61	,	,	PUNCT
dpc-4969	132	62	at	at	ADP
dpc-4969	132	63	3	3	NUM
dpc-4969	132	64	and	and	CCONJ
dpc-4969	132	65	6	6	NUM
dpc-4969	132	66	months	month	NOUN
dpc-4969	132	67	(	(	PUNCT
dpc-4969	132	68	3	3	NUM
dpc-4969	132	69	months	month	NOUN
dpc-4969	132	70	p	p	X
dpc-4969	132	71	=	=	NOUN
dpc-4969	132	72	0.014	0.014	NUM
dpc-4969	132	73	;	;	PUNCT
dpc-4969	132	74	6th	6th	ADJ
dpc-4969	132	75	month	month	NOUN
dpc-4969	132	76	p	p	X
dpc-4969	132	77	=	=	NOUN
dpc-4969	132	78	0.001	0.001	NUM
dpc-4969	132	79	)	)	PUNCT
dpc-4969	132	80	.	.	PUNCT
dpc-4969	133	1	these	these	DET
dpc-4969	133	2	findings	finding	NOUN
dpc-4969	133	3	demonstrate	demonstrate	VERB
dpc-4969	133	4	the	the	DET
dpc-4969	133	5	potential	potential	ADJ
dpc-4969	133	6	utility	utility	NOUN
dpc-4969	133	7	of	of	ADP
dpc-4969	133	8	nlr	nlr	PROPN
dpc-4969	133	9	to	to	PART
dpc-4969	133	10	monitor	monitor	VERB
dpc-4969	133	11	treatment	treatment	NOUN
dpc-4969	133	12	response	response	NOUN
dpc-4969	133	13	early	early	ADV
dpc-4969	133	14	and	and	CCONJ
dpc-4969	133	15	predict	predict	VERB
dpc-4969	133	16	disease	disease	NOUN
dpc-4969	133	17	severity	severity	NOUN
dpc-4969	133	18	at	at	ADP
dpc-4969	133	19	follow	follow	NOUN
dpc-4969	133	20	-	-	PUNCT
dpc-4969	133	21	up	up	NOUN
dpc-4969	133	22	.	.	PUNCT
dpc-4969	134	1	plr	plr	NOUN
dpc-4969	134	2	,	,	PUNCT
dpc-4969	134	3	obtained	obtain	VERB
dpc-4969	134	4	by	by	ADP
dpc-4969	134	5	dividing	divide	VERB
dpc-4969	134	6	the	the	DET
dpc-4969	134	7	number	number	NOUN
dpc-4969	134	8	of	of	ADP
dpc-4969	134	9	platelets	platelet	NOUN
dpc-4969	134	10	measured	measure	VERB
dpc-4969	134	11	in	in	ADP
dpc-4969	134	12	peripheral	peripheral	ADJ
dpc-4969	134	13	blood	blood	NOUN
dpc-4969	134	14	by	by	ADP
dpc-4969	134	15	the	the	DET
dpc-4969	134	16	number	number	NOUN
dpc-4969	134	17	of	of	ADP
dpc-4969	134	18	lymphocytes	lymphocyte	NOUN
dpc-4969	134	19	,	,	PUNCT
dpc-4969	134	20	is	be	AUX
dpc-4969	134	21	a	a	DET
dpc-4969	134	22	marker	marker	NOUN
dpc-4969	134	23	that	that	PRON
dpc-4969	134	24	reveals	reveal	VERB
dpc-4969	134	25	changes	change	NOUN
dpc-4969	134	26	in	in	ADP
dpc-4969	134	27	platelet	platelet	NOUN
dpc-4969	134	28	and	and	CCONJ
dpc-4969	134	29	lymphocyte	lymphocyte	ADJ
dpc-4969	134	30	numbers	number	NOUN
dpc-4969	134	31	due	due	ADJ
dpc-4969	134	32	to	to	ADP
dpc-4969	134	33	acute	acute	VERB
dpc-4969	134	34	inflammatory	inflammatory	ADJ
dpc-4969	134	35	and	and	CCONJ
dpc-4969	134	36	prothrombotic	prothrombotic	ADJ
dpc-4969	134	37	conditions	condition	NOUN
dpc-4969	134	38	[	[	X
dpc-4969	134	39	34	34	NUM
dpc-4969	134	40	]	]	PUNCT
dpc-4969	134	41	.	.	PUNCT
dpc-4969	135	1	in	in	ADP
dpc-4969	135	2	the	the	DET
dpc-4969	135	3	study	study	NOUN
dpc-4969	135	4	by	by	ADP
dpc-4969	135	5	hayta	hayta	PROPN
dpc-4969	135	6	et	et	PROPN
dpc-4969	135	7	al	al	PROPN
dpc-4969	135	8	,	,	PUNCT
dpc-4969	135	9	the	the	DET
dpc-4969	135	10	plr	plr	NOUN
dpc-4969	135	11	value	value	NOUN
dpc-4969	135	12	was	be	AUX
dpc-4969	135	13	found	find	VERB
dpc-4969	135	14	in	in	ADP
dpc-4969	135	15	pemphigus	pemphigus	NOUN
dpc-4969	135	16	patients	patient	NOUN
dpc-4969	135	17	to	to	PART
dpc-4969	135	18	be	be	AUX
dpc-4969	135	19	higher	high	ADJ
dpc-4969	135	20	than	than	ADP
dpc-4969	135	21	in	in	ADP
dpc-4969	135	22	healthy	healthy	ADJ
dpc-4969	135	23	controls	control	NOUN
dpc-4969	135	24	,	,	PUNCT
dpc-4969	135	25	but	but	CCONJ
dpc-4969	135	26	no	no	DET
dpc-4969	135	27	relationship	relationship	NOUN
dpc-4969	135	28	was	be	AUX
dpc-4969	135	29	found	find	VERB
dpc-4969	135	30	between	between	ADP
dpc-4969	135	31	the	the	DET
dpc-4969	135	32	plr	plr	NOUN
dpc-4969	135	33	value	value	NOUN
dpc-4969	135	34	and	and	CCONJ
dpc-4969	135	35	the	the	DET
dpc-4969	135	36	course	course	NOUN
dpc-4969	135	37	of	of	ADP
dpc-4969	135	38	the	the	DET
dpc-4969	135	39	disease	disease	NOUN
dpc-4969	135	40	[	[	X
dpc-4969	135	41	35	35	NUM
dpc-4969	135	42	]	]	PUNCT
dpc-4969	135	43	.	.	PUNCT
dpc-4969	136	1	on	on	ADP
dpc-4969	136	2	the	the	DET
dpc-4969	136	3	contrary	contrary	NOUN
dpc-4969	136	4	,	,	PUNCT
dpc-4969	136	5	in	in	ADP
dpc-4969	136	6	the	the	DET
dpc-4969	136	7	study	study	NOUN
dpc-4969	136	8	conducted	conduct	VERB
dpc-4969	136	9	by	by	ADP
dpc-4969	136	10	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	136	11	et	et	PROPN
dpc-4969	136	12	al	al	PROPN
dpc-4969	136	13	,	,	PUNCT
dpc-4969	136	14	it	it	PRON
dpc-4969	136	15	was	be	AUX
dpc-4969	136	16	revealed	reveal	VERB
dpc-4969	136	17	that	that	SCONJ
dpc-4969	136	18	there	there	PRON
dpc-4969	136	19	was	be	VERB
dpc-4969	136	20	a	a	DET
dpc-4969	136	21	significant	significant	ADJ
dpc-4969	136	22	decrease	decrease	NOUN
dpc-4969	136	23	in	in	ADP
dpc-4969	136	24	plr	plr	NOUN
dpc-4969	136	25	in	in	ADP
dpc-4969	136	26	remission	remission	NOUN
dpc-4969	136	27	compared	compare	VERB
dpc-4969	136	28	to	to	PART
dpc-4969	136	29	baseline	baseline	VERB
dpc-4969	136	30	[	[	X
dpc-4969	136	31	33	33	NUM
dpc-4969	136	32	]	]	PUNCT
dpc-4969	136	33	.	.	PUNCT
dpc-4969	137	1	in	in	ADP
dpc-4969	137	2	our	our	PRON
dpc-4969	137	3	study	study	NOUN
dpc-4969	137	4	,	,	PUNCT
dpc-4969	137	5	a	a	DET
dpc-4969	137	6	significant	significant	ADJ
dpc-4969	137	7	decrease	decrease	NOUN
dpc-4969	137	8	in	in	ADP
dpc-4969	137	9	plr	plr	NOUN
dpc-4969	137	10	values	value	NOUN
dpc-4969	137	11	was	be	AUX
dpc-4969	137	12	observed	observe	VERB
dpc-4969	137	13	in	in	ADP
dpc-4969	137	14	the	the	DET
dpc-4969	137	15	third	third	ADJ
dpc-4969	137	16	month	month	NOUN
dpc-4969	137	17	,	,	PUNCT
dpc-4969	137	18	consistent	consistent	ADJ
dpc-4969	137	19	with	with	ADP
dpc-4969	137	20	the	the	DET
dpc-4969	137	21	study	study	NOUN
dpc-4969	137	22	by	by	ADP
dpc-4969	137	23	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	137	24	et	et	PROPN
dpc-4969	137	25	al	al	PROPN
dpc-4969	137	26	additionally	additionally	ADV
dpc-4969	137	27	,	,	PUNCT
dpc-4969	137	28	a	a	DET
dpc-4969	137	29	significant	significant	ADJ
dpc-4969	137	30	positive	positive	ADJ
dpc-4969	137	31	correlation	correlation	NOUN
dpc-4969	137	32	was	be	AUX
dpc-4969	137	33	detected	detect	VERB
dpc-4969	137	34	between	between	ADP
dpc-4969	137	35	the	the	DET
dpc-4969	137	36	pdai	pdai	NOUN
dpc-4969	137	37	score	score	NOUN
dpc-4969	137	38	and	and	CCONJ
dpc-4969	137	39	the	the	DET
dpc-4969	137	40	plr	plr	NOUN
dpc-4969	137	41	value	value	NOUN
dpc-4969	137	42	at	at	ADP
dpc-4969	137	43	3	3	NUM
dpc-4969	137	44	and	and	CCONJ
dpc-4969	137	45	6	6	NUM
dpc-4969	137	46	months	month	NOUN
dpc-4969	137	47	.	.	PUNCT
dpc-4969	138	1	in	in	ADP
dpc-4969	138	2	these	these	DET
dpc-4969	138	3	respects	respect	NOUN
dpc-4969	138	4	,	,	PUNCT
dpc-4969	138	5	it	it	PRON
dpc-4969	138	6	can	can	AUX
dpc-4969	138	7	be	be	AUX
dpc-4969	138	8	said	say	VERB
dpc-4969	138	9	that	that	SCONJ
dpc-4969	138	10	plr	plr	NOUN
dpc-4969	138	11	and	and	CCONJ
dpc-4969	138	12	nlr	nlr	PROPN
dpc-4969	138	13	show	show	VERB
dpc-4969	138	14	similar	similar	ADJ
dpc-4969	138	15	features	feature	NOUN
dpc-4969	138	16	in	in	ADP
dpc-4969	138	17	our	our	PRON
dpc-4969	138	18	study	study	NOUN
dpc-4969	138	19	,	,	PUNCT
dpc-4969	138	20	consistent	consistent	ADJ
dpc-4969	138	21	with	with	ADP
dpc-4969	138	22	the	the	DET
dpc-4969	138	23	study	study	NOUN
dpc-4969	138	24	by	by	ADP
dpc-4969	138	25	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	138	26	et	et	PROPN
dpc-4969	138	27	al	al	PROPN
dpc-4969	138	28	.	.	PUNCT
dpc-4969	139	1	therefore	therefore	ADV
dpc-4969	139	2	,	,	PUNCT
dpc-4969	139	3	both	both	CCONJ
dpc-4969	139	4	the	the	DET
dpc-4969	139	5	plr	plr	NOUN
dpc-4969	139	6	and	and	CCONJ
dpc-4969	139	7	nlr	nlr	PROPN
dpc-4969	139	8	values	value	NOUN
dpc-4969	139	9	may	may	AUX
dpc-4969	139	10	play	play	VERB
dpc-4969	139	11	a	a	DET
dpc-4969	139	12	role	role	NOUN
dpc-4969	139	13	in	in	ADP
dpc-4969	139	14	monitoring	monitor	VERB
dpc-4969	139	15	the	the	DET
dpc-4969	139	16	response	response	NOUN
dpc-4969	139	17	to	to	ADP
dpc-4969	139	18	treatment	treatment	NOUN
dpc-4969	139	19	in	in	ADP
dpc-4969	139	20	pemphigus	pemphigus	NOUN
dpc-4969	139	21	disease	disease	NOUN
dpc-4969	139	22	in	in	ADP
dpc-4969	139	23	the	the	DET
dpc-4969	139	24	early	early	ADJ
dpc-4969	139	25	stages	stage	NOUN
dpc-4969	139	26	and	and	CCONJ
dpc-4969	139	27	predicting	predict	VERB
dpc-4969	139	28	the	the	DET
dpc-4969	139	29	severity	severity	NOUN
dpc-4969	139	30	of	of	ADP
dpc-4969	139	31	the	the	DET
dpc-4969	139	32	disease	disease	NOUN
dpc-4969	139	33	during	during	ADP
dpc-4969	139	34	follow	follow	NOUN
dpc-4969	139	35	-	-	PUNCT
dpc-4969	139	36	up	up	NOUN
dpc-4969	139	37	.	.	PUNCT
dpc-4969	140	1	lmr	lmr	PROPN
dpc-4969	140	2	is	be	AUX
dpc-4969	140	3	a	a	DET
dpc-4969	140	4	marker	marker	NOUN
dpc-4969	140	5	obtained	obtain	VERB
dpc-4969	140	6	by	by	ADP
dpc-4969	140	7	dividing	divide	VERB
dpc-4969	140	8	the	the	DET
dpc-4969	140	9	number	number	NOUN
dpc-4969	140	10	of	of	ADP
dpc-4969	140	11	lymphocytes	lymphocyte	NOUN
dpc-4969	140	12	in	in	ADP
dpc-4969	140	13	peripheral	peripheral	ADJ
dpc-4969	140	14	blood	blood	NOUN
dpc-4969	140	15	by	by	ADP
dpc-4969	140	16	the	the	DET
dpc-4969	140	17	number	number	NOUN
dpc-4969	140	18	of	of	ADP
dpc-4969	140	19	monocytes	monocyte	NOUN
dpc-4969	140	20	.	.	PUNCT
dpc-4969	141	1	low	low	PROPN
dpc-4969	141	2	lmr	lmr	PROPN
dpc-4969	141	3	values	value	NOUN
dpc-4969	141	4	have	have	AUX
dpc-4969	141	5	been	be	AUX
dpc-4969	141	6	thought	think	VERB
dpc-4969	141	7	to	to	PART
dpc-4969	141	8	be	be	AUX
dpc-4969	141	9	an	an	DET
dpc-4969	141	10	indicator	indicator	NOUN
dpc-4969	141	11	since	since	SCONJ
dpc-4969	141	12	they	they	PRON
dpc-4969	141	13	show	show	VERB
dpc-4969	141	14	a	a	DET
dpc-4969	141	15	significant	significant	ADJ
dpc-4969	141	16	decrease	decrease	NOUN
dpc-4969	141	17	with	with	ADP
dpc-4969	141	18	treatment	treatment	NOUN
dpc-4969	141	19	and	and	CCONJ
dpc-4969	141	20	are	be	AUX
dpc-4969	141	21	significantly	significantly	ADV
dpc-4969	141	22	positively	positively	ADV
dpc-4969	141	23	correlated	correlate	VERB
dpc-4969	141	24	with	with	ADP
dpc-4969	141	25	pdai	pdai	PROPN
dpc-4969	141	26	,	,	PUNCT
dpc-4969	141	27	which	which	PRON
dpc-4969	141	28	indicates	indicate	VERB
dpc-4969	141	29	the	the	DET
dpc-4969	141	30	severity	severity	NOUN
dpc-4969	141	31	of	of	ADP
dpc-4969	141	32	the	the	DET
dpc-4969	141	33	disease	disease	NOUN
dpc-4969	141	34	.	.	PUNCT
dpc-4969	142	1	lmr	lmr	PROPN
dpc-4969	142	2	values	value	NOUN
dpc-4969	142	3	were	be	AUX
dpc-4969	142	4	indicators	indicator	NOUN
dpc-4969	142	5	of	of	ADP
dpc-4969	142	6	a	a	DET
dpc-4969	142	7	poor	poor	ADJ
dpc-4969	142	8	prognosis	prognosis	NOUN
dpc-4969	142	9	.	.	PUNCT
dpc-4969	143	1	we	we	PRON
dpc-4969	143	2	found	find	VERB
dpc-4969	143	3	that	that	SCONJ
dpc-4969	143	4	the	the	DET
dpc-4969	143	5	duration	duration	NOUN
dpc-4969	143	6	of	of	ADP
dpc-4969	143	7	remission	remission	NOUN
dpc-4969	143	8	was	be	AUX
dpc-4969	143	9	longer	long	ADJ
dpc-4969	143	10	in	in	ADP
dpc-4969	143	11	the	the	DET
dpc-4969	143	12	group	group	NOUN
dpc-4969	143	13	receiving	receive	VERB
dpc-4969	143	14	ivig	ivig	NOUN
dpc-4969	143	15	,	,	PUNCT
dpc-4969	143	16	and	and	CCONJ
dpc-4969	143	17	although	although	SCONJ
dpc-4969	143	18	there	there	PRON
dpc-4969	143	19	was	be	VERB
dpc-4969	143	20	no	no	DET
dpc-4969	143	21	difference	difference	NOUN
dpc-4969	143	22	between	between	ADP
dpc-4969	143	23	the	the	DET
dpc-4969	143	24	treatments	treatment	NOUN
dpc-4969	143	25	in	in	ADP
dpc-4969	143	26	terms	term	NOUN
dpc-4969	143	27	of	of	ADP
dpc-4969	143	28	disease	disease	NOUN
dpc-4969	143	29	recovery	recovery	NOUN
dpc-4969	143	30	,	,	PUNCT
dpc-4969	143	31	it	it	PRON
dpc-4969	143	32	should	should	AUX
dpc-4969	143	33	be	be	AUX
dpc-4969	143	34	noted	note	VERB
dpc-4969	143	35	that	that	SCONJ
dpc-4969	143	36	ivig	ivig	NOUN
dpc-4969	143	37	treatment	treatment	NOUN
dpc-4969	143	38	prolonged	prolong	VERB
dpc-4969	143	39	the	the	DET
dpc-4969	143	40	duration	duration	NOUN
dpc-4969	143	41	of	of	ADP
dpc-4969	143	42	remission	remission	NOUN
dpc-4969	143	43	.	.	PUNCT
dpc-4969	144	1	neutrophils	neutrophil	NOUN
dpc-4969	144	2	have	have	AUX
dpc-4969	144	3	also	also	ADV
dpc-4969	144	4	been	be	AUX
dpc-4969	144	5	studied	study	VERB
dpc-4969	144	6	in	in	ADP
dpc-4969	144	7	dermatological	dermatological	ADJ
dpc-4969	144	8	diseases	disease	NOUN
dpc-4969	144	9	.	.	PUNCT
dpc-4969	145	1	park	park	NOUN
dpc-4969	145	2	et	et	PROPN
dpc-4969	145	3	al	al	PROPN
dpc-4969	145	4	reported	report	VERB
dpc-4969	145	5	that	that	SCONJ
dpc-4969	145	6	neutrophil	neutrophil	ADJ
dpc-4969	145	7	counts	count	NOUN
dpc-4969	145	8	were	be	AUX
dpc-4969	145	9	positively	positively	ADV
dpc-4969	145	10	correlated	correlate	VERB
dpc-4969	145	11	with	with	ADP
dpc-4969	145	12	disease	disease	NOUN
dpc-4969	145	13	severity	severity	NOUN
dpc-4969	145	14	in	in	ADP
dpc-4969	145	15	bullous	bullous	ADJ
dpc-4969	145	16	pemphigoid	pemphigoid	ADJ
dpc-4969	145	17	patients	patient	NOUN
dpc-4969	145	18	[	[	X
dpc-4969	145	19	17	17	NUM
dpc-4969	145	20	]	]	PUNCT
dpc-4969	145	21	.	.	PUNCT
dpc-4969	146	1	ameglio	ameglio	PROPN
dpc-4969	146	2	et	et	PROPN
dpc-4969	146	3	al	al	PROPN
dpc-4969	146	4	reported	report	VERB
dpc-4969	146	5	that	that	SCONJ
dpc-4969	146	6	there	there	PRON
dpc-4969	146	7	was	be	VERB
dpc-4969	146	8	a	a	DET
dpc-4969	146	9	significant	significant	ADJ
dpc-4969	146	10	correlation	correlation	NOUN
dpc-4969	146	11	between	between	ADP
dpc-4969	146	12	antibody	antibody	NOUN
dpc-4969	146	13	titers	titer	NOUN
dpc-4969	146	14	and	and	CCONJ
dpc-4969	146	15	the	the	DET
dpc-4969	146	16	number	number	NOUN
dpc-4969	146	17	of	of	ADP
dpc-4969	146	18	lesions	lesion	NOUN
dpc-4969	146	19	in	in	ADP
dpc-4969	146	20	patients	patient	NOUN
dpc-4969	146	21	with	with	ADP
dpc-4969	146	22	pv	pv	NOUN
dpc-4969	147	1	and	and	CCONJ
dpc-4969	147	2	the	the	DET
dpc-4969	147	3	number	number	NOUN
dpc-4969	147	4	of	of	ADP
dpc-4969	147	5	neutrophils	neutrophil	NOUN
dpc-4969	147	6	in	in	ADP
dpc-4969	147	7	peripheral	peripheral	ADJ
dpc-4969	147	8	blood	blood	NOUN
dpc-4969	147	9	[	[	X
dpc-4969	147	10	18	18	NUM
dpc-4969	147	11	]	]	PUNCT
dpc-4969	147	12	.	.	PUNCT
dpc-4969	148	1	in	in	ADP
dpc-4969	148	2	our	our	PRON
dpc-4969	148	3	study	study	NOUN
dpc-4969	148	4	,	,	PUNCT
dpc-4969	148	5	similar	similar	ADJ
dpc-4969	148	6	to	to	ADP
dpc-4969	148	7	the	the	DET
dpc-4969	148	8	studies	study	NOUN
dpc-4969	148	9	above	above	ADV
dpc-4969	148	10	,	,	PUNCT
dpc-4969	148	11	neutrophil	neutrophil	ADJ
dpc-4969	148	12	count	count	NOUN
dpc-4969	148	13	and	and	CCONJ
dpc-4969	148	14	disease	disease	NOUN
dpc-4969	148	15	severity	severity	NOUN
dpc-4969	148	16	were	be	AUX
dpc-4969	148	17	positively	positively	ADV
dpc-4969	148	18	correlated	correlate	VERB
dpc-4969	148	19	,	,	PUNCT
dpc-4969	148	20	and	and	CCONJ
dpc-4969	148	21	although	although	SCONJ
dpc-4969	148	22	all	all	DET
dpc-4969	148	23	patients	patient	NOUN
dpc-4969	148	24	received	receive	VERB
dpc-4969	148	25	systemic	systemic	ADJ
dpc-4969	148	26	steroid	steroid	NOUN
dpc-4969	148	27	treatment	treatment	NOUN
dpc-4969	148	28	,	,	PUNCT
dpc-4969	148	29	which	which	PRON
dpc-4969	148	30	is	be	AUX
dpc-4969	148	31	known	know	VERB
dpc-4969	148	32	to	to	PART
dpc-4969	148	33	increase	increase	VERB
dpc-4969	148	34	the	the	DET
dpc-4969	148	35	number	number	NOUN
dpc-4969	148	36	of	of	ADP
dpc-4969	148	37	neutrophils	neutrophil	NOUN
dpc-4969	148	38	,	,	PUNCT
dpc-4969	148	39	there	there	PRON
dpc-4969	148	40	was	be	VERB
dpc-4969	148	41	a	a	DET
dpc-4969	148	42	significant	significant	ADJ
dpc-4969	148	43	decrease	decrease	NOUN
dpc-4969	148	44	in	in	ADP
dpc-4969	148	45	the	the	DET
dpc-4969	148	46	number	number	NOUN
dpc-4969	148	47	of	of	ADP
dpc-4969	148	48	neutrophils	neutrophil	NOUN
dpc-4969	148	49	in	in	ADP
dpc-4969	148	50	the	the	DET
dpc-4969	148	51	sixth	sixth	ADJ
dpc-4969	148	52	month	month	NOUN
dpc-4969	148	53	.	.	PUNCT
dpc-4969	149	1	we	we	PRON
dpc-4969	149	2	thought	think	VERB
dpc-4969	149	3	that	that	SCONJ
dpc-4969	149	4	the	the	DET
dpc-4969	149	5	change	change	NOUN
dpc-4969	149	6	in	in	ADP
dpc-4969	149	7	neutrophil	neutrophil	ADJ
dpc-4969	149	8	values	value	NOUN
dpc-4969	149	9	in	in	ADP
dpc-4969	149	10	pv	pv	NOUN
dpc-4969	149	11	patients	patient	NOUN
dpc-4969	149	12	could	could	AUX
dpc-4969	149	13	be	be	AUX
dpc-4969	149	14	used	use	VERB
dpc-4969	149	15	in	in	ADP
dpc-4969	149	16	disease	disease	NOUN
dpc-4969	149	17	treatment	treatment	NOUN
dpc-4969	149	18	and	and	CCONJ
dpc-4969	149	19	follow	follow	NOUN
dpc-4969	149	20	-	-	PUNCT
dpc-4969	149	21	up	up	NOUN
dpc-4969	149	22	.	.	PUNCT
dpc-4969	150	1	there	there	PRON
dpc-4969	150	2	are	be	VERB
dpc-4969	150	3	no	no	DET
dpc-4969	150	4	studies	study	NOUN
dpc-4969	150	5	in	in	ADP
dpc-4969	150	6	the	the	DET
dpc-4969	150	7	literature	literature	NOUN
dpc-4969	150	8	on	on	ADP
dpc-4969	150	9	the	the	DET
dpc-4969	150	10	role	role	NOUN
dpc-4969	150	11	of	of	ADP
dpc-4969	150	12	platelet	platelet	NOUN
dpc-4969	150	13	counts	count	NOUN
dpc-4969	150	14	in	in	ADP
dpc-4969	150	15	pemphigus	pemphigus	NOUN
dpc-4969	150	16	disease	disease	NOUN
dpc-4969	150	17	.	.	PUNCT
dpc-4969	151	1	from	from	ADP
dpc-4969	151	2	this	this	DET
dpc-4969	151	3	perspective	perspective	NOUN
dpc-4969	151	4	,	,	PUNCT
dpc-4969	151	5	our	our	PRON
dpc-4969	151	6	work	work	NOUN
dpc-4969	151	7	has	have	AUX
dpc-4969	151	8	gained	gain	VERB
dpc-4969	151	9	importance	importance	NOUN
dpc-4969	151	10	.	.	PUNCT
dpc-4969	152	1	in	in	ADP
dpc-4969	152	2	our	our	PRON
dpc-4969	152	3	study	study	NOUN
dpc-4969	152	4	,	,	PUNCT
dpc-4969	152	5	platelet	platelet	NOUN
dpc-4969	152	6	counts	count	NOUN
dpc-4969	152	7	decreased	decrease	VERB
dpc-4969	152	8	significantly	significantly	ADV
dpc-4969	152	9	at	at	ADP
dpc-4969	152	10	6	6	NUM
dpc-4969	152	11	months	month	NOUN
dpc-4969	152	12	compared	compare	VERB
dpc-4969	152	13	to	to	PART
dpc-4969	152	14	baseline	baseline	VERB
dpc-4969	152	15	.	.	PUNCT
dpc-4969	153	1	however	however	ADV
dpc-4969	153	2	,	,	PUNCT
dpc-4969	153	3	it	it	PRON
dpc-4969	153	4	did	do	AUX
dpc-4969	153	5	not	not	PART
dpc-4969	153	6	correlate	correlate	VERB
dpc-4969	153	7	significantly	significantly	ADV
dpc-4969	153	8	with	with	ADP
dpc-4969	153	9	pdai	pdai	NOUN
dpc-4969	153	10	at	at	ADP
dpc-4969	153	11	any	any	DET
dpc-4969	153	12	time	time	NOUN
dpc-4969	153	13	point	point	NOUN
dpc-4969	153	14	.	.	PUNCT
dpc-4969	154	1	consequently	consequently	ADV
dpc-4969	154	2	,	,	PUNCT
dpc-4969	154	3	we	we	PRON
dpc-4969	154	4	think	think	VERB
dpc-4969	154	5	platelet	platelet	NOUN
dpc-4969	154	6	count	count	NOUN
dpc-4969	154	7	may	may	AUX
dpc-4969	154	8	be	be	AUX
dpc-4969	154	9	a	a	DET
dpc-4969	154	10	parameter	parameter	NOUN
dpc-4969	154	11	that	that	PRON
dpc-4969	154	12	can	can	AUX
dpc-4969	154	13	be	be	AUX
dpc-4969	154	14	measured	measure	VERB
dpc-4969	154	15	at	at	ADP
dpc-4969	154	16	the	the	DET
dpc-4969	154	17	beginning	beginning	NOUN
dpc-4969	154	18	and	and	CCONJ
dpc-4969	154	19	sixth	sixth	ADJ
dpc-4969	154	20	month	month	NOUN
dpc-4969	154	21	of	of	ADP
dpc-4969	154	22	treatment	treatment	NOUN
dpc-4969	154	23	to	to	PART
dpc-4969	154	24	evaluate	evaluate	VERB
dpc-4969	154	25	the	the	DET
dpc-4969	154	26	response	response	NOUN
dpc-4969	154	27	to	to	ADP
dpc-4969	154	28	treatment	treatment	NOUN
dpc-4969	154	29	in	in	ADP
dpc-4969	154	30	pemphigus	pemphigus	NOUN
dpc-4969	154	31	,	,	PUNCT
dpc-4969	154	32	but	but	CCONJ
dpc-4969	154	33	more	more	ADJ
dpc-4969	154	34	studies	study	NOUN
dpc-4969	154	35	are	be	AUX
dpc-4969	154	36	needed	need	VERB
dpc-4969	154	37	to	to	PART
dpc-4969	154	38	investigate	investigate	VERB
dpc-4969	154	39	the	the	DET
dpc-4969	154	40	role	role	NOUN
dpc-4969	154	41	of	of	ADP
dpc-4969	154	42	platelets	platelet	NOUN
dpc-4969	154	43	in	in	ADP
dpc-4969	154	44	the	the	DET
dpc-4969	154	45	follow	follow	NOUN
dpc-4969	154	46	-	-	PUNCT
dpc-4969	154	47	up	up	NOUN
dpc-4969	154	48	of	of	ADP
dpc-4969	154	49	the	the	DET
dpc-4969	154	50	severity	severity	NOUN
dpc-4969	154	51	and	and	CCONJ
dpc-4969	154	52	treatment	treatment	NOUN
dpc-4969	154	53	of	of	ADP
dpc-4969	154	54	pemphigus	pemphigus	NOUN
dpc-4969	154	55	disease	disease	NOUN
dpc-4969	154	56	.	.	PUNCT
dpc-4969	155	1	the	the	DET
dpc-4969	155	2	role	role	NOUN
dpc-4969	155	3	of	of	ADP
dpc-4969	155	4	lymphocytes	lymphocyte	NOUN
dpc-4969	155	5	in	in	ADP
dpc-4969	155	6	pemphigus	pemphigus	NOUN
dpc-4969	155	7	has	have	AUX
dpc-4969	155	8	been	be	AUX
dpc-4969	155	9	investigated	investigate	VERB
dpc-4969	155	10	in	in	ADP
dpc-4969	155	11	various	various	ADJ
dpc-4969	155	12	studies	study	NOUN
dpc-4969	155	13	.	.	PUNCT
dpc-4969	156	1	when	when	SCONJ
dpc-4969	156	2	lesional	lesional	ADJ
dpc-4969	156	3	biopsies	biopsy	NOUN
dpc-4969	156	4	in	in	ADP
dpc-4969	156	5	pemphigus	pemphigus	PROPN
dpc-4969	156	6	were	be	AUX
dpc-4969	156	7	examined	examine	VERB
dpc-4969	156	8	,	,	PUNCT
dpc-4969	156	9	a	a	DET
dpc-4969	156	10	large	large	ADJ
dpc-4969	156	11	number	number	NOUN
dpc-4969	156	12	of	of	ADP
dpc-4969	156	13	lymphocytes	lymphocyte	NOUN
dpc-4969	156	14	were	be	AUX
dpc-4969	156	15	detected	detect	VERB
dpc-4969	156	16	in	in	ADP
dpc-4969	156	17	the	the	DET
dpc-4969	156	18	infiltrates	infiltrate	NOUN
dpc-4969	156	19	of	of	ADP
dpc-4969	156	20	the	the	DET
dpc-4969	156	21	lesions	lesion	NOUN
dpc-4969	156	22	,	,	PUNCT
dpc-4969	156	23	and	and	CCONJ
dpc-4969	156	24	it	it	PRON
dpc-4969	156	25	was	be	AUX
dpc-4969	156	26	suggested	suggest	VERB
dpc-4969	156	27	that	that	SCONJ
dpc-4969	156	28	they	they	PRON
dpc-4969	156	29	played	play	VERB
dpc-4969	156	30	an	an	DET
dpc-4969	156	31	important	important	ADJ
dpc-4969	156	32	role	role	NOUN
dpc-4969	156	33	in	in	ADP
dpc-4969	156	34	the	the	DET
dpc-4969	156	35	pathogenesis	pathogenesis	NOUN
dpc-4969	156	36	of	of	ADP
dpc-4969	156	37	pemphigus	pemphigus	NOUN
dpc-4969	156	38	[	[	X
dpc-4969	156	39	19	19	NUM
dpc-4969	156	40	]	]	PUNCT
dpc-4969	156	41	.	.	PUNCT
dpc-4969	157	1	el	el	PROPN
dpc-4969	157	2	-	-	PUNCT
dpc-4969	157	3	naby	naby	PROPN
dpc-4969	157	4	et	et	PROPN
dpc-4969	157	5	al	al	PROPN
dpc-4969	157	6	found	find	VERB
dpc-4969	157	7	that	that	SCONJ
dpc-4969	157	8	the	the	DET
dpc-4969	157	9	number	number	NOUN
dpc-4969	157	10	of	of	ADP
dpc-4969	157	11	t	t	PROPN
dpc-4969	157	12	lymphocytes	lymphocyte	VERB
dpc-4969	157	13	in	in	ADP
dpc-4969	157	14	the	the	DET
dpc-4969	157	15	lesional	lesional	ADJ
dpc-4969	157	16	infiltrate	infiltrate	NOUN
dpc-4969	157	17	was	be	AUX
dpc-4969	157	18	correlated	correlate	VERB
dpc-4969	157	19	with	with	ADP
dpc-4969	157	20	the	the	DET
dpc-4969	157	21	severity	severity	NOUN
dpc-4969	157	22	of	of	ADP
dpc-4969	157	23	the	the	DET
dpc-4969	157	24	disease	disease	NOUN
dpc-4969	157	25	in	in	ADP
dpc-4969	157	26	40	40	NUM
dpc-4969	157	27	pv	pv	NOUN
dpc-4969	157	28	patients	patient	NOUN
dpc-4969	157	29	[	[	X
dpc-4969	157	30	20	20	NUM
dpc-4969	157	31	]	]	PUNCT
dpc-4969	157	32	.	.	PUNCT
dpc-4969	158	1	in	in	ADP
dpc-4969	158	2	a	a	DET
dpc-4969	158	3	study	study	NOUN
dpc-4969	158	4	conducted	conduct	VERB
dpc-4969	158	5	by	by	ADP
dpc-4969	158	6	kowalska	kowalska	PROPN
dpc-4969	158	7	-	-	PUNCT
dpc-4969	158	8	kępczyńska	kępczyńska	PROPN
dpc-4969	158	9	et	et	PROPN
dpc-4969	158	10	al	al	PROPN
dpc-4969	158	11	,	,	PUNCT
dpc-4969	158	12	it	it	PRON
dpc-4969	158	13	was	be	AUX
dpc-4969	158	14	determined	determine	VERB
dpc-4969	158	15	that	that	SCONJ
dpc-4969	158	16	the	the	DET
dpc-4969	158	17	lymphocyte	lymphocyte	ADJ
dpc-4969	158	18	count	count	NOUN
dpc-4969	158	19	of	of	ADP
dpc-4969	158	20	32	32	NUM
dpc-4969	158	21	patients	patient	NOUN
dpc-4969	158	22	with	with	ADP
dpc-4969	158	23	pemphigus	pemphigus	PROPN
dpc-4969	158	24	was	be	AUX
dpc-4969	158	25	correlated	correlate	VERB
dpc-4969	158	26	with	with	ADP
dpc-4969	158	27	the	the	DET
dpc-4969	158	28	pdai	pdai	ADJ
dpc-4969	158	29	score	score	NOUN
dpc-4969	159	1	[	[	X
dpc-4969	159	2	21	21	NUM
dpc-4969	159	3	]	]	PUNCT
dpc-4969	159	4	.	.	PUNCT
dpc-4969	160	1	however	however	ADV
dpc-4969	160	2	,	,	PUNCT
dpc-4969	160	3	no	no	DET
dpc-4969	160	4	studies	study	NOUN
dpc-4969	160	5	were	be	AUX
dpc-4969	160	6	found	find	VERB
dpc-4969	160	7	in	in	ADP
dpc-4969	160	8	the	the	DET
dpc-4969	160	9	literature	literature	NOUN
dpc-4969	160	10	on	on	ADP
dpc-4969	160	11	the	the	DET
dpc-4969	160	12	use	use	NOUN
dpc-4969	160	13	of	of	ADP
dpc-4969	160	14	the	the	DET
dpc-4969	160	15	absolute	absolute	ADJ
dpc-4969	160	16	lymphocyte	lymphocyte	ADJ
dpc-4969	160	17	value	value	NOUN
dpc-4969	160	18	in	in	ADP
dpc-4969	160	19	peripheral	peripheral	ADJ
dpc-4969	160	20	blood	blood	NOUN
dpc-4969	160	21	,	,	PUNCT
dpc-4969	160	22	which	which	PRON
dpc-4969	160	23	we	we	PRON
dpc-4969	160	24	evaluated	evaluate	VERB
dpc-4969	160	25	in	in	ADP
dpc-4969	160	26	our	our	PRON
dpc-4969	160	27	study	study	NOUN
dpc-4969	160	28	,	,	PUNCT
dpc-4969	160	29	in	in	ADP
dpc-4969	160	30	pemphigus	pemphigus	NOUN
dpc-4969	160	31	disease	disease	NOUN
dpc-4969	160	32	.	.	PUNCT
dpc-4969	161	1	in	in	ADP
dpc-4969	161	2	our	our	PRON
dpc-4969	161	3	study	study	NOUN
dpc-4969	161	4	,	,	PUNCT
dpc-4969	161	5	the	the	DET
dpc-4969	161	6	absolute	absolute	ADJ
dpc-4969	161	7	lymphocyte	lymphocyte	ADJ
dpc-4969	161	8	value	value	NOUN
dpc-4969	161	9	measured	measure	VERB
dpc-4969	161	10	in	in	ADP
dpc-4969	161	11	peripheral	peripheral	ADJ
dpc-4969	161	12	blood	blood	NOUN
dpc-4969	161	13	decreased	decrease	VERB
dpc-4969	161	14	in	in	ADP
dpc-4969	161	15	the	the	DET
dpc-4969	161	16	sixth	sixth	ADJ
dpc-4969	161	17	month	month	NOUN
dpc-4969	161	18	.	.	PUNCT
dpc-4969	162	1	furthermore	furthermore	ADV
dpc-4969	162	2	,	,	PUNCT
dpc-4969	162	3	a	a	DET
dpc-4969	162	4	significant	significant	ADJ
dpc-4969	162	5	negative	negative	ADJ
dpc-4969	162	6	correlation	correlation	NOUN
dpc-4969	162	7	was	be	AUX
dpc-4969	162	8	found	find	VERB
dpc-4969	162	9	between	between	ADP
dpc-4969	162	10	the	the	DET
dpc-4969	162	11	absolute	absolute	ADJ
dpc-4969	162	12	lymphocyte	lymphocyte	ADJ
dpc-4969	162	13	value	value	NOUN
dpc-4969	162	14	measured	measure	VERB
dpc-4969	162	15	in	in	ADP
dpc-4969	162	16	peripheral	peripheral	ADJ
dpc-4969	162	17	blood	blood	NOUN
dpc-4969	162	18	at	at	ADP
dpc-4969	162	19	3	3	NUM
dpc-4969	162	20	and	and	CCONJ
dpc-4969	162	21	6	6	NUM
dpc-4969	162	22	months	month	NOUN
dpc-4969	162	23	and	and	CCONJ
dpc-4969	162	24	the	the	DET
dpc-4969	162	25	pdai	pdai	ADJ
dpc-4969	162	26	values	value	NOUN
dpc-4969	162	27	measured	measure	VERB
dpc-4969	162	28	at	at	ADP
dpc-4969	162	29	the	the	DET
dpc-4969	162	30	same	same	ADJ
dpc-4969	162	31	time	time	NOUN
dpc-4969	162	32	.	.	PUNCT
dpc-4969	163	1	in	in	ADP
dpc-4969	163	2	this	this	DET
dpc-4969	163	3	regard	regard	NOUN
dpc-4969	163	4	,	,	PUNCT
dpc-4969	163	5	we	we	PRON
dpc-4969	163	6	original	original	ADJ
dpc-4969	163	7	article	article	NOUN
dpc-4969	163	8	|	|	ADV
dpc-4969	163	9	dermatol	dermatol	ADJ
dpc-4969	163	10	pract	pract	NOUN
dpc-4969	163	11	concept	concept	NOUN
dpc-4969	163	12	.	.	PUNCT
dpc-4969	164	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	164	2	7	7	NUM
dpc-4969	164	3	of	of	ADP
dpc-4969	164	4	a	a	DET
dpc-4969	164	5	poor	poor	ADJ
dpc-4969	164	6	prognosis	prognosis	NOUN
dpc-4969	164	7	in	in	ADP
dpc-4969	164	8	several	several	ADJ
dpc-4969	164	9	types	type	NOUN
dpc-4969	164	10	of	of	ADP
dpc-4969	164	11	tumor	tumor	NOUN
dpc-4969	164	12	[	[	X
dpc-4969	164	13	36	36	NUM
dpc-4969	164	14	-	-	SYM
dpc-4969	164	15	38	38	NUM
dpc-4969	164	16	]	]	PUNCT
dpc-4969	164	17	.	.	PUNCT
dpc-4969	165	1	in	in	ADP
dpc-4969	165	2	the	the	DET
dpc-4969	165	3	study	study	NOUN
dpc-4969	165	4	by	by	ADP
dpc-4969	165	5	sirin	sirin	NOUN
dpc-4969	165	6	et	et	NOUN
dpc-4969	165	7	al	al	PROPN
dpc-4969	165	8	with	with	ADP
dpc-4969	165	9	patients	patient	NOUN
dpc-4969	165	10	with	with	ADP
dpc-4969	165	11	psoriasis	psoriasis	NOUN
dpc-4969	165	12	vulgaris	vulgaris	NOUN
dpc-4969	165	13	,	,	PUNCT
dpc-4969	165	14	it	it	PRON
dpc-4969	165	15	was	be	AUX
dpc-4969	165	16	found	find	VERB
dpc-4969	165	17	that	that	SCONJ
dpc-4969	165	18	lmr	lmr	PROPN
dpc-4969	165	19	levels	level	NOUN
dpc-4969	165	20	did	do	AUX
dpc-4969	165	21	not	not	PART
dpc-4969	165	22	differ	differ	VERB
dpc-4969	165	23	significantly	significantly	ADV
dpc-4969	165	24	between	between	ADP
dpc-4969	165	25	healthy	healthy	ADJ
dpc-4969	165	26	controls	control	NOUN
dpc-4969	165	27	and	and	CCONJ
dpc-4969	165	28	the	the	DET
dpc-4969	165	29	group	group	NOUN
dpc-4969	165	30	of	of	ADP
dpc-4969	165	31	patients	patient	NOUN
dpc-4969	165	32	,	,	PUNCT
dpc-4969	165	33	but	but	CCONJ
dpc-4969	165	34	lmr	lmr	PROPN
dpc-4969	165	35	was	be	AUX
dpc-4969	165	36	negatively	negatively	ADV
dpc-4969	165	37	correlated	correlate	VERB
dpc-4969	165	38	with	with	ADP
dpc-4969	165	39	the	the	DET
dpc-4969	165	40	psoriasis	psoriasis	NOUN
dpc-4969	165	41	area	area	NOUN
dpc-4969	165	42	severity	severity	NOUN
dpc-4969	165	43	index	index	NOUN
dpc-4969	165	44	(	(	PUNCT
dpc-4969	165	45	pasi	pasi	NOUN
dpc-4969	165	46	)	)	PUNCT
dpc-4969	165	47	,	,	PUNCT
dpc-4969	165	48	which	which	PRON
dpc-4969	165	49	expresses	express	VERB
dpc-4969	165	50	the	the	DET
dpc-4969	165	51	severity	severity	NOUN
dpc-4969	165	52	of	of	ADP
dpc-4969	165	53	the	the	DET
dpc-4969	165	54	disease	disease	NOUN
dpc-4969	165	55	in	in	ADP
dpc-4969	165	56	psoriasis	psoriasis	NOUN
dpc-4969	165	57	[	[	X
dpc-4969	165	58	39	39	NUM
dpc-4969	165	59	]	]	PUNCT
dpc-4969	165	60	.	.	PUNCT
dpc-4969	166	1	in	in	ADP
dpc-4969	166	2	the	the	DET
dpc-4969	166	3	literature	literature	NOUN
dpc-4969	166	4	,	,	PUNCT
dpc-4969	166	5	no	no	DET
dpc-4969	166	6	study	study	NOUN
dpc-4969	166	7	investigating	investigate	VERB
dpc-4969	166	8	the	the	DET
dpc-4969	166	9	relationship	relationship	NOUN
dpc-4969	166	10	between	between	ADP
dpc-4969	166	11	pemphigus	pemphigus	NOUN
dpc-4969	166	12	disease	disease	NOUN
dpc-4969	166	13	and	and	CCONJ
dpc-4969	166	14	lmr	lmr	PROPN
dpc-4969	166	15	was	be	AUX
dpc-4969	166	16	found	find	VERB
dpc-4969	166	17	.	.	PUNCT
dpc-4969	167	1	in	in	ADP
dpc-4969	167	2	our	our	PRON
dpc-4969	167	3	study	study	NOUN
dpc-4969	167	4	,	,	PUNCT
dpc-4969	167	5	lmr	lmr	PROPN
dpc-4969	167	6	values	value	NOUN
dpc-4969	167	7	showed	show	VERB
dpc-4969	167	8	a	a	DET
dpc-4969	167	9	significant	significant	ADJ
dpc-4969	167	10	negative	negative	ADJ
dpc-4969	167	11	correlation	correlation	NOUN
dpc-4969	167	12	with	with	ADP
dpc-4969	167	13	pdai	pdai	PROPN
dpc-4969	167	14	scores	score	NOUN
dpc-4969	167	15	at	at	ADP
dpc-4969	167	16	3	3	NUM
dpc-4969	167	17	and	and	CCONJ
dpc-4969	167	18	6	6	NUM
dpc-4969	167	19	months	month	NOUN
dpc-4969	167	20	.	.	PUNCT
dpc-4969	168	1	in	in	ADP
dpc-4969	168	2	this	this	DET
dpc-4969	168	3	case	case	NOUN
dpc-4969	168	4	,	,	PUNCT
dpc-4969	168	5	it	it	PRON
dpc-4969	168	6	can	can	AUX
dpc-4969	168	7	be	be	AUX
dpc-4969	168	8	thought	think	VERB
dpc-4969	168	9	that	that	SCONJ
dpc-4969	168	10	lmr	lmr	PROPN
dpc-4969	168	11	values	value	NOUN
dpc-4969	168	12	may	may	AUX
dpc-4969	168	13	be	be	AUX
dpc-4969	168	14	an	an	DET
dpc-4969	168	15	indicator	indicator	NOUN
dpc-4969	168	16	of	of	ADP
dpc-4969	168	17	a	a	DET
dpc-4969	168	18	poor	poor	ADJ
dpc-4969	168	19	prognosis	prognosis	NOUN
dpc-4969	168	20	for	for	ADP
dpc-4969	168	21	the	the	DET
dpc-4969	168	22	disease	disease	NOUN
dpc-4969	168	23	.	.	PUNCT
dpc-4969	169	1	again	again	ADV
dpc-4969	169	2	,	,	PUNCT
dpc-4969	169	3	we	we	PRON
dpc-4969	169	4	think	think	VERB
dpc-4969	169	5	that	that	SCONJ
dpc-4969	169	6	lmr	lmr	PROPN
dpc-4969	169	7	values	value	NOUN
dpc-4969	169	8	can	can	AUX
dpc-4969	169	9	be	be	AUX
dpc-4969	169	10	used	use	VERB
dpc-4969	169	11	to	to	PART
dpc-4969	169	12	predict	predict	VERB
dpc-4969	169	13	the	the	DET
dpc-4969	169	14	severity	severity	NOUN
dpc-4969	169	15	of	of	ADP
dpc-4969	169	16	the	the	DET
dpc-4969	169	17	disease	disease	NOUN
dpc-4969	169	18	in	in	ADP
dpc-4969	169	19	the	the	DET
dpc-4969	169	20	third	third	ADJ
dpc-4969	169	21	and	and	CCONJ
dpc-4969	169	22	sixth	sixth	ADJ
dpc-4969	169	23	months	month	NOUN
dpc-4969	169	24	of	of	ADP
dpc-4969	169	25	treatment	treatment	NOUN
dpc-4969	169	26	in	in	ADP
dpc-4969	169	27	pemphigus	pemphigus	PROPN
dpc-4969	169	28	.	.	PUNCT
dpc-4969	170	1	another	another	DET
dpc-4969	170	2	issue	issue	NOUN
dpc-4969	170	3	that	that	PRON
dpc-4969	170	4	draws	draw	VERB
dpc-4969	170	5	attention	attention	NOUN
dpc-4969	170	6	in	in	ADP
dpc-4969	170	7	our	our	PRON
dpc-4969	170	8	study	study	NOUN
dpc-4969	170	9	is	be	AUX
dpc-4969	170	10	a	a	DET
dpc-4969	170	11	significant	significant	ADJ
dpc-4969	170	12	difference	difference	NOUN
dpc-4969	170	13	in	in	ADP
dpc-4969	170	14	lmr	lmr	PROPN
dpc-4969	170	15	was	be	AUX
dpc-4969	170	16	observed	observe	VERB
dpc-4969	170	17	between	between	ADP
dpc-4969	170	18	the	the	DET
dpc-4969	170	19	treatment	treatment	NOUN
dpc-4969	170	20	groups	group	NOUN
dpc-4969	170	21	.	.	PUNCT
dpc-4969	171	1	the	the	DET
dpc-4969	171	2	lmr	lmr	PROPN
dpc-4969	171	3	change	change	NOUN
dpc-4969	171	4	in	in	ADP
dpc-4969	171	5	the	the	DET
dpc-4969	171	6	group	group	NOUN
dpc-4969	171	7	receiving	receive	VERB
dpc-4969	171	8	ivig	ivig	NOUN
dpc-4969	171	9	was	be	AUX
dpc-4969	171	10	significantly	significantly	ADV
dpc-4969	171	11	higher	high	ADJ
dpc-4969	171	12	than	than	ADP
dpc-4969	171	13	the	the	DET
dpc-4969	171	14	lmr	lmr	PROPN
dpc-4969	171	15	change	change	NOUN
dpc-4969	171	16	in	in	ADP
dpc-4969	171	17	the	the	DET
dpc-4969	171	18	group	group	NOUN
dpc-4969	171	19	not	not	PART
dpc-4969	171	20	receiving	receive	VERB
dpc-4969	171	21	ivig	ivig	NOUN
dpc-4969	171	22	.	.	PUNCT
dpc-4969	172	1	to	to	PART
dpc-4969	172	2	investigate	investigate	VERB
dpc-4969	172	3	whether	whether	SCONJ
dpc-4969	172	4	the	the	DET
dpc-4969	172	5	significant	significant	ADJ
dpc-4969	172	6	difference	difference	NOUN
dpc-4969	172	7	in	in	ADP
dpc-4969	172	8	lmr	lmr	PROPN
dpc-4969	172	9	change	change	NOUN
dpc-4969	172	10	in	in	ADP
dpc-4969	172	11	those	those	PRON
dpc-4969	172	12	receiving	receive	VERB
dpc-4969	172	13	ivig	ivig	NOUN
dpc-4969	172	14	compared	compare	VERB
dpc-4969	172	15	to	to	ADP
dpc-4969	172	16	those	those	PRON
dpc-4969	172	17	not	not	PART
dpc-4969	172	18	receiving	receive	VERB
dpc-4969	172	19	ivig	ivig	NOUN
dpc-4969	172	20	was	be	AUX
dpc-4969	172	21	related	relate	VERB
dpc-4969	172	22	to	to	ADP
dpc-4969	172	23	the	the	DET
dpc-4969	172	24	difference	difference	NOUN
dpc-4969	172	25	in	in	ADP
dpc-4969	172	26	the	the	DET
dpc-4969	172	27	duration	duration	NOUN
dpc-4969	172	28	of	of	ADP
dpc-4969	172	29	remission	remission	NOUN
dpc-4969	172	30	between	between	ADP
dpc-4969	172	31	treatment	treatment	NOUN
dpc-4969	172	32	groups	group	NOUN
dpc-4969	172	33	,	,	PUNCT
dpc-4969	172	34	the	the	DET
dpc-4969	172	35	duration	duration	NOUN
dpc-4969	172	36	of	of	ADP
dpc-4969	172	37	remission	remission	NOUN
dpc-4969	172	38	in	in	ADP
dpc-4969	172	39	the	the	DET
dpc-4969	172	40	group	group	NOUN
dpc-4969	172	41	receiving	receive	VERB
dpc-4969	172	42	ivig	ivig	NOUN
dpc-4969	172	43	was	be	AUX
dpc-4969	172	44	found	find	VERB
dpc-4969	172	45	to	to	PART
dpc-4969	172	46	be	be	AUX
dpc-4969	172	47	significantly	significantly	ADV
dpc-4969	172	48	higher	high	ADJ
dpc-4969	172	49	than	than	ADP
dpc-4969	172	50	the	the	DET
dpc-4969	172	51	duration	duration	NOUN
dpc-4969	172	52	in	in	ADP
dpc-4969	172	53	the	the	DET
dpc-4969	172	54	group	group	NOUN
dpc-4969	172	55	not	not	PART
dpc-4969	172	56	receiving	receive	VERB
dpc-4969	172	57	ivig	ivig	NOUN
dpc-4969	172	58	.	.	PUNCT
dpc-4969	173	1	in	in	ADP
dpc-4969	173	2	patients	patient	NOUN
dpc-4969	173	3	receiving	receive	VERB
dpc-4969	173	4	ivig	ivig	NOUN
dpc-4969	173	5	,	,	PUNCT
dpc-4969	173	6	a	a	DET
dpc-4969	173	7	significant	significant	ADJ
dpc-4969	173	8	positive	positive	ADJ
dpc-4969	173	9	correlation	correlation	NOUN
dpc-4969	173	10	was	be	AUX
dpc-4969	173	11	observed	observe	VERB
dpc-4969	173	12	between	between	ADP
dpc-4969	173	13	the	the	DET
dpc-4969	173	14	duration	duration	NOUN
dpc-4969	173	15	of	of	ADP
dpc-4969	173	16	remission	remission	NOUN
dpc-4969	173	17	and	and	CCONJ
dpc-4969	173	18	the	the	DET
dpc-4969	173	19	lmr	lmr	PROPN
dpc-4969	173	20	values	value	NOUN
dpc-4969	173	21	measured	measure	VERB
dpc-4969	173	22	at	at	ADP
dpc-4969	173	23	baseline	baseline	NOUN
dpc-4969	173	24	,	,	PUNCT
dpc-4969	173	25	3	3	NUM
dpc-4969	173	26	months	month	NOUN
dpc-4969	173	27	and	and	CCONJ
dpc-4969	173	28	6	6	NUM
dpc-4969	173	29	months	month	NOUN
dpc-4969	173	30	.	.	PUNCT
dpc-4969	174	1	we	we	PRON
dpc-4969	174	2	propose	propose	VERB
dpc-4969	174	3	that	that	SCONJ
dpc-4969	174	4	lmr	lmr	PROPN
dpc-4969	174	5	levels	level	NOUN
dpc-4969	174	6	can	can	AUX
dpc-4969	174	7	be	be	AUX
dpc-4969	174	8	used	use	VERB
dpc-4969	174	9	to	to	PART
dpc-4969	174	10	predict	predict	VERB
dpc-4969	174	11	the	the	DET
dpc-4969	174	12	length	length	NOUN
dpc-4969	174	13	of	of	ADP
dpc-4969	174	14	time	time	NOUN
dpc-4969	174	15	the	the	DET
dpc-4969	174	16	disease	disease	NOUN
dpc-4969	174	17	remains	remain	VERB
dpc-4969	174	18	in	in	ADP
dpc-4969	174	19	remission	remission	NOUN
dpc-4969	174	20	.	.	PUNCT
dpc-4969	175	1	in	in	ADP
dpc-4969	175	2	our	our	PRON
dpc-4969	175	3	study	study	NOUN
dpc-4969	175	4	,	,	PUNCT
dpc-4969	175	5	no	no	DET
dpc-4969	175	6	significant	significant	ADJ
dpc-4969	175	7	differences	difference	NOUN
dpc-4969	175	8	were	be	AUX
dpc-4969	175	9	found	find	VERB
dpc-4969	175	10	in	in	ADP
dpc-4969	175	11	changes	change	NOUN
dpc-4969	175	12	in	in	ADP
dpc-4969	175	13	inflammatory	inflammatory	ADJ
dpc-4969	175	14	markers	marker	NOUN
dpc-4969	175	15	and	and	CCONJ
dpc-4969	175	16	disease	disease	NOUN
dpc-4969	175	17	severity	severity	NOUN
dpc-4969	175	18	in	in	ADP
dpc-4969	175	19	the	the	DET
dpc-4969	175	20	group	group	NOUN
dpc-4969	175	21	receiving	receive	VERB
dpc-4969	175	22	ivig	ivig	NOUN
dpc-4969	175	23	,	,	PUNCT
dpc-4969	175	24	except	except	SCONJ
dpc-4969	175	25	for	for	ADP
dpc-4969	175	26	the	the	DET
dpc-4969	175	27	lmr	lmr	PROPN
dpc-4969	175	28	value	value	NOUN
dpc-4969	175	29	.	.	PUNCT
dpc-4969	176	1	in	in	ADP
dpc-4969	176	2	our	our	PRON
dpc-4969	176	3	study	study	NOUN
dpc-4969	176	4	,	,	PUNCT
dpc-4969	176	5	the	the	DET
dpc-4969	176	6	mean	mean	ADJ
dpc-4969	176	7	follow	follow	VERB
dpc-4969	176	8	-	-	PUNCT
dpc-4969	176	9	up	up	NOUN
dpc-4969	176	10	period	period	NOUN
dpc-4969	176	11	of	of	ADP
dpc-4969	176	12	the	the	DET
dpc-4969	176	13	patients	patient	NOUN
dpc-4969	176	14	was	be	AUX
dpc-4969	176	15	determined	determine	VERB
dpc-4969	176	16	to	to	PART
dpc-4969	176	17	be	be	AUX
dpc-4969	176	18	57	57	NUM
dpc-4969	176	19	months	month	NOUN
dpc-4969	176	20	(	(	PUNCT
dpc-4969	176	21	min	min	NOUN
dpc-4969	176	22	=	=	SYM
dpc-4969	176	23	18	18	NUM
dpc-4969	176	24	,	,	PUNCT
dpc-4969	176	25	max	max	PROPN
dpc-4969	176	26	123	123	NUM
dpc-4969	176	27	)	)	PUNCT
dpc-4969	176	28	.	.	PUNCT
dpc-4969	177	1	according	accord	VERB
dpc-4969	177	2	to	to	ADP
dpc-4969	177	3	the	the	DET
dpc-4969	177	4	consensus	consensus	NOUN
dpc-4969	177	5	determined	determine	VERB
dpc-4969	177	6	by	by	ADP
dpc-4969	177	7	the	the	DET
dpc-4969	177	8	international	international	ADJ
dpc-4969	177	9	pemphigus	pemphigus	PROPN
dpc-4969	177	10	committee	committee	PROPN
dpc-4969	177	11	,	,	PUNCT
dpc-4969	177	12	the	the	DET
dpc-4969	177	13	criteria	criterion	NOUN
dpc-4969	177	14	for	for	ADP
dpc-4969	177	15	complete	complete	ADJ
dpc-4969	177	16	remission	remission	NOUN
dpc-4969	177	17	under	under	ADP
dpc-4969	177	18	minimal	minimal	ADJ
dpc-4969	177	19	treatment	treatment	NOUN
dpc-4969	177	20	or	or	CCONJ
dpc-4969	177	21	without	without	ADP
dpc-4969	177	22	treatment	treatment	NOUN
dpc-4969	177	23	were	be	AUX
dpc-4969	177	24	taken	take	VERB
dpc-4969	177	25	into	into	ADP
dpc-4969	177	26	account	account	NOUN
dpc-4969	177	27	,	,	PUNCT
dpc-4969	177	28	and	and	CCONJ
dpc-4969	177	29	when	when	SCONJ
dpc-4969	177	30	the	the	DET
dpc-4969	177	31	duration	duration	NOUN
dpc-4969	177	32	of	of	ADP
dpc-4969	177	33	the	the	DET
dpc-4969	177	34	first	first	ADJ
dpc-4969	177	35	remission	remission	NOUN
dpc-4969	177	36	after	after	SCONJ
dpc-4969	177	37	treatment	treatment	NOUN
dpc-4969	177	38	was	be	AUX
dpc-4969	177	39	considered	consider	VERB
dpc-4969	177	40	,	,	PUNCT
dpc-4969	177	41	the	the	DET
dpc-4969	177	42	duration	duration	NOUN
dpc-4969	177	43	of	of	ADP
dpc-4969	177	44	remission	remission	NOUN
dpc-4969	177	45	in	in	ADP
dpc-4969	177	46	the	the	DET
dpc-4969	177	47	group	group	NOUN
dpc-4969	177	48	receiving	receive	VERB
dpc-4969	177	49	ivig	ivig	NOUN
dpc-4969	177	50	was	be	AUX
dpc-4969	177	51	found	find	VERB
dpc-4969	177	52	to	to	PART
dpc-4969	177	53	be	be	AUX
dpc-4969	177	54	significantly	significantly	ADV
dpc-4969	177	55	longer	long	ADV
dpc-4969	177	56	.	.	PUNCT
dpc-4969	178	1	in	in	ADP
dpc-4969	178	2	the	the	DET
dpc-4969	178	3	study	study	NOUN
dpc-4969	178	4	by	by	ADP
dpc-4969	178	5	svecova	svecova	PROPN
dpc-4969	178	6	et	et	PROPN
dpc-4969	178	7	al	al	PROPN
dpc-4969	178	8	,	,	PUNCT
dpc-4969	178	9	10	10	NUM
dpc-4969	178	10	pv	pv	NOUN
dpc-4969	178	11	patients	patient	NOUN
dpc-4969	178	12	receiving	receive	VERB
dpc-4969	178	13	ivig	ivig	NOUN
dpc-4969	178	14	were	be	AUX
dpc-4969	178	15	followed	follow	VERB
dpc-4969	178	16	for	for	ADP
dpc-4969	178	17	12	12	NUM
dpc-4969	178	18	months	month	NOUN
dpc-4969	178	19	,	,	PUNCT
dpc-4969	178	20	and	and	CCONJ
dpc-4969	178	21	long	long	ADJ
dpc-4969	178	22	remission	remission	NOUN
dpc-4969	178	23	periods	period	NOUN
dpc-4969	178	24	were	be	AUX
dpc-4969	178	25	observed	observe	VERB
dpc-4969	178	26	and	and	CCONJ
dpc-4969	178	27	a	a	DET
dpc-4969	178	28	significant	significant	ADJ
dpc-4969	178	29	decrease	decrease	NOUN
dpc-4969	178	30	in	in	ADP
dpc-4969	178	31	pdai	pdai	PROPN
dpc-4969	178	32	was	be	AUX
dpc-4969	178	33	observed	observe	VERB
dpc-4969	178	34	[	[	X
dpc-4969	178	35	40	40	NUM
dpc-4969	178	36	]	]	PUNCT
dpc-4969	178	37	.	.	PUNCT
dpc-4969	179	1	more	more	ADJ
dpc-4969	179	2	studies	study	NOUN
dpc-4969	179	3	are	be	AUX
dpc-4969	179	4	needed	need	VERB
dpc-4969	179	5	to	to	PART
dpc-4969	179	6	investigate	investigate	VERB
dpc-4969	179	7	the	the	DET
dpc-4969	179	8	duration	duration	NOUN
dpc-4969	179	9	of	of	ADP
dpc-4969	179	10	remission	remission	NOUN
dpc-4969	179	11	of	of	ADP
dpc-4969	179	12	treatments	treatment	NOUN
dpc-4969	179	13	in	in	ADP
dpc-4969	179	14	pemphigus	pemphigus	PROPN
dpc-4969	179	15	.	.	PUNCT
dpc-4969	180	1	pemphigus	pemphigus	PROPN
dpc-4969	180	2	is	be	AUX
dpc-4969	180	3	a	a	DET
dpc-4969	180	4	serious	serious	ADJ
dpc-4969	180	5	disease	disease	NOUN
dpc-4969	180	6	that	that	PRON
dpc-4969	180	7	can	can	AUX
dpc-4969	180	8	lead	lead	VERB
dpc-4969	180	9	to	to	ADP
dpc-4969	180	10	mortality	mortality	NOUN
dpc-4969	180	11	.	.	PUNCT
dpc-4969	181	1	a	a	DET
dpc-4969	181	2	treatment	treatment	NOUN
dpc-4969	181	3	modality	modality	NOUN
dpc-4969	181	4	that	that	PRON
dpc-4969	181	5	provides	provide	VERB
dpc-4969	181	6	complete	complete	ADJ
dpc-4969	181	7	remission	remission	NOUN
dpc-4969	181	8	is	be	AUX
dpc-4969	181	9	not	not	PART
dpc-4969	181	10	yet	yet	ADV
dpc-4969	181	11	available	available	ADJ
dpc-4969	181	12	.	.	PUNCT
dpc-4969	182	1	the	the	DET
dpc-4969	182	2	existence	existence	NOUN
dpc-4969	182	3	of	of	ADP
dpc-4969	182	4	markers	marker	NOUN
dpc-4969	182	5	that	that	PRON
dpc-4969	182	6	can	can	AUX
dpc-4969	182	7	be	be	AUX
dpc-4969	182	8	used	use	VERB
dpc-4969	182	9	in	in	ADP
dpc-4969	182	10	daily	daily	ADJ
dpc-4969	182	11	practice	practice	NOUN
dpc-4969	182	12	,	,	PUNCT
dpc-4969	182	13	which	which	PRON
dpc-4969	182	14	can	can	AUX
dpc-4969	182	15	evaluate	evaluate	VERB
dpc-4969	182	16	the	the	DET
dpc-4969	182	17	effectiveness	effectiveness	NOUN
dpc-4969	182	18	of	of	ADP
dpc-4969	182	19	existing	exist	VERB
dpc-4969	182	20	treatments	treatment	NOUN
dpc-4969	182	21	and	and	CCONJ
dpc-4969	182	22	provide	provide	VERB
dpc-4969	182	23	guidance	guidance	NOUN
dpc-4969	182	24	for	for	ADP
dpc-4969	182	25	remission	remission	NOUN
dpc-4969	182	26	periods	period	NOUN
dpc-4969	182	27	,	,	PUNCT
dpc-4969	182	28	will	will	AUX
dpc-4969	182	29	facilitate	facilitate	VERB
dpc-4969	182	30	the	the	DET
dpc-4969	182	31	follow	follow	NOUN
dpc-4969	182	32	-	-	PUNCT
dpc-4969	182	33	up	up	NOUN
dpc-4969	182	34	and	and	CCONJ
dpc-4969	182	35	treatment	treatment	NOUN
dpc-4969	182	36	of	of	ADP
dpc-4969	182	37	the	the	DET
dpc-4969	182	38	disease	disease	NOUN
dpc-4969	182	39	for	for	ADP
dpc-4969	182	40	the	the	DET
dpc-4969	182	41	physician	physician	NOUN
dpc-4969	182	42	.	.	PUNCT
dpc-4969	183	1	references	reference	NOUN
dpc-4969	183	2	1	1	NUM
dpc-4969	183	3	.	.	PUNCT
dpc-4969	183	4	schmidt	schmidt	PROPN
dpc-4969	183	5	e	e	PROPN
dpc-4969	183	6	,	,	PUNCT
dpc-4969	183	7	kasperkiewicz	kasperkiewicz	PROPN
dpc-4969	183	8	m	m	PROPN
dpc-4969	183	9	,	,	PUNCT
dpc-4969	183	10	joly	joly	PROPN
dpc-4969	183	11	p.	p.	PROPN
dpc-4969	183	12	pemphigus	pemphigus	PROPN
dpc-4969	183	13	.	.	PUNCT
dpc-4969	184	1	lancet	lancet	PROPN
dpc-4969	184	2	.	.	PUNCT
dpc-4969	185	1	2019;394(10201):882	2019;394(10201):882	NUM
dpc-4969	185	2	-	-	SYM
dpc-4969	185	3	894	894	NUM
dpc-4969	185	4	.	.	PUNCT
dpc-4969	185	5	doi	doi	NOUN
dpc-4969	185	6	:	:	PUNCT
dpc-4969	185	7	10.1016	10.1016	NUM
dpc-4969	185	8	/	/	SYM
dpc-4969	185	9	s0140	s0140	PROPN
dpc-4969	185	10	-	-	PUNCT
dpc-4969	185	11	6736(19	6736(19	NUM
dpc-4969	185	12	)	)	PUNCT
dpc-4969	185	13	31778	31778	NUM
dpc-4969	185	14	-	-	SYM
dpc-4969	185	15	7	7	NUM
dpc-4969	185	16	.	.	PUNCT
dpc-4969	186	1	pmid	pmid	NOUN
dpc-4969	186	2	:	:	PUNCT
dpc-4969	186	3	31498102	31498102	NUM
dpc-4969	186	4	.	.	PUNCT
dpc-4969	187	1	2	2	X
dpc-4969	187	2	.	.	X
dpc-4969	187	3	porro	porro	PROPN
dpc-4969	187	4	am	be	AUX
dpc-4969	187	5	,	,	PUNCT
dpc-4969	187	6	caetano	caetano	PROPN
dpc-4969	187	7	lde	lde	PROPN
dpc-4969	187	8	v	v	PROPN
dpc-4969	187	9	,	,	PUNCT
dpc-4969	187	10	maehara	maehara	X
dpc-4969	187	11	lde	lde	X
dpc-4969	187	12	s	s	PROPN
dpc-4969	187	13	,	,	PUNCT
dpc-4969	187	14	enokihara	enokihara	VERB
dpc-4969	187	15	mm	mm	PROPN
dpc-4969	187	16	.	.	PUNCT
dpc-4969	188	1	non	non	ADJ
dpc-4969	188	2	-	-	ADJ
dpc-4969	188	3	classical	classical	ADJ
dpc-4969	188	4	forms	form	NOUN
dpc-4969	188	5	of	of	ADP
dpc-4969	188	6	pemphigus	pemphigus	NOUN
dpc-4969	188	7	:	:	PUNCT
dpc-4969	188	8	pemphigus	pemphigus	PROPN
dpc-4969	188	9	herpetiformis	herpetiformis	PROPN
dpc-4969	188	10	,	,	PUNCT
dpc-4969	188	11	iga	iga	PROPN
dpc-4969	188	12	pemphigus	pemphigus	NOUN
dpc-4969	188	13	,	,	PUNCT
dpc-4969	188	14	paraneoplastic	paraneoplastic	ADJ
dpc-4969	188	15	pemphigus	pemphigus	NOUN
dpc-4969	188	16	and	and	CCONJ
dpc-4969	188	17	igg	igg	PROPN
dpc-4969	188	18	/	/	SYM
dpc-4969	188	19	iga	iga	PROPN
dpc-4969	188	20	pemphigus	pemphigus	NOUN
dpc-4969	188	21	.	.	PUNCT
dpc-4969	188	22	  	  	SPACE
dpc-4969	189	1	an	an	DET
dpc-4969	189	2	bras	bras	NOUN
dpc-4969	189	3	dermatol	dermatol	NOUN
dpc-4969	189	4	.	.	PUNCT
dpc-4969	189	5	  	  	SPACE
dpc-4969	190	1	2014;89(1):96	2014;89(1):96	NUM
dpc-4969	190	2	-	-	SYM
dpc-4969	190	3	106	106	NUM
dpc-4969	190	4	.	.	PUNCT
dpc-4969	191	1	doi	doi	NOUN
dpc-4969	191	2	:	:	PUNCT
dpc-4969	191	3	10.1590	10.1590	NUM
dpc-4969	191	4	/abd1806	/abd1806	SYM
dpc-4969	191	5	-	-	PUNCT
dpc-4969	191	6	4841.20142459	4841.20142459	NOUN
dpc-4969	191	7	 	 	SPACE
dpc-4969	191	8	pmid:24626654	pmid:24626654	NOUN
dpc-4969	191	9	  	  	SPACE
dpc-4969	191	10	3	3	NUM
dpc-4969	191	11	.	.	PUNCT
dpc-4969	192	1	chen	chen	PROPN
dpc-4969	192	2	l	l	PROPN
dpc-4969	192	3	,	,	PUNCT
dpc-4969	192	4	deng	deng	PROPN
dpc-4969	192	5	h	h	PROPN
dpc-4969	192	6	,	,	PUNCT
dpc-4969	192	7	cui	cui	PROPN
dpc-4969	192	8	h	h	PROPN
dpc-4969	192	9	,	,	PUNCT
dpc-4969	192	10	et	et	PROPN
dpc-4969	192	11	al	al	PROPN
dpc-4969	192	12	.	.	PUNCT
dpc-4969	192	13	inflammatory	inflammatory	ADJ
dpc-4969	192	14	responses	response	NOUN
dpc-4969	192	15	and	and	CCONJ
dpc-4969	192	16	inflammation	inflammation	NOUN
dpc-4969	192	17	-	-	PUNCT
dpc-4969	192	18	associated	associate	VERB
dpc-4969	192	19	diseases	disease	NOUN
dpc-4969	192	20	in	in	ADP
dpc-4969	192	21	organs	organ	NOUN
dpc-4969	192	22	.	.	PUNCT
dpc-4969	193	1	oncotarget	oncotarget	NOUN
dpc-4969	193	2	.	.	PUNCT
dpc-4969	194	1	2018;9(6	2018;9(6	NUM
dpc-4969	194	2	):	):	PUNCT
dpc-4969	194	3	7204	7204	NUM
dpc-4969	194	4	-	-	SYM
dpc-4969	194	5	18	18	NUM
dpc-4969	194	6	.	.	PUNCT
dpc-4969	195	1	doi	doi	NOUN
dpc-4969	195	2	:	:	PUNCT
dpc-4969	195	3	10.18632	10.18632	NUM
dpc-4969	195	4	/	/	SYM
dpc-4969	195	5	oncotarget.23208	oncotarget.23208	PROPN
dpc-4969	195	6	pmid:29467962	pmid:29467962	ADP
dpc-4969	195	7	  	  	SPACE
dpc-4969	195	8	4	4	NUM
dpc-4969	195	9	.	.	PUNCT
dpc-4969	195	10	bartneck	bartneck	PROPN
dpc-4969	195	11	m	m	PROPN
dpc-4969	195	12	,	,	PUNCT
dpc-4969	195	13	wang	wang	PROPN
dpc-4969	195	14	j.	j.	PROPN
dpc-4969	195	15	therapeutic	therapeutic	ADJ
dpc-4969	195	16	targeting	targeting	NOUN
dpc-4969	195	17	of	of	ADP
dpc-4969	195	18	neutrophil	neutrophil	ADJ
dpc-4969	195	19	granulocytes	granulocyte	NOUN
dpc-4969	195	20	in	in	ADP
dpc-4969	195	21	inflammatory	inflammatory	ADJ
dpc-4969	195	22	liver	liver	NOUN
dpc-4969	195	23	disease	disease	NOUN
dpc-4969	195	24	.	.	PUNCT
dpc-4969	195	25	 	 	SPACE
dpc-4969	196	1	front	front	ADJ
dpc-4969	196	2	immunol	immunol	NOUN
dpc-4969	196	3	.	.	PUNCT
dpc-4969	196	4	 	 	SPACE
dpc-4969	197	1	2019;10:2257	2019;10:2257	NUM
dpc-4969	197	2	.	.	PUNCT
dpc-4969	197	3	doi:10.3389	doi:10.3389	PROPN
dpc-4969	197	4	/	/	SYM
dpc-4969	197	5	fimmu.2019.02257	fimmu.2019.02257	NOUN
dpc-4969	197	6	 	 	SPACE
dpc-4969	197	7	pmid:31616430	pmid:31616430	X
dpc-4969	197	8	  	  	SPACE
dpc-4969	197	9	5	5	NUM
dpc-4969	197	10	.	.	PUNCT
dpc-4969	198	1	yoon	yoon	PROPN
dpc-4969	198	2	ci	ci	PROPN
dpc-4969	198	3	,	,	PUNCT
dpc-4969	198	4	park	park	NOUN
dpc-4969	198	5	s	s	PROPN
dpc-4969	198	6	,	,	PUNCT
dpc-4969	198	7	cha	cha	PROPN
dpc-4969	198	8	yj	yj	PROPN
dpc-4969	198	9	,	,	PUNCT
dpc-4969	198	10	et	et	PROPN
dpc-4969	198	11	al	al	PROPN
dpc-4969	198	12	.	.	PROPN
dpc-4969	198	13	associations	association	NOUN
dpc-4969	198	14	between	between	ADP
dpc-4969	198	15	absolute	absolute	ADJ
dpc-4969	198	16	neutrophil	neutrophil	ADJ
dpc-4969	198	17	count	count	NOUN
dpc-4969	198	18	and	and	CCONJ
dpc-4969	198	19	lymphocyte	lymphocyte	ADJ
dpc-4969	198	20	-	-	PUNCT
dpc-4969	198	21	predominant	predominant	ADJ
dpc-4969	198	22	breast	breast	NOUN
dpc-4969	198	23	cancer	cancer	NOUN
dpc-4969	198	24	.	.	PUNCT
dpc-4969	199	1	breast	breast	NOUN
dpc-4969	199	2	.	.	PUNCT
dpc-4969	200	1	2020;50:141	2020;50:141	NOUN
dpc-4969	200	2	-	-	SYM
dpc-4969	200	3	8	8	NUM
dpc-4969	200	4	.	.	PUNCT
dpc-4969	200	5	doi	doi	NOUN
dpc-4969	200	6	:	:	PUNCT
dpc-4969	200	7	10.1016	10.1016	NUM
dpc-4969	200	8	/	/	SYM
dpc-4969	200	9	j.breast.2019.09.013	j.breast.2019.09.013	PROPN
dpc-4969	200	10	pmid	pmid	PROPN
dpc-4969	200	11	:	:	PUNCT
dpc-4969	200	12	31607527	31607527	NUM
dpc-4969	200	13	  	  	SPACE
dpc-4969	200	14	6	6	NUM
dpc-4969	200	15	.	.	PUNCT
dpc-4969	201	1	zhu	zhu	PROPN
dpc-4969	201	2	x	x	SYM
dpc-4969	201	3	,	,	PUNCT
dpc-4969	201	4	chen	chen	PROPN
dpc-4969	201	5	y	y	PROPN
dpc-4969	201	6	,	,	PUNCT
dpc-4969	201	7	cui	cui	VERB
dpc-4969	201	8	y.	y.	PROPN
dpc-4969	201	9	absolute	absolute	ADJ
dpc-4969	201	10	neutrophil	neutrophil	ADJ
dpc-4969	201	11	count	count	NOUN
dpc-4969	201	12	and	and	CCONJ
dpc-4969	201	13	mean	mean	VERB
dpc-4969	201	14	platelet	platelet	NOUN
dpc-4969	201	15	volume	volume	NOUN
dpc-4969	201	16	in	in	ADP
dpc-4969	201	17	the	the	DET
dpc-4969	201	18	blood	blood	NOUN
dpc-4969	201	19	as	as	SCONJ
dpc-4969	201	20	biomarkers	biomarker	NOUN
dpc-4969	201	21	to	to	PART
dpc-4969	201	22	detect	detect	VERB
dpc-4969	201	23	lung	lung	NOUN
dpc-4969	201	24	cancer	cancer	NOUN
dpc-4969	201	25	.	.	PUNCT
dpc-4969	202	1	dis	dis	PROPN
dpc-4969	202	2	markers	marker	NOUN
dpc-4969	202	3	.	.	PUNCT
dpc-4969	203	1	2020;2020:1371964	2020;2020:1371964	NUM
dpc-4969	203	2	.	.	PUNCT
dpc-4969	204	1	doi	doi	NOUN
dpc-4969	204	2	:	:	PUNCT
dpc-4969	204	3	10.1155/2020/	10.1155/2020/	NUM
dpc-4969	204	4	1371964	1371964	NUM
dpc-4969	204	5	 	 	SPACE
dpc-4969	204	6	pmid:32377267	pmid:32377267	ADJ
dpc-4969	204	7	7	7	NUM
dpc-4969	204	8	.	.	PUNCT
dpc-4969	204	9	katoh	katoh	PROPN
dpc-4969	204	10	n.	n.	NOUN
dpc-4969	204	11	platelets	platelet	VERB
dpc-4969	204	12	as	as	ADP
dpc-4969	204	13	versatile	versatile	ADJ
dpc-4969	204	14	regulators	regulator	NOUN
dpc-4969	204	15	of	of	ADP
dpc-4969	204	16	cutaneous	cutaneous	ADJ
dpc-4969	204	17	inflammation	inflammation	NOUN
dpc-4969	204	18	.	.	PUNCT
dpc-4969	205	1	j	j	PROPN
dpc-4969	205	2	dermatol	dermatol	NOUN
dpc-4969	205	3	sci	sci	PROPN
dpc-4969	205	4	.	.	PUNCT
dpc-4969	206	1	2009;53(2):89	2009;53(2):89	NUM
dpc-4969	206	2	-	-	SYM
dpc-4969	206	3	95	95	NUM
dpc-4969	206	4	.	.	PUNCT
dpc-4969	207	1	doi	doi	NOUN
dpc-4969	207	2	:	:	PUNCT
dpc-4969	207	3	10.1016	10.1016	NUM
dpc-4969	207	4	/j.jdermsci.2008.08.019	/j.jdermsci.2008.08.019	PUNCT
dpc-4969	207	5	pmid:18922681	pmid:18922681	X
dpc-4969	207	6	8	8	NUM
dpc-4969	207	7	.	.	PUNCT
dpc-4969	208	1	dan	dan	PROPN
dpc-4969	208	2	k	k	PROPN
dpc-4969	208	3	,	,	PUNCT
dpc-4969	208	4	gomi	gomi	PROPN
dpc-4969	208	5	s	s	PROPN
dpc-4969	208	6	,	,	PUNCT
dpc-4969	208	7	inokuchi	inokuchi	PROPN
dpc-4969	208	8	k	k	PROPN
dpc-4969	208	9	,	,	PUNCT
dpc-4969	208	10	et	et	PROPN
dpc-4969	208	11	al	al	PROPN
dpc-4969	208	12	.	.	PUNCT
dpc-4969	208	13	effects	effect	NOUN
dpc-4969	208	14	of	of	ADP
dpc-4969	208	15	interleukin-1	interleukin-1	NUM
dpc-4969	208	16	and	and	CCONJ
dpc-4969	208	17	tumor	tumor	NOUN
dpc-4969	208	18	necrosis	necrosis	NOUN
dpc-4969	208	19	factor	factor	NOUN
dpc-4969	208	20	on	on	ADP
dpc-4969	208	21	megakaryocytopoiesis	megakaryocytopoiesis	NOUN
dpc-4969	208	22	:	:	PUNCT
dpc-4969	208	23	mechanism	mechanism	NOUN
dpc-4969	208	24	of	of	ADP
dpc-4969	208	25	reactive	reactive	ADJ
dpc-4969	208	26	thrombocytosis	thrombocytosis	NOUN
dpc-4969	208	27	.	.	PUNCT
dpc-4969	209	1	acta	acta	PROPN
dpc-4969	209	2	haematol	haematol	PROPN
dpc-4969	209	3	.	.	PUNCT
dpc-4969	210	1	1995;93(2	1995;93(2	NUM
dpc-4969	210	2	-	-	SYM
dpc-4969	210	3	4):67	4):67	NUM
dpc-4969	210	4	-	-	SYM
dpc-4969	210	5	72	72	NUM
dpc-4969	210	6	.	.	PUNCT
dpc-4969	211	1	doi	doi	NOUN
dpc-4969	211	2	:	:	PUNCT
dpc-4969	211	3	10.1159/000204114	10.1159/000204114	NUM
dpc-4969	211	4	pmid:7639054	pmid:7639054	NOUN
dpc-4969	211	5	9	9	NUM
dpc-4969	211	6	.	.	PUNCT
dpc-4969	212	1	leblanc	leblanc	PROPN
dpc-4969	212	2	r	r	PROPN
dpc-4969	212	3	,	,	PUNCT
dpc-4969	212	4	peyruchaud	peyruchaud	ADJ
dpc-4969	212	5	o.	o.	NOUN
dpc-4969	212	6	metastasis	metastasis	NOUN
dpc-4969	212	7	:	:	PUNCT
dpc-4969	212	8	new	new	ADJ
dpc-4969	212	9	functional	functional	ADJ
dpc-4969	212	10	implications	implication	NOUN
dpc-4969	212	11	of	of	ADP
dpc-4969	212	12	platelets	platelet	NOUN
dpc-4969	212	13	and	and	CCONJ
dpc-4969	212	14	megakaryocytes	megakaryocyte	NOUN
dpc-4969	212	15	.	.	PUNCT
dpc-4969	212	16	  	  	SPACE
dpc-4969	212	17	blood	blood	NOUN
dpc-4969	212	18	.	.	PUNCT
dpc-4969	212	19	  	  	SPACE
dpc-4969	212	20	2016;128(1	2016;128(1	NOUN
dpc-4969	212	21	):	):	PUNCT
dpc-4969	212	22	24	24	NUM
dpc-4969	212	23	-	-	SYM
dpc-4969	212	24	31	31	NUM
dpc-4969	212	25	.	.	PUNCT
dpc-4969	213	1	doi	doi	NOUN
dpc-4969	213	2	:	:	PUNCT
dpc-4969	213	3	10.1182	10.1182	NUM
dpc-4969	213	4	/	/	SYM
dpc-4969	213	5	blood-2016	blood-2016	PROPN
dpc-4969	213	6	-	-	PUNCT
dpc-4969	213	7	01	01	NUM
dpc-4969	213	8	-	-	PUNCT
dpc-4969	213	9	636399	636399	NUM
dpc-4969	213	10	pmid:27154188	pmid:27154188	NOUN
dpc-4969	213	11	10	10	NUM
dpc-4969	213	12	.	.	PUNCT
dpc-4969	214	1	bednarz	bednarz	NOUN
dpc-4969	214	2	-	-	PUNCT
dpc-4969	214	3	knoll	knoll	NOUN
dpc-4969	214	4	n	n	CCONJ
dpc-4969	214	5	,	,	PUNCT
dpc-4969	214	6	popęda	popęda	PROPN
dpc-4969	214	7	m	m	PROPN
dpc-4969	214	8	,	,	PUNCT
dpc-4969	214	9	kryczka	kryczka	PROPN
dpc-4969	214	10	t	t	PROPN
dpc-4969	214	11	,	,	PUNCT
dpc-4969	214	12	et	et	PROPN
dpc-4969	214	13	al	al	PROPN
dpc-4969	214	14	.	.	PUNCT
dpc-4969	215	1	higher	high	ADJ
dpc-4969	215	2	platelet	platelet	NOUN
dpc-4969	215	3	counts	count	NOUN
dpc-4969	215	4	correlate	correlate	VERB
dpc-4969	215	5	to	to	ADP
dpc-4969	215	6	tumour	tumour	NOUN
dpc-4969	215	7	progression	progression	NOUN
dpc-4969	215	8	and	and	CCONJ
dpc-4969	215	9	can	can	AUX
dpc-4969	215	10	be	be	AUX
dpc-4969	215	11	induced	induce	VERB
dpc-4969	215	12	by	by	ADP
dpc-4969	215	13	intratumoural	intratumoural	ADJ
dpc-4969	215	14	stroma	stroma	NOUN
dpc-4969	215	15	in	in	ADP
dpc-4969	215	16	non	non	ADJ
dpc-4969	215	17	-	-	ADJ
dpc-4969	215	18	metastatic	metastatic	ADJ
dpc-4969	215	19	breast	breast	NOUN
dpc-4969	215	20	carcinomas	carcinoma	NOUN
dpc-4969	215	21	.	.	PUNCT
dpc-4969	216	1	br	br	X
dpc-4969	216	2	j	j	PROPN
dpc-4969	216	3	cancer	cancer	NOUN
dpc-4969	216	4	.	.	PUNCT
dpc-4969	216	5	  	  	SPACE
dpc-4969	217	1	2022;126(3):464	2022;126(3):464	NUM
dpc-4969	217	2	-	-	SYM
dpc-4969	217	3	71	71	NUM
dpc-4969	217	4	.	.	PUNCT
dpc-4969	218	1	doi	doi	NOUN
dpc-4969	218	2	:	:	PUNCT
dpc-4969	218	3	10.1038	10.1038	NUM
dpc-4969	218	4	/	/	SYM
dpc-4969	218	5	s41416	s41416	PROPN
dpc-4969	218	6	-	-	PUNCT
dpc-4969	218	7	021	021	NUM
dpc-4969	218	8	-01647	-01647	ADJ
dpc-4969	218	9	-	-	PUNCT
dpc-4969	218	10	9	9	NUM
dpc-4969	218	11	pmid:34857895	pmid:34857895	PROPN
dpc-4969	218	12	11	11	NUM
dpc-4969	218	13	.	.	PUNCT
dpc-4969	219	1	kim	kim	PROPN
dpc-4969	219	2	kh	kh	PROPN
dpc-4969	219	3	,	,	PUNCT
dpc-4969	219	4	park	park	NOUN
dpc-4969	219	5	ty	ty	NUM
dpc-4969	219	6	,	,	PUNCT
dpc-4969	219	7	lee	lee	PROPN
dpc-4969	219	8	jy	jy	PROPN
dpc-4969	219	9	,	,	PUNCT
dpc-4969	219	10	et	et	PROPN
dpc-4969	219	11	al	al	PROPN
dpc-4969	219	12	.	.	PROPN
dpc-4969	220	1	prognostic	prognostic	ADJ
dpc-4969	220	2	significance	significance	NOUN
dpc-4969	220	3	of	of	ADP
dpc-4969	220	4	initial	initial	ADJ
dpc-4969	220	5	platelet	platelet	NOUN
dpc-4969	220	6	counts	count	NOUN
dpc-4969	220	7	and	and	CCONJ
dpc-4969	220	8	fibrinogen	fibrinogen	NOUN
dpc-4969	220	9	level	level	NOUN
dpc-4969	220	10	in	in	ADP
dpc-4969	220	11	advanced	advanced	ADJ
dpc-4969	220	12	non	non	ADJ
dpc-4969	220	13	-	-	ADJ
dpc-4969	220	14	small	small	ADJ
dpc-4969	220	15	cell	cell	NOUN
dpc-4969	220	16	lung	lung	NOUN
dpc-4969	220	17	cancer	cancer	NOUN
dpc-4969	220	18	.	.	PUNCT
dpc-4969	220	19	  	  	SPACE
dpc-4969	221	1	j	j	PROPN
dpc-4969	221	2	korean	korean	PROPN
dpc-4969	221	3	med	med	PROPN
dpc-4969	221	4	sci	sci	PROPN
dpc-4969	221	5	.	.	PUNCT
dpc-4969	221	6	  	  	SPACE
dpc-4969	221	7	2014;29(4):507	2014;29(4):507	NUM
dpc-4969	221	8	-	-	SYM
dpc-4969	221	9	11	11	NUM
dpc-4969	221	10	.	.	PUNCT
dpc-4969	222	1	doi	doi	NOUN
dpc-4969	222	2	:	:	PUNCT
dpc-4969	222	3	10.3346	10.3346	NUM
dpc-4969	222	4	/	/	SYM
dpc-4969	222	5	jkms.2014.29.4.507	jkms.2014.29.4.507	PROPN
dpc-4969	222	6	pmid:24753697	pmid:24753697	PROPN
dpc-4969	222	7	12	12	NUM
dpc-4969	222	8	.	.	PUNCT
dpc-4969	223	1	shen	shen	PROPN
dpc-4969	223	2	h	h	PROPN
dpc-4969	223	3	,	,	PUNCT
dpc-4969	223	4	xu	xu	PROPN
dpc-4969	224	1	c	c	X
dpc-4969	224	2	,	,	PUNCT
dpc-4969	224	3	chen	chen	PROPN
dpc-4969	224	4	c.	c.	PROPN
dpc-4969	225	1	[	[	X
dpc-4969	225	2	platelet	platelet	NOUN
dpc-4969	225	3	count	count	NOUN
dpc-4969	225	4	predicts	predict	VERB
dpc-4969	225	5	therapeutic	therapeutic	ADJ
dpc-4969	225	6	response	response	NOUN
dpc-4969	225	7	of	of	ADP
dpc-4969	225	8	infliximab	infliximab	NOUN
dpc-4969	225	9	for	for	ADP
dpc-4969	225	10	active	active	ADJ
dpc-4969	225	11	crohn	crohn	PROPN
dpc-4969	225	12	’s	’s	PART
dpc-4969	225	13	disease	disease	NOUN
dpc-4969	225	14	]	]	PUNCT
dpc-4969	225	15	.	.	PUNCT
dpc-4969	225	16	  	  	SPACE
dpc-4969	226	1	zhejiang	zhejiang	PROPN
dpc-4969	226	2	da	da	PROPN
dpc-4969	226	3	xue	xue	PROPN
dpc-4969	226	4	xue	xue	PROPN
dpc-4969	226	5	bao	bao	PROPN
dpc-4969	226	6	yi	yi	PROPN
dpc-4969	226	7	xue	xue	PROPN
dpc-4969	226	8	ban	ban	PROPN
dpc-4969	226	9	.	.	PUNCT
dpc-4969	226	10	 	 	SPACE
dpc-4969	227	1	2016;45(1):81	2016;45(1):81	NUM
dpc-4969	227	2	-	-	SYM
dpc-4969	227	3	5	5	NUM
dpc-4969	227	4	.	.	PUNCT
dpc-4969	227	5	doi	doi	NOUN
dpc-4969	227	6	:	:	PUNCT
dpc-4969	227	7	10.3785	10.3785	NUM
dpc-4969	227	8	/	/	SYM
dpc-4969	227	9	j.issn	j.issn	NOUN
dpc-4969	227	10	.1008	.1008	NOUN
dpc-4969	227	11	-	-	PUNCT
dpc-4969	227	12	9292.2016.01.13	9292.2016.01.13	NOUN
dpc-4969	227	13	  	  	SPACE
dpc-4969	227	14	pmid:27045246	pmid:27045246	PROPN
dpc-4969	227	15	13	13	NUM
dpc-4969	227	16	.	.	PUNCT
dpc-4969	228	1	willeke	willeke	ADJ
dpc-4969	228	2	p	p	X
dpc-4969	228	3	,	,	PUNCT
dpc-4969	228	4	kümpers	kümper	NOUN
dpc-4969	228	5	p	p	NOUN
dpc-4969	228	6	,	,	PUNCT
dpc-4969	228	7	schlüter	schlüter	NOUN
dpc-4969	228	8	b	b	PROPN
dpc-4969	228	9	,	,	PUNCT
dpc-4969	228	10	limani	limani	X
dpc-4969	228	11	a	a	X
dpc-4969	228	12	,	,	PUNCT
dpc-4969	228	13	becker	becker	PROPN
dpc-4969	228	14	h	h	PROPN
dpc-4969	228	15	,	,	PUNCT
dpc-4969	228	16	schotte	schotte	PROPN
dpc-4969	228	17	h.	h.	PROPN
dpc-4969	228	18	platelet	platelet	NOUN
dpc-4969	228	19	counts	count	NOUN
dpc-4969	228	20	as	as	ADP
dpc-4969	228	21	a	a	DET
dpc-4969	228	22	biomarker	biomarker	NOUN
dpc-4969	228	23	in	in	ADP
dpc-4969	228	24	anca	anca	NOUN
dpc-4969	228	25	-	-	PUNCT
dpc-4969	228	26	associated	associate	VERB
dpc-4969	228	27	vasculitis	vasculitis	PROPN
dpc-4969	228	28	.	.	PUNCT
dpc-4969	228	29	 	 	SPACE
dpc-4969	229	1	scand	scand	PROPN
dpc-4969	229	2	j	j	PROPN
dpc-4969	229	3	rheumatol	rheumatol	PROPN
dpc-4969	229	4	.	.	PUNCT
dpc-4969	229	5	 	 	SPACE
dpc-4969	230	1	2015;44(4):302	2015;44(4):302	NUM
dpc-4969	230	2	-	-	SYM
dpc-4969	230	3	8	8	NUM
dpc-4969	230	4	.	.	PUNCT
dpc-4969	231	1	doi	doi	NOUN
dpc-4969	231	2	:	:	PUNCT
dpc-4969	231	3	10.3109/03009	10.3109/03009	NUM
dpc-4969	231	4	742.2015.1006247	742.2015.1006247	NUM
dpc-4969	231	5	  	  	SPACE
dpc-4969	231	6	pmid:25744854	pmid:25744854	NOUN
dpc-4969	231	7	14	14	NUM
dpc-4969	231	8	.	.	PUNCT
dpc-4969	232	1	tamer	tame	ADJ
dpc-4969	232	2	f	f	NOUN
dpc-4969	232	3	,	,	PUNCT
dpc-4969	232	4	gulekon	gulekon	PROPN
dpc-4969	232	5	a.	a.	NOUN
dpc-4969	232	6	novel	novel	NOUN
dpc-4969	232	7	inflammatory	inflammatory	ADJ
dpc-4969	232	8	biomarkers	biomarker	NOUN
dpc-4969	232	9	in	in	ADP
dpc-4969	232	10	patients	patient	NOUN
dpc-4969	232	11	with	with	ADP
dpc-4969	232	12	mycosis	mycosis	NOUN
dpc-4969	232	13	fungoides	fungoide	NOUN
dpc-4969	232	14	treated	treat	VERB
dpc-4969	232	15	with	with	ADP
dpc-4969	232	16	bexarotene	bexarotene	NOUN
dpc-4969	232	17	.	.	PUNCT
dpc-4969	232	18	 	 	SPACE
dpc-4969	233	1	j	j	PROPN
dpc-4969	233	2	coll	coll	PROPN
dpc-4969	233	3	physicians	physicians	PROPN
dpc-4969	233	4	surg	surg	PROPN
dpc-4969	233	5	pak	pak	PROPN
dpc-4969	233	6	.	.	PUNCT
dpc-4969	233	7	 	 	SPACE
dpc-4969	234	1	2021;31(6):716	2021;31(6):716	PROPN
dpc-4969	234	2	-	-	PUNCT
dpc-4969	234	3	8	8	NUM
dpc-4969	234	4	.	.	PUNCT
dpc-4969	235	1	doi	doi	NOUN
dpc-4969	235	2	:	:	PUNCT
dpc-4969	235	3	10.29271	10.29271	NUM
dpc-4969	235	4	/	/	SYM
dpc-4969	236	1	jcpsp.2021.0	jcpsp.2021.0	ADP
dpc-4969	236	2	6.716	6.716	NUM
dpc-4969	236	3	  	  	SPACE
dpc-4969	236	4	pmid:34102787	pmid:34102787	NUM
dpc-4969	236	5	15	15	NUM
dpc-4969	236	6	.	.	PUNCT
dpc-4969	237	1	murrell	murrell	PROPN
dpc-4969	237	2	df	df	PROPN
dpc-4969	237	3	,	,	PUNCT
dpc-4969	237	4	dick	dick	PROPN
dpc-4969	237	5	s	s	PROPN
dpc-4969	237	6	,	,	PUNCT
dpc-4969	237	7	ahmed	ahmed	PROPN
dpc-4969	237	8	ar	ar	PROPN
dpc-4969	237	9	,	,	PUNCT
dpc-4969	237	10	et	et	PROPN
dpc-4969	237	11	al	al	PROPN
dpc-4969	237	12	.	.	PUNCT
dpc-4969	238	1	consensus	consensus	NOUN
dpc-4969	238	2	statement	statement	NOUN
dpc-4969	238	3	on	on	ADP
dpc-4969	238	4	definitions	definition	NOUN
dpc-4969	238	5	of	of	ADP
dpc-4969	238	6	disease	disease	NOUN
dpc-4969	238	7	,	,	PUNCT
dpc-4969	238	8	end	end	NOUN
dpc-4969	238	9	points	point	NOUN
dpc-4969	238	10	,	,	PUNCT
dpc-4969	238	11	and	and	CCONJ
dpc-4969	238	12	therapeutic	therapeutic	ADJ
dpc-4969	238	13	response	response	NOUN
dpc-4969	238	14	for	for	ADP
dpc-4969	238	15	pemphigus	pemphigus	PROPN
dpc-4969	238	16	.	.	PUNCT
dpc-4969	239	1	j	j	PROPN
dpc-4969	239	2	am	be	AUX
dpc-4969	239	3	acad	acad	ADJ
dpc-4969	239	4	dermatol	dermatol	NOUN
dpc-4969	239	5	.	.	PUNCT
dpc-4969	239	6	 	 	SPACE
dpc-4969	240	1	2008;58(6):1043	2008;58(6):1043	NUM
dpc-4969	240	2	-	-	SYM
dpc-4969	240	3	6	6	NUM
dpc-4969	240	4	.	.	PUNCT
dpc-4969	240	5	doi	doi	NOUN
dpc-4969	240	6	:	:	PUNCT
dpc-4969	240	7	10.1016	10.1016	NUM
dpc-4969	240	8	/j.jaad.2008.01.012	/j.jaad.2008.01.012	PUNCT
dpc-4969	240	9	pmid:18339444	pmid:18339444	ADJ
dpc-4969	240	10	16	16	NUM
dpc-4969	240	11	.	.	PUNCT
dpc-4969	241	1	hertl	hertl	PROPN
dpc-4969	241	2	m	m	PROPN
dpc-4969	241	3	,	,	PUNCT
dpc-4969	241	4	jedlickova	jedlickova	PROPN
dpc-4969	241	5	h	h	PROPN
dpc-4969	241	6	,	,	PUNCT
dpc-4969	241	7	karpati	karpati	PROPN
dpc-4969	241	8	s	s	PART
dpc-4969	241	9	,	,	PUNCT
dpc-4969	241	10	et	et	PROPN
dpc-4969	241	11	al	al	PROPN
dpc-4969	241	12	.	.	PROPN
dpc-4969	241	13	pemphigus	pemphigus	PROPN
dpc-4969	241	14	.	.	PUNCT
dpc-4969	242	1	s2	s2	PROPN
dpc-4969	242	2	guideline	guideline	NOUN
dpc-4969	242	3	for	for	ADP
dpc-4969	242	4	diagnosis	diagnosis	NOUN
dpc-4969	242	5	and	and	CCONJ
dpc-4969	242	6	treatment	treatment	NOUN
dpc-4969	242	7	--	--	PUNCT
dpc-4969	242	8	guided	guide	VERB
dpc-4969	242	9	by	by	ADP
dpc-4969	242	10	the	the	DET
dpc-4969	242	11	european	european	ADJ
dpc-4969	242	12	8	8	NUM
dpc-4969	242	13	original	original	ADJ
dpc-4969	242	14	article	article	NOUN
dpc-4969	242	15	|	|	ADV
dpc-4969	242	16	dermatol	dermatol	ADJ
dpc-4969	242	17	pract	pract	NOUN
dpc-4969	242	18	concept	concept	NOUN
dpc-4969	242	19	.	.	PUNCT
dpc-4969	243	1	2025;15(1):4969	2025;15(1):4969	NUM
dpc-4969	243	2	dermatology	dermatology	NOUN
dpc-4969	243	3	forum	forum	NOUN
dpc-4969	243	4	(	(	PUNCT
dpc-4969	243	5	edf	edf	PROPN
dpc-4969	243	6	)	)	PUNCT
dpc-4969	243	7	in	in	ADP
dpc-4969	243	8	cooperation	cooperation	NOUN
dpc-4969	243	9	with	with	ADP
dpc-4969	243	10	the	the	DET
dpc-4969	243	11	european	european	PROPN
dpc-4969	243	12	academy	academy	PROPN
dpc-4969	243	13	of	of	ADP
dpc-4969	243	14	dermatology	dermatology	NOUN
dpc-4969	243	15	and	and	CCONJ
dpc-4969	243	16	venereology	venereology	NOUN
dpc-4969	243	17	(	(	PUNCT
dpc-4969	243	18	eadv	eadv	ADJ
dpc-4969	243	19	)	)	PUNCT
dpc-4969	243	20	.	.	PUNCT
dpc-4969	243	21	  	  	SPACE
dpc-4969	244	1	j	j	PROPN
dpc-4969	244	2	eur	eur	PROPN
dpc-4969	244	3	acad	acad	PROPN
dpc-4969	244	4	dermatol	dermatol	NOUN
dpc-4969	244	5	venereol	venereol	NOUN
dpc-4969	244	6	.	.	PUNCT
dpc-4969	244	7	  	  	SPACE
dpc-4969	245	1	2015;29(3):405	2015;29(3):405	NUM
dpc-4969	245	2	-	-	SYM
dpc-4969	245	3	14	14	NUM
dpc-4969	245	4	.	.	PUNCT
dpc-4969	246	1	doi	doi	NOUN
dpc-4969	246	2	:	:	PUNCT
dpc-4969	246	3	10.1111/	10.1111/	NUM
dpc-4969	246	4	jdv.12772	jdv.12772	NUM
dpc-4969	246	5	pmid:25338479	pmid:25338479	VERB
dpc-4969	246	6	17	17	NUM
dpc-4969	246	7	.	.	PUNCT
dpc-4969	247	1	park	park	PROPN
dpc-4969	247	2	sh	sh	PROPN
dpc-4969	247	3	,	,	PUNCT
dpc-4969	247	4	lee	lee	PROPN
dpc-4969	247	5	sh	sh	PROPN
dpc-4969	247	6	,	,	PUNCT
dpc-4969	247	7	kim	kim	PROPN
dpc-4969	247	8	jh	jh	PROPN
dpc-4969	247	9	,	,	PUNCT
dpc-4969	247	10	kim	kim	PROPN
dpc-4969	247	11	sc	sc	PROPN
dpc-4969	247	12	.	.	PUNCT
dpc-4969	247	13	circulating	circulate	VERB
dpc-4969	247	14	eosinophil	eosinophil	ADJ
dpc-4969	247	15	and	and	CCONJ
dpc-4969	247	16	neutrophil	neutrophil	ADJ
dpc-4969	247	17	counts	count	NOUN
dpc-4969	247	18	correlate	correlate	VERB
dpc-4969	247	19	with	with	ADP
dpc-4969	247	20	disease	disease	NOUN
dpc-4969	247	21	severity	severity	NOUN
dpc-4969	247	22	in	in	ADP
dpc-4969	247	23	bullous	bullous	ADJ
dpc-4969	247	24	pemphigoid	pemphigoid	NOUN
dpc-4969	247	25	.	.	PUNCT
dpc-4969	247	26	  	  	SPACE
dpc-4969	248	1	ann	ann	PROPN
dpc-4969	248	2	dermatol	dermatol	NOUN
dpc-4969	248	3	.	.	PUNCT
dpc-4969	248	4	  	  	SPACE
dpc-4969	248	5	2018;30(5):544	2018;30(5):544	NUM
dpc-4969	248	6	-	-	SYM
dpc-4969	248	7	9	9	NUM
dpc-4969	248	8	.	.	PUNCT
dpc-4969	248	9	doi	doi	NOUN
dpc-4969	248	10	:	:	PUNCT
dpc-4969	248	11	10.5021	10.5021	NUM
dpc-4969	248	12	/ad.2018.30.5.544	/ad.2018.30.5.544	PUNCT
dpc-4969	248	13	pmid:33911476	pmid:33911476	PROPN
dpc-4969	248	14	18	18	NUM
dpc-4969	248	15	.	.	PUNCT
dpc-4969	249	1	ameglio	ameglio	PROPN
dpc-4969	249	2	f	f	PROPN
dpc-4969	249	3	,	,	PUNCT
dpc-4969	249	4	d’auria	d’auria	PROPN
dpc-4969	249	5	l	l	NOUN
dpc-4969	249	6	,	,	PUNCT
dpc-4969	249	7	cordiali	cordiali	ADJ
dpc-4969	249	8	-	-	PROPN
dpc-4969	249	9	fei	fei	PROPN
dpc-4969	249	10	p	p	NOUN
dpc-4969	249	11	,	,	PUNCT
dpc-4969	249	12	et	et	PROPN
dpc-4969	249	13	al	al	PROPN
dpc-4969	249	14	.	.	PUNCT
dpc-4969	250	1	anti	anti	ADJ
dpc-4969	250	2	-	-	ADJ
dpc-4969	250	3	intercellular	intercellular	ADJ
dpc-4969	250	4	substance	substance	NOUN
dpc-4969	250	5	antibody	antibody	NOUN
dpc-4969	250	6	log	log	NOUN
dpc-4969	250	7	titres	titre	NOUN
dpc-4969	250	8	are	be	AUX
dpc-4969	250	9	correlated	correlate	VERB
dpc-4969	250	10	with	with	ADP
dpc-4969	250	11	serum	serum	NOUN
dpc-4969	250	12	concentrations	concentration	NOUN
dpc-4969	250	13	of	of	ADP
dpc-4969	250	14	interleukin-6	interleukin-6	NUM
dpc-4969	250	15	,	,	PUNCT
dpc-4969	250	16	interleukin-15	interleukin-15	PROPN
dpc-4969	250	17	and	and	CCONJ
dpc-4969	250	18	tumor	tumor	NOUN
dpc-4969	250	19	necrosis	necrosis	NOUN
dpc-4969	250	20	factor	factor	NOUN
dpc-4969	250	21	-	-	PUNCT
dpc-4969	250	22	alpha	alpha	NOUN
dpc-4969	250	23	in	in	ADP
dpc-4969	250	24	patients	patient	NOUN
dpc-4969	250	25	with	with	ADP
dpc-4969	250	26	pemphigus	pemphigus	NOUN
dpc-4969	250	27	vulgaris	vulgaris	NOUN
dpc-4969	250	28	relationships	relationship	NOUN
dpc-4969	250	29	with	with	ADP
dpc-4969	250	30	peripheral	peripheral	ADJ
dpc-4969	250	31	blood	blood	NOUN
dpc-4969	250	32	neutrophil	neutrophil	ADJ
dpc-4969	250	33	counts	count	NOUN
dpc-4969	250	34	,	,	PUNCT
dpc-4969	250	35	disease	disease	NOUN
dpc-4969	250	36	severity	severity	NOUN
dpc-4969	250	37	and	and	CCONJ
dpc-4969	250	38	duration	duration	NOUN
dpc-4969	250	39	and	and	CCONJ
dpc-4969	250	40	patients	patient	NOUN
dpc-4969	250	41	’	'	PUNCT
dpc-4969	250	42	age	age	NOUN
dpc-4969	250	43	.	.	PUNCT
dpc-4969	251	1	j	j	PROPN
dpc-4969	251	2	biol	biol	PROPN
dpc-4969	251	3	regul	regul	PROPN
dpc-4969	251	4	homeost	homeost	ADJ
dpc-4969	251	5	agents	agent	NOUN
dpc-4969	251	6	.	.	PUNCT
dpc-4969	252	1	1999;13(4	1999;13(4	NUM
dpc-4969	252	2	):	):	PUNCT
dpc-4969	252	3	220	220	NUM
dpc-4969	252	4	-	-	SYM
dpc-4969	252	5	4	4	NUM
dpc-4969	252	6	.	.	NOUN
dpc-4969	252	7	pmid:10703946	pmid:10703946	PROPN
dpc-4969	252	8	19	19	NUM
dpc-4969	252	9	.	.	PUNCT
dpc-4969	252	10	yuan	yuan	PROPN
dpc-4969	252	11	h	h	PROPN
dpc-4969	252	12	,	,	PUNCT
dpc-4969	252	13	zhou	zhou	PROPN
dpc-4969	252	14	s	s	PROPN
dpc-4969	252	15	,	,	PUNCT
dpc-4969	252	16	liu	liu	PROPN
dpc-4969	252	17	z	z	PROPN
dpc-4969	252	18	,	,	PUNCT
dpc-4969	252	19	et	et	PROPN
dpc-4969	252	20	al	al	PROPN
dpc-4969	252	21	.	.	PUNCT
dpc-4969	253	1	pivotal	pivotal	ADJ
dpc-4969	253	2	role	role	NOUN
dpc-4969	253	3	of	of	ADP
dpc-4969	253	4	lesional	lesional	ADJ
dpc-4969	253	5	and	and	CCONJ
dpc-4969	253	6	perilesional	perilesional	PROPN
dpc-4969	253	7	t	t	PROPN
dpc-4969	253	8	/	/	SYM
dpc-4969	253	9	b	b	PROPN
dpc-4969	253	10	lymphocytes	lymphocyte	NOUN
dpc-4969	253	11	in	in	ADP
dpc-4969	253	12	pemphigus	pemphigus	NOUN
dpc-4969	253	13	pathogenesis	pathogenesis	NOUN
dpc-4969	253	14	.	.	PUNCT
dpc-4969	254	1	j	j	PROPN
dpc-4969	254	2	invest	invest	VERB
dpc-4969	254	3	dermatol	dermatol	NOUN
dpc-4969	254	4	.	.	PUNCT
dpc-4969	255	1	2017;137(11):2362	2017;137(11):2362	PROPN
dpc-4969	255	2	-	-	PUNCT
dpc-4969	255	3	70	70	NUM
dpc-4969	255	4	.	.	PUNCT
dpc-4969	256	1	doi	doi	NOUN
dpc-4969	256	2	:	:	PUNCT
dpc-4969	256	3	10.1016	10.1016	NUM
dpc-4969	256	4	/	/	SYM
dpc-4969	256	5	j.jid.2017.05.032	j.jid.2017.05.032	ADV
dpc-4969	256	6	pmid:28647348	pmid:28647348	VERB
dpc-4969	256	7	20	20	NUM
dpc-4969	256	8	.	.	PUNCT
dpc-4969	257	1	el	el	PROPN
dpc-4969	257	2	-	-	PUNCT
dpc-4969	257	3	naby	naby	PROPN
dpc-4969	257	4	sm	sm	PROPN
dpc-4969	257	5	,	,	PUNCT
dpc-4969	257	6	amin	amin	PROPN
dpc-4969	257	7	mm	mm	PROPN
dpc-4969	257	8	,	,	PUNCT
dpc-4969	257	9	ali	ali	PROPN
dpc-4969	257	10	ma	ma	PROPN
dpc-4969	257	11	,	,	PUNCT
dpc-4969	257	12	gaballah	gaballah	PROPN
dpc-4969	257	13	ma	ma	PROPN
dpc-4969	257	14	.	.	PROPN
dpc-4969	257	15	evaluation	evaluation	NOUN
dpc-4969	257	16	of	of	ADP
dpc-4969	257	17	the	the	DET
dpc-4969	257	18	relation	relation	NOUN
dpc-4969	257	19	between	between	ADP
dpc-4969	257	20	t	t	PROPN
dpc-4969	257	21	-	-	PUNCT
dpc-4969	257	22	lymphocytes	lymphocyte	NOUN
dpc-4969	257	23	(	(	PUNCT
dpc-4969	257	24	cd4	cd4	PROPN
dpc-4969	257	25	+	+	PROPN
dpc-4969	257	26	ve	ve	VERB
dpc-4969	257	27	and	and	CCONJ
dpc-4969	257	28	cd8	cd8	PROPN
dpc-4969	257	29	+	+	PROPN
dpc-4969	257	30	ve	ve	PROPN
dpc-4969	257	31	)	)	PUNCT
dpc-4969	257	32	and	and	CCONJ
dpc-4969	257	33	pemphigus	pemphigus	NOUN
dpc-4969	257	34	vulgaris	vulgaris	NOUN
dpc-4969	257	35	pathogenesis	pathogenesis	NOUN
dpc-4969	257	36	and	and	CCONJ
dpc-4969	257	37	severity	severity	NOUN
dpc-4969	257	38	.	.	PUNCT
dpc-4969	258	1	indian	indian	PROPN
dpc-4969	258	2	j	j	PROPN
dpc-4969	258	3	dermatopathol	dermatopathol	NOUN
dpc-4969	258	4	diagn	diagn	ADJ
dpc-4969	258	5	dermatol	dermatol	NOUN
dpc-4969	258	6	2019;6:30	2019;6:30	NOUN
dpc-4969	258	7	-	-	SYM
dpc-4969	258	8	5	5	NUM
dpc-4969	258	9	doi	doi	NOUN
dpc-4969	258	10	:	:	PUNCT
dpc-4969	258	11	10.4103	10.4103	NUM
dpc-4969	258	12	/	/	SYM
dpc-4969	258	13	ijdpdd	ijdpdd	NOUN
dpc-4969	258	14	.	.	PUNCT
dpc-4969	259	1	ijdpdd_70_18	ijdpdd_70_18	PROPN
dpc-4969	260	1	21	21	NUM
dpc-4969	260	2	.	.	PUNCT
dpc-4969	261	1	kowalska	kowalska	NOUN
dpc-4969	261	2	-	-	PUNCT
dpc-4969	261	3	kępczyńska	kępczyńska	PROPN
dpc-4969	261	4	a	a	X
dpc-4969	261	5	,	,	PUNCT
dpc-4969	261	6	mleczko	mleczko	NOUN
dpc-4969	261	7	m	m	PROPN
dpc-4969	261	8	,	,	PUNCT
dpc-4969	261	9	domerecka	domerecka	PROPN
dpc-4969	261	10	w	w	PROPN
dpc-4969	261	11	,	,	PUNCT
dpc-4969	261	12	krasowska	krasowska	PROPN
dpc-4969	261	13	d	d	PROPN
dpc-4969	261	14	,	,	PUNCT
dpc-4969	261	15	donica	donica	PROPN
dpc-4969	261	16	h.	h.	PROPN
dpc-4969	261	17	assessment	assessment	NOUN
dpc-4969	261	18	of	of	ADP
dpc-4969	261	19	immune	immune	ADJ
dpc-4969	261	20	cell	cell	NOUN
dpc-4969	261	21	activation	activation	NOUN
dpc-4969	261	22	in	in	ADP
dpc-4969	261	23	pemphigus	pemphigus	PROPN
dpc-4969	261	24	.	.	PUNCT
dpc-4969	262	1	cells	cell	NOUN
dpc-4969	262	2	.	.	PUNCT
dpc-4969	263	1	2022;11(12):1912	2022;11(12):1912	NUM
dpc-4969	263	2	.	.	X
dpc-4969	263	3	doi	doi	NOUN
dpc-4969	263	4	:	:	PUNCT
dpc-4969	263	5	10.3390	10.3390	NUM
dpc-4969	263	6	/	/	SYM
dpc-4969	263	7	cells11121912	cells11121912	PROPN
dpc-4969	263	8	pmid:35741041	pmid:35741041	NOUN
dpc-4969	263	9	22	22	NUM
dpc-4969	263	10	.	.	PUNCT
dpc-4969	264	1	yang	yang	PROPN
dpc-4969	264	2	z	z	PROPN
dpc-4969	264	3	,	,	PUNCT
dpc-4969	264	4	zhang	zhang	PROPN
dpc-4969	264	5	z	z	PROPN
dpc-4969	264	6	,	,	PUNCT
dpc-4969	264	7	lin	lin	PROPN
dpc-4969	264	8	f	f	PROPN
dpc-4969	264	9	,	,	PUNCT
dpc-4969	264	10	et	et	PROPN
dpc-4969	264	11	al	al	PROPN
dpc-4969	264	12	.	.	PUNCT
dpc-4969	264	13	comparisons	comparison	NOUN
dpc-4969	264	14	of	of	ADP
dpc-4969	264	15	neutrophil-	neutrophil-	NOUN
dpc-4969	264	16	,	,	PUNCT
dpc-4969	264	17	monocyte-	monocyte-	X
dpc-4969	264	18	,	,	PUNCT
dpc-4969	264	19	eosinophil-	eosinophil-	NOUN
dpc-4969	264	20	,	,	PUNCT
dpc-4969	264	21	and	and	CCONJ
dpc-4969	264	22	basophillymphocyte	basophillymphocyte	NOUN
dpc-4969	264	23	ratios	ratio	NOUN
dpc-4969	264	24	among	among	ADP
dpc-4969	264	25	various	various	ADJ
dpc-4969	264	26	systemic	systemic	ADJ
dpc-4969	264	27	autoimmune	autoimmune	ADJ
dpc-4969	264	28	rheumatic	rheumatic	ADJ
dpc-4969	264	29	diseases	disease	NOUN
dpc-4969	264	30	.	.	PUNCT
dpc-4969	265	1	apmis	apmis	PROPN
dpc-4969	265	2	.	.	PUNCT
dpc-4969	266	1	2017	2017	NUM
dpc-4969	266	2	;	;	PUNCT
dpc-4969	266	3	125(10):863	125(10):863	NUM
dpc-4969	266	4	-	-	SYM
dpc-4969	266	5	71	71	NUM
dpc-4969	266	6	.	.	PUNCT
dpc-4969	267	1	doi	doi	NOUN
dpc-4969	267	2	:	:	PUNCT
dpc-4969	267	3	10.1111	10.1111	NUM
dpc-4969	267	4	/	/	SYM
dpc-4969	267	5	apm.12722	apm.12722	NOUN
dpc-4969	267	6	pmid:28766758	pmid:28766758	NOUN
dpc-4969	267	7	23	23	NUM
dpc-4969	267	8	.	.	PUNCT
dpc-4969	268	1	al	al	PROPN
dpc-4969	268	2	-	-	PUNCT
dpc-4969	268	3	osami	osami	PROPN
dpc-4969	268	4	mh	mh	PROPN
dpc-4969	268	5	,	,	PUNCT
dpc-4969	268	6	awadh	awadh	VERB
dpc-4969	268	7	ni	ni	PROPN
dpc-4969	268	8	,	,	PUNCT
dpc-4969	268	9	khalid	khalid	PROPN
dpc-4969	268	10	kb	kb	PROPN
dpc-4969	268	11	,	,	PUNCT
dpc-4969	268	12	awadh	awadh	PROPN
dpc-4969	268	13	ai	ai	VERB
dpc-4969	268	14	.	.	PROPN
dpc-4969	269	1	neutrophil/	neutrophil/	NUM
dpc-4969	269	2	lymphocyte	lymphocyte	ADJ
dpc-4969	269	3	and	and	CCONJ
dpc-4969	269	4	platelet	platelet	ADJ
dpc-4969	269	5	/	/	SYM
dpc-4969	269	6	lymphocyte	lymphocyte	ADJ
dpc-4969	269	7	ratios	ratio	NOUN
dpc-4969	269	8	as	as	ADP
dpc-4969	269	9	potential	potential	ADJ
dpc-4969	269	10	markers	marker	NOUN
dpc-4969	269	11	of	of	ADP
dpc-4969	269	12	disease	disease	NOUN
dpc-4969	269	13	activity	activity	NOUN
dpc-4969	269	14	in	in	ADP
dpc-4969	269	15	patients	patient	NOUN
dpc-4969	269	16	with	with	ADP
dpc-4969	269	17	ankylosing	ankylose	VERB
dpc-4969	269	18	spondylitis	spondylitis	NOUN
dpc-4969	269	19	:	:	PUNCT
dpc-4969	269	20	a	a	DET
dpc-4969	269	21	case	case	NOUN
dpc-4969	269	22	-	-	PUNCT
dpc-4969	269	23	control	control	NOUN
dpc-4969	269	24	study	study	NOUN
dpc-4969	269	25	.	.	PUNCT
dpc-4969	270	1	adv	adv	PROPN
dpc-4969	270	2	rheumatol	rheumatol	NOUN
dpc-4969	270	3	.	.	PUNCT
dpc-4969	271	1	2020;60(1):13	2020;60(1):13	X
dpc-4969	271	2	.	.	PUNCT
dpc-4969	272	1	doi	doi	NOUN
dpc-4969	272	2	:	:	PUNCT
dpc-4969	272	3	10.1186	10.1186	NUM
dpc-4969	272	4	/	/	SYM
dpc-4969	272	5	s42358	s42358	PROPN
dpc-4969	272	6	-	-	PUNCT
dpc-4969	272	7	020	020	NUM
dpc-4969	272	8	-	-	PUNCT
dpc-4969	272	9	0113	0113	NUM
dpc-4969	272	10	-	-	SYM
dpc-4969	272	11	5	5	NUM
dpc-4969	272	12	pmid:32000859	pmid:32000859	NOUN
dpc-4969	272	13	24	24	NUM
dpc-4969	272	14	.	.	PUNCT
dpc-4969	273	1	mercan	mercan	PROPN
dpc-4969	273	2	r	r	NOUN
dpc-4969	273	3	,	,	PUNCT
dpc-4969	273	4	bitik	bitik	NOUN
dpc-4969	273	5	b	b	NOUN
dpc-4969	273	6	,	,	PUNCT
dpc-4969	273	7	tufan	tufan	NOUN
dpc-4969	273	8	a	a	X
dpc-4969	273	9	,	,	PUNCT
dpc-4969	273	10	et	et	PROPN
dpc-4969	273	11	al	al	PROPN
dpc-4969	273	12	.	.	PUNCT
dpc-4969	274	1	the	the	DET
dpc-4969	274	2	association	association	NOUN
dpc-4969	274	3	between	between	ADP
dpc-4969	274	4	neutrophil	neutrophil	ADJ
dpc-4969	274	5	/	/	SYM
dpc-4969	274	6	lymphocyte	lymphocyte	ADJ
dpc-4969	274	7	ratio	ratio	NOUN
dpc-4969	274	8	and	and	CCONJ
dpc-4969	274	9	disease	disease	NOUN
dpc-4969	274	10	activity	activity	NOUN
dpc-4969	274	11	in	in	ADP
dpc-4969	274	12	rheumatoid	rheumatoid	NOUN
dpc-4969	274	13	arthritis	arthritis	NOUN
dpc-4969	274	14	and	and	CCONJ
dpc-4969	274	15	ankylosing	ankylose	VERB
dpc-4969	274	16	spondylitis	spondylitis	NOUN
dpc-4969	274	17	.	.	PUNCT
dpc-4969	275	1	j	j	PROPN
dpc-4969	275	2	clin	clin	PROPN
dpc-4969	275	3	lab	lab	PROPN
dpc-4969	275	4	anal	anal	PROPN
dpc-4969	275	5	.	.	PUNCT
dpc-4969	276	1	2016;30(5):597	2016;30(5):597	NUM
dpc-4969	276	2	-	-	SYM
dpc-4969	276	3	601	601	NUM
dpc-4969	276	4	.	.	PUNCT
dpc-4969	277	1	doi	doi	NOUN
dpc-4969	277	2	:	:	PUNCT
dpc-4969	277	3	10.1002	10.1002	NUM
dpc-4969	277	4	/	/	SYM
dpc-4969	277	5	jcla.21908	jcla.21908	PROPN
dpc-4969	277	6	pmid:26666737	pmid:26666737	VERB
dpc-4969	277	7	25	25	NUM
dpc-4969	277	8	.	.	PUNCT
dpc-4969	278	1	langley	langley	PROPN
dpc-4969	278	2	bo	bo	PROPN
dpc-4969	278	3	,	,	PUNCT
dpc-4969	278	4	guedry	guedry	PROPN
dpc-4969	278	5	se	se	PROPN
dpc-4969	278	6	,	,	PUNCT
dpc-4969	278	7	goldenberg	goldenberg	PROPN
dpc-4969	278	8	jz	jz	PROPN
dpc-4969	278	9	,	,	PUNCT
dpc-4969	278	10	hanes	hanes	PROPN
dpc-4969	278	11	da	da	PROPN
dpc-4969	278	12	,	,	PUNCT
dpc-4969	278	13	beardsley	beardsley	PROPN
dpc-4969	278	14	ja	ja	PROPN
dpc-4969	278	15	,	,	PUNCT
dpc-4969	278	16	ryan	ryan	PROPN
dpc-4969	278	17	jj	jj	PROPN
dpc-4969	278	18	.	.	PROPN
dpc-4969	278	19	inflammatory	inflammatory	ADJ
dpc-4969	278	20	bowel	bowel	NOUN
dpc-4969	278	21	disease	disease	NOUN
dpc-4969	278	22	and	and	CCONJ
dpc-4969	278	23	neutrophil	neutrophil	ADJ
dpc-4969	278	24	lymphocyte	lymphocyte	ADJ
dpc-4969	278	25	ratio	ratio	NOUN
dpc-4969	278	26	:	:	PUNCT
dpc-4969	278	27	a	a	DET
dpc-4969	278	28	systematic	systematic	ADJ
dpc-4969	278	29	scoping	scoping	NOUN
dpc-4969	278	30	review	review	NOUN
dpc-4969	278	31	.	.	PUNCT
dpc-4969	279	1	j	j	PROPN
dpc-4969	279	2	clin	clin	PROPN
dpc-4969	279	3	med	med	PROPN
dpc-4969	279	4	.	.	PUNCT
dpc-4969	280	1	2021;10(18):4219	2021;10(18):4219	X
dpc-4969	280	2	.	.	PUNCT
dpc-4969	280	3	doi	doi	NOUN
dpc-4969	280	4	:	:	PUNCT
dpc-4969	280	5	10.3390	10.3390	NUM
dpc-4969	280	6	/	/	SYM
dpc-4969	280	7	jcm10184219	jcm10184219	NOUN
dpc-4969	280	8	pmid:34575330	pmid:34575330	NOUN
dpc-4969	280	9	26	26	NUM
dpc-4969	280	10	.	.	PUNCT
dpc-4969	281	1	najjar	najjar	PROPN
dpc-4969	281	2	m	m	PROPN
dpc-4969	281	3	,	,	PUNCT
dpc-4969	281	4	agrawal	agrawal	PROPN
dpc-4969	281	5	s	s	PROPN
dpc-4969	281	6	,	,	PUNCT
dpc-4969	281	7	emond	emond	PROPN
dpc-4969	281	8	jc	jc	PROPN
dpc-4969	281	9	,	,	PUNCT
dpc-4969	282	1	halazun	halazun	PROPN
dpc-4969	282	2	kj	kj	PROPN
dpc-4969	282	3	.	.	PUNCT
dpc-4969	283	1	pretreatment	pretreatment	NOUN
dpc-4969	283	2	neutrophil	neutrophil	ADJ
dpc-4969	283	3	-	-	PUNCT
dpc-4969	283	4	lymphocyte	lymphocyte	NOUN
dpc-4969	283	5	ratio	ratio	NOUN
dpc-4969	283	6	:	:	PUNCT
dpc-4969	283	7	useful	useful	ADJ
dpc-4969	283	8	prognostic	prognostic	ADJ
dpc-4969	283	9	biomarker	biomarker	NOUN
dpc-4969	283	10	in	in	ADP
dpc-4969	283	11	hepatocellular	hepatocellular	ADJ
dpc-4969	283	12	carcinoma	carcinoma	NOUN
dpc-4969	283	13	.	.	PUNCT
dpc-4969	284	1	j	j	PROPN
dpc-4969	284	2	hepatocell	hepatocell	PROPN
dpc-4969	284	3	carcinoma	carcinoma	NOUN
dpc-4969	284	4	.	.	PUNCT
dpc-4969	285	1	2018;5:17	2018;5:17	VERB
dpc-4969	285	2	-	-	PUNCT
dpc-4969	285	3	28	28	NUM
dpc-4969	285	4	.	.	PUNCT
dpc-4969	286	1	doi	doi	NOUN
dpc-4969	286	2	:	:	PUNCT
dpc-4969	286	3	10.2147	10.2147	NUM
dpc-4969	286	4	/	/	SYM
dpc-4969	286	5	jhc.s86792	jhc.s86792	NOUN
dpc-4969	286	6	pmid:29404284	pmid:29404284	ADP
dpc-4969	286	7	27	27	NUM
dpc-4969	286	8	.	.	PUNCT
dpc-4969	287	1	tang	tang	PROPN
dpc-4969	287	2	h	h	PROPN
dpc-4969	287	3	,	,	PUNCT
dpc-4969	287	4	lu	lu	PROPN
dpc-4969	287	5	w	w	PROPN
dpc-4969	287	6	,	,	PUNCT
dpc-4969	287	7	li	li	PROPN
dpc-4969	287	8	b	b	PROPN
dpc-4969	287	9	,	,	PUNCT
dpc-4969	287	10	li	li	PROPN
dpc-4969	287	11	c	c	PROPN
dpc-4969	287	12	,	,	PUNCT
dpc-4969	287	13	xu	xu	PROPN
dpc-4969	287	14	y	y	PROPN
dpc-4969	287	15	,	,	PUNCT
dpc-4969	287	16	dong	dong	PROPN
dpc-4969	287	17	j.	j.	PROPN
dpc-4969	287	18	prognostic	prognostic	PROPN
dpc-4969	287	19	significance	significance	NOUN
dpc-4969	287	20	of	of	ADP
dpc-4969	287	21	neutrophil	neutrophil	ADJ
dpc-4969	287	22	-	-	PUNCT
dpc-4969	287	23	to	to	ADP
dpc-4969	287	24	-	-	PUNCT
dpc-4969	287	25	lymphocyte	lymphocyte	ADJ
dpc-4969	287	26	ratio	ratio	NOUN
dpc-4969	287	27	in	in	ADP
dpc-4969	287	28	biliary	biliary	ADJ
dpc-4969	287	29	tract	tract	ADJ
dpc-4969	287	30	cancers	cancer	NOUN
dpc-4969	287	31	:	:	PUNCT
dpc-4969	287	32	a	a	DET
dpc-4969	287	33	systematic	systematic	ADJ
dpc-4969	287	34	review	review	NOUN
dpc-4969	287	35	and	and	CCONJ
dpc-4969	287	36	meta	meta	ADJ
dpc-4969	287	37	-	-	PUNCT
dpc-4969	287	38	analysis	analysis	NOUN
dpc-4969	287	39	.	.	PUNCT
dpc-4969	288	1	oncotarget	oncotarget	NOUN
dpc-4969	288	2	.	.	PUNCT
dpc-4969	289	1	2017;8(22):36857	2017;8(22):36857	NUM
dpc-4969	289	2	-	-	SYM
dpc-4969	289	3	68	68	NUM
dpc-4969	289	4	.	.	PUNCT
dpc-4969	290	1	28	28	NUM
dpc-4969	290	2	.	.	PUNCT
dpc-4969	291	1	marazziti	marazziti	PROPN
dpc-4969	291	2	d	d	PROPN
dpc-4969	291	3	,	,	PUNCT
dpc-4969	291	4	torrigiani	torrigiani	PROPN
dpc-4969	291	5	s	s	PROPN
dpc-4969	291	6	,	,	PUNCT
dpc-4969	291	7	carbone	carbone	PROPN
dpc-4969	291	8	mg	mg	PROPN
dpc-4969	291	9	,	,	PUNCT
dpc-4969	291	10	et	et	PROPN
dpc-4969	291	11	al	al	PROPN
dpc-4969	291	12	.	.	PROPN
dpc-4969	292	1	neutrophil/	neutrophil/	NUM
dpc-4969	292	2	lymphocyte	lymphocyte	ADJ
dpc-4969	292	3	,	,	PUNCT
dpc-4969	292	4	platelet	platelet	NOUN
dpc-4969	292	5	/	/	SYM
dpc-4969	292	6	lymphocyte	lymphocyte	ADJ
dpc-4969	292	7	,	,	PUNCT
dpc-4969	292	8	and	and	CCONJ
dpc-4969	292	9	monocyte	monocyte	ADJ
dpc-4969	292	10	/	/	SYM
dpc-4969	292	11	lymphocyte	lymphocyte	ADJ
dpc-4969	292	12	ratios	ratio	NOUN
dpc-4969	292	13	in	in	ADP
dpc-4969	292	14	mood	mood	NOUN
dpc-4969	292	15	disorders	disorder	NOUN
dpc-4969	292	16	.	.	PUNCT
dpc-4969	293	1	curr	curr	PROPN
dpc-4969	293	2	med	med	PROPN
dpc-4969	293	3	chem	chem	NOUN
dpc-4969	293	4	.	.	PUNCT
dpc-4969	294	1	2022;29(36):5758	2022;29(36):5758	NUM
dpc-4969	294	2	-	-	SYM
dpc-4969	294	3	81	81	NUM
dpc-4969	295	1	.	.	PUNCT
dpc-4969	295	2	doi	doi	NOUN
dpc-4969	295	3	:	:	PUNCT
dpc-4969	295	4	10.2174/0929867328666210922160116	10.2174/0929867328666210922160116	NUM
dpc-4969	295	5	pmid:34551689	pmid:34551689	NOUN
dpc-4969	295	6	29	29	NUM
dpc-4969	295	7	.	.	PUNCT
dpc-4969	296	1	şereflican	şereflican	PROPN
dpc-4969	296	2	b	b	PROPN
dpc-4969	296	3	,	,	PUNCT
dpc-4969	296	4	parlak	parlak	NOUN
dpc-4969	296	5	ah	ah	INTJ
dpc-4969	296	6	.	.	PUNCT
dpc-4969	297	1	clinical	clinical	ADJ
dpc-4969	297	2	,	,	PUNCT
dpc-4969	297	3	demographical	demographical	ADJ
dpc-4969	297	4	features	feature	NOUN
dpc-4969	297	5	,	,	PUNCT
dpc-4969	297	6	accompanying	accompany	VERB
dpc-4969	297	7	diseases	disease	NOUN
dpc-4969	297	8	and	and	CCONJ
dpc-4969	297	9	neutrophil	neutrophil	NOUN
dpc-4969	297	10	to	to	ADP
dpc-4969	297	11	lymphocyte	lymphocyte	ADJ
dpc-4969	297	12	ratio	ratio	NOUN
dpc-4969	297	13	platelet	platelet	NOUN
dpc-4969	297	14	to	to	ADP
dpc-4969	297	15	lymphocyte	lymphocyte	ADJ
dpc-4969	297	16	ratio	ratio	NOUN
dpc-4969	297	17	in	in	ADP
dpc-4969	297	18	patients	patient	NOUN
dpc-4969	297	19	with	with	ADP
dpc-4969	297	20	bullous	bullous	ADJ
dpc-4969	297	21	pemphigoid	pemphigoid	NOUN
dpc-4969	297	22	in	in	ADP
dpc-4969	297	23	bolu	bolu	PROPN
dpc-4969	297	24	.	.	PUNCT
dpc-4969	298	1	cumhur	cumhur	PROPN
dpc-4969	298	2	med	med	PROPN
dpc-4969	298	3	j.	j.	PROPN
dpc-4969	298	4	2019	2019	NUM
dpc-4969	298	5	;	;	PUNCT
dpc-4969	298	6	41(1):88	41(1):88	PROPN
dpc-4969	298	7	-	-	PUNCT
dpc-4969	298	8	93	93	NUM
dpc-4969	298	9	.	.	PUNCT
dpc-4969	299	1	https://doi	https://doi	PROPN
dpc-4969	299	2	.	.	PUNCT
dpc-4969	299	3	org/10.7197/223.vi.475189	org/10.7197/223.vi.475189	PROPN
dpc-4969	299	4	30	30	NUM
dpc-4969	299	5	.	.	PUNCT
dpc-4969	300	1	wang	wang	PROPN
dpc-4969	300	2	wm	wm	PROPN
dpc-4969	300	3	,	,	PUNCT
dpc-4969	300	4	jin	jin	PROPN
dpc-4969	300	5	hz	hz	PROPN
dpc-4969	300	6	.	.	PROPN
dpc-4969	300	7	role	role	NOUN
dpc-4969	300	8	of	of	ADP
dpc-4969	300	9	neutrophils	neutrophil	NOUN
dpc-4969	300	10	in	in	ADP
dpc-4969	300	11	psoriasis	psoriasis	NOUN
dpc-4969	300	12	.	.	PUNCT
dpc-4969	301	1	j	j	PROPN
dpc-4969	301	2	immunol	immunol	NOUN
dpc-4969	301	3	res	re	NOUN
dpc-4969	301	4	.	.	PUNCT
dpc-4969	302	1	2020;2020:3709749	2020;2020:3709749	NUM
dpc-4969	302	2	.	.	PUNCT
dpc-4969	303	1	doi	doi	NOUN
dpc-4969	303	2	:	:	PUNCT
dpc-4969	303	3	10.1155/2020/3709749	10.1155/2020/3709749	NUM
dpc-4969	303	4	pmid:32587871	pmid:32587871	NOUN
dpc-4969	303	5	31	31	NUM
dpc-4969	303	6	.	.	PUNCT
dpc-4969	304	1	ataş	ataş	ADJ
dpc-4969	304	2	h	h	NOUN
dpc-4969	304	3	,	,	PUNCT
dpc-4969	304	4	cemil	cemil	PROPN
dpc-4969	304	5	bç	bç	NOUN
dpc-4969	304	6	,	,	PUNCT
dpc-4969	304	7	kurmuş	kurmuş	PROPN
dpc-4969	304	8	gi	gi	PROPN
dpc-4969	304	9	,	,	PUNCT
dpc-4969	304	10	gönül	gönül	NOUN
dpc-4969	304	11	m.	m.	NOUN
dpc-4969	304	12	assessment	assessment	NOUN
dpc-4969	304	13	of	of	ADP
dpc-4969	304	14	systemic	systemic	ADJ
dpc-4969	304	15	inflammation	inflammation	NOUN
dpc-4969	304	16	with	with	ADP
dpc-4969	304	17	neutrophil	neutrophil	ADJ
dpc-4969	304	18	-	-	PUNCT
dpc-4969	304	19	lymphocyte	lymphocyte	ADJ
dpc-4969	304	20	ratio	ratio	NOUN
dpc-4969	304	21	in	in	ADP
dpc-4969	304	22	lichen	lichen	NOUN
dpc-4969	304	23	planus	planus	NOUN
dpc-4969	304	24	.	.	PUNCT
dpc-4969	305	1	postepy	postepy	ADJ
dpc-4969	305	2	dermatol	dermatol	NOUN
dpc-4969	305	3	alergol	alergol	NOUN
dpc-4969	305	4	.	.	PUNCT
dpc-4969	306	1	2016;33(3):188	2016;33(3):188	NUM
dpc-4969	306	2	-	-	SYM
dpc-4969	306	3	92	92	NUM
dpc-4969	306	4	.	.	PUNCT
dpc-4969	307	1	doi	doi	NOUN
dpc-4969	307	2	:	:	PUNCT
dpc-4969	307	3	10.5114/	10.5114/	NUM
dpc-4969	307	4	pdia.2016.56930	pdia.2016.56930	NOUN
dpc-4969	307	5	pmid:27512353	pmid:27512353	NOUN
dpc-4969	307	6	32	32	NUM
dpc-4969	307	7	.	.	PUNCT
dpc-4969	308	1	uçmak	uçmak	PROPN
dpc-4969	308	2	d	d	NOUN
dpc-4969	308	3	,	,	PUNCT
dpc-4969	308	4	akkurt	akkurt	PROPN
dpc-4969	308	5	m	m	PROPN
dpc-4969	308	6	,	,	PUNCT
dpc-4969	308	7	uçak	uçak	PROPN
dpc-4969	309	1	h	h	PROPN
dpc-4969	309	2	,	,	PUNCT
dpc-4969	309	3	arica	arica	PROPN
dpc-4969	309	4	m	m	PROPN
dpc-4969	309	5	nötrofil/	nötrofil/	NUM
dpc-4969	309	6	lenfosit	lenfosit	PROPN
dpc-4969	309	7	oranının	oranının	PROPN
dpc-4969	309	8	pemfigus	pemfigus	PROPN
dpc-4969	309	9	vulgaris	vulgaris	PROPN
dpc-4969	309	10	ile	ile	PROPN
dpc-4969	309	11	i̇lişkisi	i̇lişkisi	PROPN
dpc-4969	309	12	.	.	PUNCT
dpc-4969	310	1	konuralp	konuralp	PROPN
dpc-4969	310	2	tip	tip	PROPN
dpc-4969	310	3	dergi̇si̇.	dergi̇si̇.	VERB
dpc-4969	310	4	2015;7(2):88	2015;7(2):88	NUM
dpc-4969	310	5	-	-	SYM
dpc-4969	310	6	92	92	NUM
dpc-4969	310	7	.	.	PUNCT
dpc-4969	311	1	33	33	NUM
dpc-4969	311	2	.	.	PUNCT
dpc-4969	312	1	lyakhovitsky	lyakhovitsky	PROPN
dpc-4969	312	2	a	a	PROPN
dpc-4969	312	3	,	,	PUNCT
dpc-4969	312	4	dascalu	dascalu	NOUN
dpc-4969	312	5	j	j	PROPN
dpc-4969	312	6	,	,	PUNCT
dpc-4969	312	7	drousiotis	drousiotis	PROPN
dpc-4969	312	8	t	t	PROPN
dpc-4969	312	9	,	,	PUNCT
dpc-4969	312	10	barzilai	barzilai	PROPN
dpc-4969	312	11	a	a	PROPN
dpc-4969	312	12	,	,	PUNCT
dpc-4969	312	13	baum	baum	PROPN
dpc-4969	312	14	s.	s.	PROPN
dpc-4969	312	15	hematological	hematological	ADJ
dpc-4969	312	16	inflammatory	inflammatory	ADJ
dpc-4969	312	17	markers	marker	NOUN
dpc-4969	312	18	in	in	ADP
dpc-4969	312	19	patients	patient	NOUN
dpc-4969	312	20	with	with	ADP
dpc-4969	312	21	pemphigus	pemphigus	NOUN
dpc-4969	312	22	vulgaris	vulgaris	NOUN
dpc-4969	312	23	.	.	PUNCT
dpc-4969	313	1	dermatology	dermatology	NOUN
dpc-4969	313	2	.	.	PUNCT
dpc-4969	314	1	2021;237(6):912	2021;237(6):912	NUM
dpc-4969	314	2	-	-	SYM
dpc-4969	314	3	20	20	NUM
dpc-4969	314	4	.	.	PUNCT
dpc-4969	315	1	doi	doi	NOUN
dpc-4969	315	2	:	:	PUNCT
dpc-4969	315	3	10.1159	10.1159	NUM
dpc-4969	315	4	/000512916	/000512916	SYM
dpc-4969	315	5	pmid:33472194	pmid:33472194	PROPN
dpc-4969	316	1	34	34	NUM
dpc-4969	316	2	.	.	PUNCT
dpc-4969	316	3	gasparyan	gasparyan	PROPN
dpc-4969	316	4	ay	ay	PROPN
dpc-4969	316	5	,	,	PUNCT
dpc-4969	316	6	ayvazyan	ayvazyan	PROPN
dpc-4969	316	7	l	l	PROPN
dpc-4969	316	8	,	,	PUNCT
dpc-4969	316	9	mukanova	mukanova	PROPN
dpc-4969	316	10	u	u	PROPN
dpc-4969	316	11	,	,	PUNCT
dpc-4969	316	12	yessirkepov	yessirkepov	PROPN
dpc-4969	316	13	m	m	PROPN
dpc-4969	316	14	,	,	PUNCT
dpc-4969	316	15	kitas	kitas	PROPN
dpc-4969	316	16	gd	gd	PROPN
dpc-4969	316	17	.	.	PUNCT
dpc-4969	317	1	the	the	DET
dpc-4969	317	2	platelet	platelet	NOUN
dpc-4969	317	3	-	-	PUNCT
dpc-4969	317	4	to	to	ADP
dpc-4969	317	5	-	-	PUNCT
dpc-4969	317	6	lymphocyte	lymphocyte	NOUN
dpc-4969	317	7	ratio	ratio	NOUN
dpc-4969	317	8	as	as	ADP
dpc-4969	317	9	an	an	DET
dpc-4969	317	10	inflammatory	inflammatory	ADJ
dpc-4969	317	11	marker	marker	NOUN
dpc-4969	317	12	in	in	ADP
dpc-4969	317	13	rheumatic	rheumatic	ADJ
dpc-4969	317	14	diseases	disease	NOUN
dpc-4969	317	15	.	.	PUNCT
dpc-4969	318	1	ann	ann	PROPN
dpc-4969	318	2	lab	lab	PROPN
dpc-4969	318	3	med	med	PROPN
dpc-4969	318	4	.	.	PUNCT
dpc-4969	319	1	2019;39(4	2019;39(4	NUM
dpc-4969	319	2	):	):	PUNCT
dpc-4969	319	3	345	345	NUM
dpc-4969	319	4	-	-	SYM
dpc-4969	319	5	57	57	NUM
dpc-4969	319	6	.	.	PUNCT
dpc-4969	320	1	doi	doi	NOUN
dpc-4969	320	2	:	:	PUNCT
dpc-4969	320	3	10.3343	10.3343	NUM
dpc-4969	320	4	/	/	SYM
dpc-4969	320	5	alm.2019.39.4.345	alm.2019.39.4.345	PROPN
dpc-4969	320	6	pmid:30809980	pmid:30809980	VERB
dpc-4969	320	7	35	35	NUM
dpc-4969	320	8	.	.	PUNCT
dpc-4969	321	1	hayta	hayta	PROPN
dpc-4969	321	2	s	s	PROPN
dpc-4969	321	3	,	,	PUNCT
dpc-4969	321	4	güner	güner	NOUN
dpc-4969	321	5	r	r	NOUN
dpc-4969	321	6	,	,	PUNCT
dpc-4969	321	7	akyol	akyol	ADJ
dpc-4969	321	8	m.	m.	NOUN
dpc-4969	321	9	blood	blood	NOUN
dpc-4969	321	10	mean	mean	VERB
dpc-4969	321	11	platelet	platelet	NOUN
dpc-4969	321	12	volume	volume	NOUN
dpc-4969	321	13	may	may	AUX
dpc-4969	321	14	be	be	AUX
dpc-4969	321	15	predictive	predictive	ADJ
dpc-4969	321	16	for	for	ADP
dpc-4969	321	17	disease	disease	NOUN
dpc-4969	321	18	course	course	NOUN
dpc-4969	321	19	in	in	ADP
dpc-4969	321	20	the	the	DET
dpc-4969	321	21	cases	case	NOUN
dpc-4969	321	22	with	with	ADP
dpc-4969	321	23	pemphigus	pemphigus	NOUN
dpc-4969	321	24	vulgaris	vulgaris	NOUN
dpc-4969	321	25	.	.	PUNCT
dpc-4969	322	1	biomed	biome	VERB
dpc-4969	322	2	res	re	NOUN
dpc-4969	322	3	(	(	PUNCT
dpc-4969	322	4	aligarh	aligarh	PROPN
dpc-4969	322	5	)	)	PUNCT
dpc-4969	322	6	.	.	PUNCT
dpc-4969	323	1	2017;9(28):4223–7.36	2017;9(28):4223–7.36	VERB
dpc-4969	323	2	)	)	PUNCT
dpc-4969	324	1	36	36	NUM
dpc-4969	324	2	.	.	PUNCT
dpc-4969	325	1	rajwa	rajwa	PROPN
dpc-4969	325	2	p	p	NOUN
dpc-4969	325	3	,	,	PUNCT
dpc-4969	325	4	życzkowski	życzkowski	PROPN
dpc-4969	325	5	m	m	PROPN
dpc-4969	325	6	,	,	PUNCT
dpc-4969	325	7	paradysz	paradysz	ADP
dpc-4969	325	8	a	a	DET
dpc-4969	325	9	,	,	PUNCT
dpc-4969	325	10	bujak	bujak	PROPN
dpc-4969	325	11	k	k	PROPN
dpc-4969	325	12	,	,	PUNCT
dpc-4969	325	13	bryniarski	bryniarski	ADJ
dpc-4969	325	14	p.	p.	NOUN
dpc-4969	325	15	evaluation	evaluation	NOUN
dpc-4969	325	16	of	of	ADP
dpc-4969	325	17	the	the	DET
dpc-4969	325	18	prognostic	prognostic	ADJ
dpc-4969	325	19	value	value	NOUN
dpc-4969	325	20	of	of	ADP
dpc-4969	325	21	lmr	lmr	PROPN
dpc-4969	325	22	,	,	PUNCT
dpc-4969	325	23	plr	plr	NOUN
dpc-4969	325	24	,	,	PUNCT
dpc-4969	325	25	nlr	nlr	PROPN
dpc-4969	325	26	,	,	PUNCT
dpc-4969	325	27	and	and	CCONJ
dpc-4969	325	28	dnlr	dnlr	NOUN
dpc-4969	325	29	in	in	ADP
dpc-4969	325	30	urothelial	urothelial	ADJ
dpc-4969	325	31	bladder	bladder	NOUN
dpc-4969	325	32	cancer	cancer	NOUN
dpc-4969	325	33	patients	patient	NOUN
dpc-4969	325	34	treated	treat	VERB
dpc-4969	325	35	with	with	ADP
dpc-4969	325	36	radical	radical	ADJ
dpc-4969	325	37	cystectomy	cystectomy	NOUN
dpc-4969	325	38	.	.	PUNCT
dpc-4969	326	1	eur	eur	PROPN
dpc-4969	326	2	rev	rev	PROPN
dpc-4969	326	3	med	med	PROPN
dpc-4969	326	4	pharmacol	pharmacol	PROPN
dpc-4969	326	5	sci	sci	PROPN
dpc-4969	326	6	.	.	PUNCT
dpc-4969	327	1	2018;22(10):3027	2018;22(10):3027	PROPN
dpc-4969	327	2	-	-	SYM
dpc-4969	327	3	37	37	NUM
dpc-4969	327	4	.	.	PUNCT
dpc-4969	328	1	doi	doi	NOUN
dpc-4969	328	2	:	:	PUNCT
dpc-4969	328	3	10.26355	10.26355	NUM
dpc-4969	328	4	/	/	SYM
dpc-4969	328	5	eurrev_201805_15060	eurrev_201805_15060	NOUN
dpc-4969	328	6	pmid:29863247	pmid:29863247	NOUN
dpc-4969	328	7	37	37	NUM
dpc-4969	328	8	.	.	PUNCT
dpc-4969	329	1	ma	ma	PROPN
dpc-4969	329	2	y	y	PROPN
dpc-4969	329	3	,	,	PUNCT
dpc-4969	329	4	zhang	zhang	PROPN
dpc-4969	329	5	j	j	PROPN
dpc-4969	329	6	,	,	PUNCT
dpc-4969	329	7	chen	chen	PROPN
dpc-4969	329	8	x.	x.	PROPN
dpc-4969	329	9	lymphocyte	lymphocyte	PROPN
dpc-4969	329	10	-	-	PUNCT
dpc-4969	329	11	to	to	ADP
dpc-4969	329	12	-	-	PUNCT
dpc-4969	329	13	monocyte	monocyte	NOUN
dpc-4969	329	14	ratio	ratio	NOUN
dpc-4969	329	15	is	be	AUX
dpc-4969	329	16	associated	associate	VERB
dpc-4969	329	17	with	with	ADP
dpc-4969	329	18	the	the	DET
dpc-4969	329	19	poor	poor	ADJ
dpc-4969	329	20	prognosis	prognosis	NOUN
dpc-4969	329	21	of	of	ADP
dpc-4969	329	22	breast	breast	NOUN
dpc-4969	329	23	cancer	cancer	NOUN
dpc-4969	329	24	patients	patient	NOUN
dpc-4969	329	25	receiving	receive	VERB
dpc-4969	329	26	neoadjuvant	neoadjuvant	ADJ
dpc-4969	329	27	chemotherapy	chemotherapy	NOUN
dpc-4969	329	28	.	.	PUNCT
dpc-4969	330	1	cancer	cancer	NOUN
dpc-4969	330	2	manag	manag	PROPN
dpc-4969	330	3	res	re	NOUN
dpc-4969	330	4	.	.	PUNCT
dpc-4969	331	1	2021;13	2021;13	NUM
dpc-4969	331	2	:	:	PUNCT
dpc-4969	331	3	1571	1571	NUM
dpc-4969	331	4	-	-	SYM
dpc-4969	331	5	80	80	NUM
dpc-4969	331	6	.	.	PUNCT
dpc-4969	332	1	doi	doi	NOUN
dpc-4969	332	2	:	:	PUNCT
dpc-4969	332	3	10.2147	10.2147	NUM
dpc-4969	332	4	/	/	SYM
dpc-4969	332	5	cmar.s292048	cmar.s292048	NOUN
dpc-4969	332	6	pmid:33623436	pmid:33623436	PROPN
dpc-4969	332	7	38	38	NUM
dpc-4969	332	8	.	.	PUNCT
dpc-4969	333	1	liu	liu	PROPN
dpc-4969	333	2	x	x	PROPN
dpc-4969	333	3	,	,	PUNCT
dpc-4969	333	4	li	li	PROPN
dpc-4969	333	5	m	m	PROPN
dpc-4969	333	6	,	,	PUNCT
dpc-4969	333	7	zhao	zhao	PROPN
dpc-4969	333	8	f	f	PROPN
dpc-4969	333	9	,	,	PUNCT
dpc-4969	333	10	et	et	PROPN
dpc-4969	333	11	al	al	PROPN
dpc-4969	333	12	.	.	PUNCT
dpc-4969	334	1	the	the	DET
dpc-4969	334	2	lymphocyte	lymphocyte	NOUN
dpc-4969	334	3	-	-	PUNCT
dpc-4969	334	4	monocyte	monocyte	NOUN
dpc-4969	334	5	ratio	ratio	NOUN
dpc-4969	334	6	predicts	predict	VERB
dpc-4969	334	7	tumor	tumor	NOUN
dpc-4969	334	8	response	response	NOUN
dpc-4969	334	9	and	and	CCONJ
dpc-4969	334	10	survival	survival	NOUN
dpc-4969	334	11	in	in	ADP
dpc-4969	334	12	patients	patient	NOUN
dpc-4969	334	13	with	with	ADP
dpc-4969	334	14	locally	locally	ADV
dpc-4969	334	15	advanced	advanced	ADJ
dpc-4969	334	16	esophageal	esophageal	ADJ
dpc-4969	334	17	cancer	cancer	NOUN
dpc-4969	334	18	who	who	PRON
dpc-4969	334	19	received	receive	VERB
dpc-4969	334	20	definitive	definitive	ADJ
dpc-4969	334	21	chemoradiotherapy	chemoradiotherapy	NOUN
dpc-4969	334	22	.	.	PUNCT
dpc-4969	335	1	onco	onco	PROPN
dpc-4969	335	2	targets	target	VERB
dpc-4969	335	3	ther	ther	ADV
dpc-4969	335	4	.	.	PUNCT
dpc-4969	336	1	2017;10:871	2017;10:871	X
dpc-4969	336	2	-	-	SYM
dpc-4969	336	3	7	7	NUM
dpc-4969	336	4	.	.	PUNCT
dpc-4969	336	5	doi	doi	NOUN
dpc-4969	336	6	:	:	PUNCT
dpc-4969	336	7	10.2147	10.2147	NUM
dpc-4969	336	8	/ott.s124915	/ott.s124915	SYM
dpc-4969	336	9	pmid:28243122	pmid:28243122	NOUN
dpc-4969	336	10	39	39	NUM
dpc-4969	336	11	.	.	PUNCT
dpc-4969	337	1	sirin	sirin	PROPN
dpc-4969	337	2	mc	mc	PROPN
dpc-4969	337	3	,	,	PUNCT
dpc-4969	337	4	korkmaz	korkmaz	PROPN
dpc-4969	337	5	s	s	PROPN
dpc-4969	337	6	,	,	PUNCT
dpc-4969	337	7	erturan	erturan	VERB
dpc-4969	337	8	i	i	PRON
dpc-4969	337	9	,	,	PUNCT
dpc-4969	337	10	et	et	PROPN
dpc-4969	337	11	al	al	PROPN
dpc-4969	337	12	.	.	PUNCT
dpc-4969	337	13	evaluation	evaluation	NOUN
dpc-4969	337	14	of	of	ADP
dpc-4969	337	15	monocyte	monocyte	NOUN
dpc-4969	337	16	to	to	ADP
dpc-4969	337	17	hdl	hdl	PROPN
dpc-4969	337	18	cholesterol	cholesterol	PROPN
dpc-4969	337	19	ratio	ratio	NOUN
dpc-4969	337	20	and	and	CCONJ
dpc-4969	337	21	other	other	ADJ
dpc-4969	337	22	inflammatory	inflammatory	ADJ
dpc-4969	337	23	markers	marker	NOUN
dpc-4969	337	24	in	in	ADP
dpc-4969	337	25	patients	patient	NOUN
dpc-4969	337	26	with	with	ADP
dpc-4969	337	27	psoriasis	psoriasis	NOUN
dpc-4969	337	28	.	.	PUNCT
dpc-4969	338	1	an	an	DET
dpc-4969	338	2	bras	bras	NOUN
dpc-4969	338	3	dermatol	dermatol	NOUN
dpc-4969	338	4	.	.	PUNCT
dpc-4969	339	1	2020;95(5):575	2020;95(5):575	NUM
dpc-4969	339	2	-	-	PUNCT
dpc-4969	339	3	82	82	NUM
dpc-4969	339	4	.	.	PUNCT
dpc-4969	340	1	doi	doi	NOUN
dpc-4969	340	2	:	:	PUNCT
dpc-4969	340	3	10.1016	10.1016	NUM
dpc-4969	340	4	/	/	SYM
dpc-4969	340	5	j.abd.2020.02.008	j.abd.2020.02.008	NOUN
dpc-4969	340	6	pmid:32711928	pmid:32711928	NOUN
dpc-4969	340	7	40	40	NUM
dpc-4969	340	8	.	.	PUNCT
dpc-4969	341	1	svecova	svecova	PROPN
dpc-4969	341	2	d.	d.	PROPN
dpc-4969	341	3	ivig	ivig	PROPN
dpc-4969	341	4	therapy	therapy	NOUN
dpc-4969	341	5	in	in	ADP
dpc-4969	341	6	pemphigus	pemphigus	NOUN
dpc-4969	341	7	vulgaris	vulgaris	NOUN
dpc-4969	341	8	has	have	VERB
dpc-4969	341	9	corticosteroid	corticosteroid	NOUN
dpc-4969	341	10	-	-	PUNCT
dpc-4969	341	11	sparing	spare	VERB
dpc-4969	341	12	and	and	CCONJ
dpc-4969	341	13	immunomodulatory	immunomodulatory	ADJ
dpc-4969	341	14	effects	effect	NOUN
dpc-4969	341	15	.	.	PUNCT
dpc-4969	342	1	australas	australas	PROPN
dpc-4969	342	2	j	j	PROPN
dpc-4969	342	3	dermatol	dermatol	NOUN
dpc-4969	342	4	.	.	PUNCT
dpc-4969	343	1	2016;57(2):141	2016;57(2):141	NUM
dpc-4969	343	2	-	-	SYM
dpc-4969	343	3	4	4	NUM
dpc-4969	343	4	.	.	PUNCT
dpc-4969	344	1	doi:10.1111	doi:10.1111	NOUN
dpc-4969	344	2	/	/	SYM
dpc-4969	344	3	ajd.12422	ajd.12422	NUM
dpc-4969	344	4	pmid	pmid	NOUN
dpc-4969	344	5	:	:	PUNCT
dpc-4969	344	6	26581165	26581165	NUM